FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.16  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (3594 ms)

Resources - All Kinds, Realm US, Authority Hl7

16251 resources

Type:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

By Version

Start Prev Rows 5400 - 5600 Next
PackageVersionIdentityName/TitleStatusDate
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/healthcareservice-new-patient-network VhDir_sp_healthcareservice_new_patient_networkdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/healthcareservice-new-patient VhDir_sp_healthcareservice_new_patientdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/healthcareservice-organization NatlDir_sp_healthcareservice_organizationactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/healthcareservice-service-category NatlDir_sp_healthcareservice_categoryactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/healthcareservice-service-type NatlDir_sp_healthcareservice_typeactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/healthcareservice-specialty NatlDir_sp_healthcareservice_specialtyactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/healthcareservice-via-intermediary VhDir_sp_healthcareservice_via_intermediarydraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/insuranceplan-administered-by NatlDir_sp_insuranceplan_administered_byactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/insuranceplan-coverage-area NatlDir_sp_insuranceplan_coverage_areaactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-coverage-benefit-type VhDir_sp_insuranceplan_coverage_benefit_typedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-coverage-limit-value VhDir_sp_insuranceplan_coverage_limit_valuedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-coverage-network VhDir_sp_insuranceplan_coverage_networkdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-coverage-type VhDir_sp_insuranceplan_coverage_typedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-endpoint VhDir_sp_insuranceplan_endpointdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-general-cost-groupsize VhDir_sp_insuranceplan_general_cost_groupsizedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-general-cost-type VhDir_sp_insuranceplan_general_cost_typedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-general-cost-value VhDir_sp_insuranceplan_general_cost_valuedraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/insuranceplan-identifier NatlDir_sp_insuranceplan_identifieractive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/insuranceplan-name NatlDir_sp_insuranceplan_nameactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-network VhDir_sp_insuranceplan_networkdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/insuranceplan-owned-by NatlDir_sp_insuranceplan_owned_byactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-plan-coverage-area VhDir_sp_insuranceplan_plan_coverage_areadraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-plan-identifier VhDir_sp_insuranceplan_plan_identifierdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-plan-network VhDir_sp_insuranceplan_plan_networkdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/insuranceplan-plan-type NatlDir_sp_insuranceplan_plan_typeactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-specific-cost-benefit-type VhDir_sp_insuranceplan_specific_cost_benefit_typedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-specific-cost-category VhDir_sp_insuranceplan_specific_cost_categorydraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-specific-cost-cost-type VhDir_sp_insuranceplan_specific_cost_cost_typedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-specific-cost-value VhDir_sp_insuranceplan_specific_cost_valuedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/insuranceplan-status VhDir_sp_insuranceplan_statusdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/insuranceplan-type NatlDir_sp_insuranceplan_typeactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/location-accessibility VhDir_sp_location_accessibilitydraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/location-address-city NatlDir_sp_location_address_cityactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/location-address-postalcode NatlDir_sp_location_address_postalcodeactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/location-address-state NatlDir_sp_location_address_stateactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/location-address NatlDir_sp_location_addressactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/location-contains VhDir_sp_location_containsdraft2018-08
hl7.fhir.us.directory-attestationR4SearchParameter/location-endpoint NatlDir_sp_location_endpointdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/location-identifier-assigner VhDir_sp_location_identifier_assignerdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/location-identifier VhDir_sp_location_identifierdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/location-new-patient-network VhDir_sp_location_new_patient_networkdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/location-new-patient VhDir_sp_location_new_patientdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/location-organization NatlDir_sp_location_organizationactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/location-partof NatlDir_sp_location_partofactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/location-status VhDir_sp_location_statusdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/location-type NatlDir_sp_location_typeactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/location-via-intermediary VhDir_sp_location_via_intermediarydraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-address-city VhDir_sp_organization_address_citydraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-address-country VhDir_sp_organization_address_countrydraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-address-postalcode VhDir_sp_organization_address_postalcodedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-address-state VhDir_sp_organization_address_statedraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organization-address NatlDir_sp_organization_addressactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organization-coverage-area NatlDir_sp_network_coverage_areaactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organization-endpoint NatlDir_sp_organization_endpointactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-identifier-assigner VhDir_sp_organization_identifier_assignerdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-identifier VhDir_sp_organization_identifierdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organization-name NatlDir_sp_organization_nameactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organization-partof NatlDir_sp_organization_partofactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-qualification-code VhDir_sp_organization_qualification_codedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-qualification-issuer VhDir_sp_organization_qualification_issuerdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-qualification-status VhDir_sp_organization_qualification_statusdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-qualification-wherevalid-code VhDir_sp_organization_qualification_wherevalid_codedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-qualification-wherevalid-location VhDir_sp_organization_qualification_wherevalid_locationdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organization-type NatlDir_sp_organization_typeactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organization-via-intermediary VhDir_sp_organization_via_intermediarydraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organizationaffiliation-endpoint NatlDir_sp_organizationaffiliation_endpointdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organizationaffiliation-identifier-assigner VhDir_sp_organizationaffiliation_identifier_assignerdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organizationaffiliation-identifier VhDir_sp_organizationaffiliation_identifierdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organizationaffiliation-location NatlDir_sp_organizationaffiliation_locationactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organizationaffiliation-network NatlDir_sp_organizationaffiliation_networkactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organizationaffiliation-participating-organization NatlDir_sp_organizationaffiliation_participating_organizationactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organizationaffiliation-primary-organization NatlDir_sp_organizationaffiliation_primary_organizationactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organizationaffiliation-role NatlDir_sp_organizationaffiliation_roleactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organizationaffiliation-service NatlDir_sp_organizationaffiliation_serviceactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/organizationaffiliation-specialty NatlDir_sp_organizationaffiliation_specialtyactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/organizationaffiliation-via-intermediary VhDir_sp_organizationaffiliation_via_intermediarydraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitioner-address-city NatDir_practitioner_address_citydraft2022-12
hl7.fhir.us.directory-attestationR4SearchParameter/practitioner-address-postalcode VhDir_sp_practitioner_address_postalcodedraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitioner-address-state NatDir_practitioner_address_statedraft2022-12
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-endpoint VhDir_sp_practitioner_endpointdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitioner-family-name NatlDir_sp_practitioner_family_nameactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitioner-given-name NatlDir_sp_practitioner_given_nameactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-identifier-assigner VhDir_sp_practitioner_identifier_assignerdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-identifier VhDir_sp_practitioner_identifierdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-name-text NatDir_sp_practitioner_name_textdraft2022-07
hl7.fhir.us.directory-attestationR4SearchParameter/practitioner-name NatlDir_sp_practitioner_nameactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-phonetic VhDir_sp_practitioner_phoneticdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-qualification-code VhDir_sp_practitioner_qualification_codedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-qualification-issuer VhDir_sp_practitioner_qualification_issuerdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-qualification-period VhDir_sp_practitioner_qualification_perioddraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-qualification-status VhDir_sp_practitioner_qualification_statusdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-qualification-wherevalid-code VhDir_sp_practitioner_qualification_wherevalid_codedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-qualification-wherevalid-location VhDir_sp_practitioner_qualification_wherevalid_locationdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitioner-via-intermediary VhDir_sp_practitioner_via_intermediarydraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-endpoint NatlDir_sp_practitionerrole_endpointactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-identifier-assigner VhDir_sp_practitionerrole_identifier_assignerdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-identifier VhDir_sp_practitionerrole_identifierdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-location NatlDir_sp_practitionerrole_locationactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-network NatlDir_sp_practitionerrole_networkactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-new-patient-network VhDir_sp_practitionerrole_new_patient_networkdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-new-patient VhDir_sp_practitionerrole_new_patientdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-organization NatlDir_sp_practitionerrole_organizationactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-period NatlDir_sp_practitionerrole_periodactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-practitioner NatlDir_sp_practitionerrole_practitioneractive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-qualification-code VhDir_sp_practitionerrole_qualification_codedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-qualification-issuer VhDir_sp_practitionerrole_qualification_issuerdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-qualification-status VhDir_sp_practitionerrole_qualification_statusdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-qualification-wherevalid-code VhDir_sp_practitionerrole_qualification_wherevalid_codedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-qualification-wherevalid-location VhDir_sp_practitionerrole_qualification_wherevalid_locationdraft2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-role NatlDir_sp_practitionerrole_roleactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-service NatlDir_sp_practitionerrole_serviceactive2018-05
hl7.fhir.us.directory-attestationR4SearchParameter/practitionerrole-specialty NatlDir_sp_practitionerrole_specialtyactive2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/practitionerrole-via-intermediary VhDir_sp_practitionerrole_via_intermediarydraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-attestation-method VhDir_sp_verificationresult_attestation_methoddraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-attestation-onbehalfof VhDir_sp_verificationresult_attestation_onbehalfofdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-attestation-who VhDir_sp_verificationresult_attestation_whodraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-primarysource-date VhDir_sp_verificationresult_primarysource_datedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-primarysource-type VhDir_sp_verificationresult_primarysource_typedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-primarysource-who VhDir_sp_verificationresult_primarysource_whodraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-status-date VhDir_sp_verificationresult_status_datedraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-target VhDir_sp_verificationresult_targetdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-validation-status VhDir_sp_verificationresult_validation_statusdraft2018-05
hl7.fhir.us.directory-attestationR4http://hl7.org/fhir/uv/vhdir/SearchParameter/verificationresult-validator-organization VhDir_sp_verificationresult_validator_organizationdraft2018-05
hl7.fhir.us.directory-attestationR4ValueSet/ConsentVS NatDir Consent Scopes Valuesetactive2022-12
hl7.fhir.us.directory-attestationR4ValueSet/OrganizationAffiliationRoleVS OrganizationAffiliation Rolesactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/AcceptingPatientsCS Accepting Patients Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/AccessibilityCS Accessibility Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/ConsentCS NatDir Consent Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/ConsentScopeCS NatDir ConsentScopeCodes Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/DeliveryMethodCS Delivery Methods Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/EndpointConnectionTypeCS Endpoint Connection Types Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/EndpointPayloadTypeCS Endpoint Payload Types Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/EndpointTypeCS Endpoint Typeactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/HealthcareServiceCategoryCS Healthcare Service Category Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/IgTypeCS IG Type Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/InsurancePlanTypeCS Insurance Plan Type Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/InsuranceProductTypeCS Insurance Product Type Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/LanguageProficiencyCS Language Proficiency Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/OrgTypeCS Organization Type Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/OrganizationAffiliationRoleCS Organization Affiliation Roleactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/ProviderRoleCS Provider Role Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/QualificationStatusCS Qualification Status Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/TrustFrameworkTypeCS Trust FrameworkType Code Systemactive2022-12
hl7.fhir.us.directory-attestationR4CodeSystem/VirtualModalitiesCS Virtual Modalities Code Systemactive2022-12
hl7.fhir.us.cdc-opioid-cpgR4ImplementationGuide/hl7.fhir.us.cdc-opioid-cpg Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioidsactive2024-11
hl7.fhir.us.cdc-opioid-cpgR4StructureDefinition/AcutePainManagementMedicationRequest Acute Pain Management MedicationRequest Profileactive2025-04
hl7.fhir.us.cdc-opioid-cpgR4StructureDefinition/AmphetamineUrineDrugScreeningResultObservation Amphetamine Urine Drug Screening Result Observationactive2025-04
hl7.fhir.us.cdc-opioid-cpgR4StructureDefinition/ChronicPainManagementMedicationRequest Chronic Pain Management MedicationRequest Profileactive2025-04
hl7.fhir.us.cdc-opioid-cpgR4StructureDefinition/MMEMedicationRequest MME MedicationRequest Profileactive2025-04
hl7.fhir.us.cdc-opioid-cpgR4StructureDefinition/OpioidMedication Opioid Medication Profileactive2025-04
hl7.fhir.us.cdc-opioid-cpgR4StructureDefinition/OpioidMedicationRequest Opioid MedicationRequest Profileactive2025-04
hl7.fhir.us.cdc-opioid-cpgR4StructureDefinition/SubacutePainManagementMedicationRequest Subacute Pain Management MedicationRequest Profileactive2025-04
hl7.fhir.us.cdc-opioid-cpgR4StructureDefinition/UrineDrugScreeningResultObservation Urine Drug Screening Result Observationactive2025-04
hl7.fhir.us.cdc-opioid-cpgR4http://fhir.org/guides/cdc/opioid-cds/ValueSet/amphetamine-drug-urine-screening-tests Amphetamine-class drugs and metabolite urine testsactive2023-05
hl7.fhir.us.identity-matchingR4ImplementationGuide/hl7.fhir.us.identity-matching Interoperable Digital Identity and Patient Matchingactive2024-07
hl7.fhir.us.identity-matchingR4StructureDefinition/FASTIDUDAPPerson FAST Identity UDAP Personactive2025-06
hl7.fhir.us.identity-matchingR4StructureDefinition/IDI-Patient-L0 IDI Patient L0active2025-06
hl7.fhir.us.identity-matchingR4StructureDefinition/IDI-Patient-L1 IDI Patient L1active2025-06
hl7.fhir.us.identity-matchingR4StructureDefinition/IDI-Patient-L2 IDI Patient L2active2025-06
hl7.fhir.us.identity-matchingR4StructureDefinition/IDI-Patient IDI Patientactive2025-06
hl7.fhir.us.identity-matchingR4StructureDefinition/idi-match-bundle IDI Match Bundleactive2025-06
hl7.fhir.us.identity-matchingR4StructureDefinition/idi-match-input-parameters IDI Match Input Parametersactive2025-06
hl7.fhir.us.identity-matchingR4StructureDefinition/idi-match-output-parameters IDI Match Output Parametersactive2025-06
hl7.fhir.us.identity-matchingR4OperationDefinition/IDI-match IDI Match Operationdraft2025-06
hl7.fhir.us.identity-matchingR4ValueSet/Identity-Identifier-vs Identity Identifier Value Setactive2025-06
hl7.fhir.us.identity-matchingR4CodeSystem/Identity-Identifier-cs Identity Identifier Code Systemactive2025-06
hl7.fhir.us.identity-matchingR4NamingSystem/Identity-HL7-Identifier HL7Identifieractive2023-02
hl7.fhir.us.mccR4ImplementationGuide/hl7.fhir.us.mcc MCC eCare Plan Implementation Guidedraft2022-11
hl7.fhir.us.mccR4StructureDefinition/DocRefPACP Document Reference to Patient's Personal Advance Care Plan (Advance Directive)active2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCCareTeam Multiple Chronic Condition Care Plan Care Teamactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCCaregiverConsiderationsObservation Multiple Chronic Condition Care Plan Caregiver Considerations Observationactive2022-09
hl7.fhir.us.mccR4StructureDefinition/MCCChronCondHealthConcern MCC Chronic Condition and Health Concern Profiledraft2020-06
hl7.fhir.us.mccR4StructureDefinition/MCCClinicalImpression Multiple Chronic Condition Care Plan Clinical Impressionactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCClinicalResultObservation Multiple Chronic Condition Care Plan Clinical Test Observationactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCDiagnosticReportAndNote Multiple Chronic Condition Care Plan Diagnostic Report and Noteactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCFamilyHistory Multiple Chronic Condition Care Plan Family Historyactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCGoal Multiple Chronic Condition Care Plan Goalactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCImagingObservation Multiple Chronic Condition Care Plan Clinical Imaging Observationactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCImmunization Multiple Chronic Condition Care Plan Immunizationactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCLaboratoryResultObservation Multiple Chronic Condition Care Plan Laboratory Result Observationdraft2021-08
hl7.fhir.us.mccR4StructureDefinition/MCCMedicationRequest Multiple Chronic Condition Care Plan Medication Requestactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCNutritionOrder Multiple Chronic Condition Care Plan Nutrition Orderactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCObservationSDOHAssessment Multiple Chronic Condition Care Plan Observation SDOH Assessmentactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCPatientCaregiverConditionStatus Multiple Chronic Condition Care Plan Patient/Caregiver Condition Status Observationactive2022-09
hl7.fhir.us.mccR4StructureDefinition/MCCProcedure Multiple Chronic Condition Care Plan Proceduredraft2020-07
hl7.fhir.us.mccR4StructureDefinition/MCCQuestionnaireResponse Multiple Chronic Condition Care Plan Questionnaire Responseactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCServiceRequest Multiple Chronic Condition Care Plan Service Requestactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCSimpleObservation Multiple Chronic Condition Care Plan Simple Observationactive2024-08
hl7.fhir.us.mccR4StructureDefinition/MCCSymptomObservation Multiple Chronic Condition Care Plan Symptom Observationactive2024-08
hl7.fhir.us.mccR4StructureDefinition/changePattern Change Pattern R5 backportactive2024-08
hl7.fhir.us.mccR4StructureDefinition/custodian Custodian R5 backportactive2024-08
hl7.fhir.us.mccR4StructureDefinition/mccCarePlan Multiple Chronic Care Condition Care Planactive2022-04
hl7.fhir.us.mccR4CapabilityStatement/mcc-client MCC Client CapabilityStatementactive2022-05
hl7.fhir.us.mccR4CapabilityStatement/mcc-server MCC Server CapabilityStatementactive2022-05
hl7.fhir.us.nhsn-adeR4ImplementationGuide/hl7.fhir.us.nhsn-ade NHSN Reporting: Adverse Drug Events - Glycemic Controldraft2022-01
hl7.fhir.us.nhsn-adeR4StructureDefinition/Composition-ade-hyperglycemia Composition - ADE Hyperglycemiaactive2022-01
hl7.fhir.us.nhsn-adeR4StructureDefinition/Composition-ade-hypoglycemia Composition - ADE Hypoglycemiaactive2022-01
hl7.fhir.us.nhsn-adeR4StructureDefinition/Condition-diabetes Condition Diabetesactive2022-01
hl7.fhir.us.nhsn-adeR4StructureDefinition/MedicationAdministration-Antidiabetics MedicationAdministration Antidiabetic Drugsactive2022-01
hl7.fhir.us.nhsn-adeR4StructureDefinition/Observation-diagnosis-diabetes-count Observation - Diagnosis Diabetes Countactive2022-01
hl7.fhir.us.nhsn-adeR4StructureDefinition/Observation-diagnosis-ersd-esld-count Observation - Diagnosis ERSD/ESLD Countactive2022-01
hl7.fhir.us.nhsn-adeR4StructureDefinition/Observation-lab-blood-glucose Observation Laboratory Blood Glucoseactive2022-01
hl7.fhir.us.nhsn-adeR4CodeSystem/CodeSystem-ade-codes ADE Code Systemactive2021-12
hl7.fhir.us.hsdsR4ImplementationGuide/hl7.fhir.us.hsds FHIR Human Services Directoryactive2023-10
hl7.fhir.us.hsdsR4StructureDefinition/hsds-HealthcareService HSDHealthcareServiceactive2023-10
hl7.fhir.us.hsdsR4StructureDefinition/hsds-Location HSDLocationactive2023-10
hl7.fhir.us.hsdsR4StructureDefinition/hsds-Organization HSDOrganizationactive2023-10
hl7.fhir.us.hsdsR4StructureDefinition/org-contactinfo Community-Based Organization Contactsactive2023-10
hl7.fhir.us.hsdsR4StructureDefinition/qualification Qualificationactive2023-10
hl7.fhir.us.hsdsR4StructureDefinition/service-contactinfo Community-Based Services Contactsactive2023-10
hl7.fhir.us.hsdsR4CapabilityStatement/HumanServicesDirectory Human Services Directory Capability Statementdraft2023-08
hl7.fhir.us.hsdsR4SearchParameter/healthcareservice-active HSD_sp_healthcareservice_activeactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/healthcareservice-communication HSD_sp_healthcareservice_communicationactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/healthcareservice-location HSD_sp_healthcareservice_locationactive2023-08
hl7.fhir.us.hsdsR4SearchParameter/healthcareservice-name HSD_sp_healthcareservice_nameactive2023-08
hl7.fhir.us.hsdsR4SearchParameter/healthcareservice-organization HSD_sp_healthcareservice_organizationactive2023-08
hl7.fhir.us.hsdsR4SearchParameter/healthcareservice-program HSD_sp_healthcareservice_programactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/healthcareservice-service-category HSD_sp_healthcareservice_categoryactive2023-08
hl7.fhir.us.hsdsR4SearchParameter/healthcareservice-service-type HSD_sp_healthcareservice_typeactive2023-08
hl7.fhir.us.hsdsR4SearchParameter/location-accessibility HSD_sp_location_accessibilityactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/location-address-city HSD_sp_location_address_cityactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/location-address-country HSD_sp_location_address_countryactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/location-address-postalcode HSD_sp_location_address_postalcodeactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/location-address-state HSD_sp_location_address_stateactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/location-address HSD_sp_location_addressactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/location-hoursofoperation HSD_sp_location_hoursofoperationactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/location-name HSD_sp_location_nameactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/location-organization HSD_sp_location_organizationactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/organization-address-city HSD_sp_organization_address_cityactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/organization-address-country HSD_sp_organization_address_countryactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/organization-address-postalcode HSD_sp_organization_address_postalcodeactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/organization-address-state HSD_sp_organization_address_stateactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/organization-address HSD_sp_organization_addressactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/organization-identifier HSD_sp_organization_identifieractive2023-10
hl7.fhir.us.hsdsR4SearchParameter/organization-name HSD_sp_organization_nameactive2023-10
hl7.fhir.us.hsdsR4SearchParameter/organization-type HSD_sp_organization_typeactive2023-10
hl7.fhir.us.hsdsR4ValueSet/HumanServiceCategory Human Service Category VSactive2023-10
hl7.fhir.us.hsdsR4ValueSet/HumanServiceCharacteristic Human Service Characteristic VSactive2023-10
hl7.fhir.us.hsdsR4ValueSet/HumanServiceProgram Human Service Program VSactive2023-10
hl7.fhir.us.hsdsR4ValueSet/HumanServiceType Human Service Type VSactive2023-10
hl7.fhir.us.hsdsR4ValueSet/NonIndividualSpecialties Non-Individual Specialtiesactive2023-10
hl7.fhir.us.hsdsR4CodeSystem/HumanServiceCharacteristicCS Human Service Characteristicactive2023-10
hl7.fhir.us.hsdsR4CodeSystem/HumanServiceProgramCS Human Service Programactive2023-10
fhir.nw-gmsa.nhs.ukR4Questionnaire/GenomicTestOrder draft2025-04
fhir.nw-gmsa.nhs.ukR4ImplementationGuide/fhir.nw-gmsa.nhs.uk North West Genomic Medicine Service Alliancedraft2025-04
fhir.nw-gmsa.nhs.ukR4MessageDefinition/laboratory-order Message Definition - Laboratory Orderdraft2024-10
fhir.nw-gmsa.nhs.ukR4MessageDefinition/unsolicited-observation Message Definition - Unsolicited Observationdraft2024-10
fhir.nw-gmsa.nhs.ukR4StructureDefinition/AccessionNumber Accession Numberdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Binary Binarydraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/CodeableReference CodeableReferencedraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Composition Compositiondraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/CorrelationIdentifier Correlation Identifierdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/DiagnosticReport Diagnostic Reportdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/DocumentReference DocumentReferencedraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Encounter Encounterdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/EnglandPractitionerIdentifier England Practitioner Identifierdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/FillerOrderNumber Filler Order Numberdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/GenomicsPedigreeNumber Genomics Pedigree Numberdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/MedicalRecordNumber Medical Record Numberdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/MessageHeader MessageHeaderdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/NHSNumber NHS Numberdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/NWAttachment Attachmentdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/NWQuestionnaire Questionnairedraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Observation-Panel Observation Paneldraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Observation Observationdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/OperationOutcome OperationOutcomedraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/OrganisationCode Organisation Codedraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/OrganisationSiteCode Organisation Site Codedraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Organization Organizationdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Patient Patientdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/PlacerGroupNumber Placer Group Numberdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/PlacerOrderNumber Placer Order Numberdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Practitioner Practitionerdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/PractitionerRole PractitionerRoledraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/QuestionnaireResponse QuestionnaireResponsedraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/ServiceRequest ServiceRequestdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/Specimen Specimendraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/VisitNumber Visit Numberdraft2025-04
fhir.nw-gmsa.nhs.ukR4StructureDefinition/ext-codeable-reference ExtCodeableReferencedraft2025-04
fhir.nw-gmsa.nhs.ukR4CapabilityStatement/CapabilityStatementRIE CapabilityStatement for NW GMSA Regional Integration Engine for Genomicsdraft2025-01
fhir.nw-gmsa.nhs.ukR4OperationDefinition/ProcessMessage Process Messagedraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/GenomicCancer Genomic Cancer Test Directorydraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/GenomicRareAndInheritedDisease Genomic Rare and Inherited Disease Test Directorydraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/NWIdentifierType NW IdentifierTypedraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/PractitionerIdentifiers Practitioner Identifiersdraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/RequestPriority Request Prioritydraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/YN Yes/Nodraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/YNU Yes/No/Unknowndraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/admission-method Admission Methoddraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/admission-source Admission Sourcedraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/discharge-destination Discharge Destinationdraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/discharge-disposition Discharge Dispositiondraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/document-entry-class DocumentEntry Classdraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/document-entry-mimetype DocumentEntry mimeTypedraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/document-entry-type DocumentEntry Typedraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/ethnicity Ethnicitydraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/facility-type Facility Typedraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/service Servicedraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/specialty Specialtydraft2025-04
fhir.nw-gmsa.nhs.ukR4ValueSet/specimen-type Specimen Typedraft2025-04
fhir.nw-gmsa.nhs.ukR4CodeSystem/ProfessionalLicense UK Professional Licensedraft2025-04
hl7.fhir.us.specialty-rxR4ImplementationGuide/hl7.fhir.us.specialty-rx Specialty Medication Enrollmentactive2023-05
hl7.fhir.us.specialty-rxR4MessageDefinition/specialty-rx-error Specialty Rx Message Definition - Erroractive2020-06
hl7.fhir.us.specialty-rxR4MessageDefinition/specialty-rx-query-response-unsolicited Specialty Rx Message Definition - Query Response - Unsolicitedactive2020-07
hl7.fhir.us.specialty-rxR4MessageDefinition/specialty-rx-query-response Specialty Rx Message Definition - Query Responseactive2020-06
hl7.fhir.us.specialty-rxR4MessageDefinition/specialty-rx-query Specialty Rx Message Definition - Queryactive2020-06
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-bundle-error Specialty Rx Bundle - Error Messageactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-bundle-query-response-unsolicited Specialty Rx Bundle - Query Response - Unsolicited Messageactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-bundle-query-response Specialty Rx Bundle - Query Response Messageactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-bundle-query Specialty Rx Bundle - Query Messageactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-bundle-search-result Specialty Rx Bundle - Search Resultactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-consent-requested Specialty Rx ConsentRequestedactive2021-12
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-consent Specialty Rx Consentactive2021-12
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-coverage Specialty Rx Coverageactive2023-04
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-medicationrequest Specialty Prescriptionactive2020-03
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-messageheader-error Specialty Rx Error MessageHeaderactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-messageheader-query-response-unsolicited Specialty Rx MessageHeader - Query Response - Unsolicitedactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-messageheader-query-response Specialty Rx Query Response MessageHeaderactive2020-05
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-messageheader-query Specialty Rx MessageHeader - Queryactive2020-05
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-organization-pharmacy Specialty Rx Organization - Pharmacyactive2020-05
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-parameters-query-response-unsolicited Specialty Rx Parameters - Query Response - Unsolicitedactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-parameters-query-response Specialty Rx Parameters - Query Responseactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-parameters-query Specialty Rx Parameters - Queryactive2020-07
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-patient Specialty Rx Patientactive2020-03
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-practitioner Specialty Prescription Practitioneractive2020-03
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-task-consent-request Specialty Rx Task - Consent Requestactive2021-12
hl7.fhir.us.specialty-rxR4StructureDefinition/specialty-rx-task-smart-launch Specialty Rx Task - SMART Launchactive2021-03
hl7.fhir.us.specialty-rxR4CapabilityStatement/specialty-rx-data-consumer-messaging Specialty Rx CapabilityStatement - Data Consumer - Messagingactive2022-07
hl7.fhir.us.specialty-rxR4CapabilityStatement/specialty-rx-data-consumer-restful Specialty Rx CapabilityStatement - Data Consumer - RESTfulactive2022-07
hl7.fhir.us.specialty-rxR4CapabilityStatement/specialty-rx-data-source-messaging Specialty Rx CapabilityStatement - Data Source - Messagingactive2022-07
hl7.fhir.us.specialty-rxR4CapabilityStatement/specialty-rx-data-source-restful Specialty Rx CapabilityStatement - Data Source - RESTfulactive2022-07
hl7.fhir.us.specialty-rxR4ValueSet/specialty-rx-consent-status Specialty Rx Value Set - Consent Statusactive2020-12
hl7.fhir.us.specialty-rxR4ValueSet/specialty-rx-event-type Specialty Rx Value Set - Event Typeactive2020-05
hl7.fhir.us.specialty-rxR4ValueSet/specialty-rx-task-input-type Specialty Rx Value Set - Task Input Typeactive2023-01
hl7.fhir.us.specialty-rxR4ValueSet/specialty-rx-task-output-type Specialty Rx Value Set - Task Output Typeactive2023-01
hl7.fhir.us.specialty-rxR4ValueSet/specialty-rx-task-type Specialty Rx Value Set - Task Typeactive2023-01
hl7.fhir.us.specialty-rxR4CodeSystem/specialty-rx-event-type Specialty Rx Code System - Event Typeactive2020-06
hl7.fhir.us.specialty-rxR4CodeSystem/specialty-rx-task-characteristic Specialty Rx Code System - Task Characteristicactive2022-01
fhir.argonaut.clinicalnotesR3CapabilityStatement/argonaut-clinical-notes-client Argonaut Clinical Notes Client CapabilityStatementactive2019-03
fhir.argonaut.clinicalnotesR3CapabilityStatement/argonaut-clinical-notes-server Argonaut Clinical Notes CapabilityStatementactive2019-03
fhir.argonaut.clinicalnotesR3CodeSystem/documentreference-category Argonaut DocumentReferences Category Code Systemdraft2018-05
fhir.argonaut.clinicalnotesR3ImplementationGuide/argonaut.us.clinicalnotes-1.0.0 Argonaut Clinical Notesdraft
fhir.argonaut.clinicalnotesR3StructureDefinition/argo-clinicalnotes Argonaut Clinical Notesactive2018-04
fhir.argonaut.clinicalnotesR3StructureDefinition/argo-diagnosticreport-notes-and-reports Argonaut Imaging Reportsactive2018-04
fhir.argonaut.clinicalnotesR3ValueSet/argonaut-clinical-note-type Argonaut DocumentReferences Type Value Setdraft2018-05
fhir.argonaut.clinicalnotesR3ValueSet/diagnosticreport-category Argonaut DiagnosticReport Category Value Setdraft2018-05
fhir.argonaut.clinicalnotesR3ValueSet/documentreference-category Argonaut DocumentReferences Category Value Setdraft2018-05
globalalliant.us.eomR4http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-history-of-metastatic-cancer History of Metastatic Cancerdraft2023-10
hl7.fhir.us.phcpR4CapabilityStatement/PhcpClient Pharmacist Care Plan Clientactive2020-08
hl7.fhir.us.phcpR4CapabilityStatement/PhcpServer Pharmacist Care Plan Serveractive2020-08
hl7.fhir.us.phcpR4ImplementationGuide/hl7.fhir.us.phcp Pharmacist Services and Summaries - FHIR (PhCP)active2020-09
hl7.fhir.us.phcpR4StructureDefinition/PhCP-CareCoordination PhCP Care Coordinationdraft2020-09
hl7.fhir.us.phcpR4StructureDefinition/PhCP-Composition PhCP Compositionactive2020-11
hl7.fhir.us.phcpR4StructureDefinition/PhCP-Coverage PhCPCoveragedraft2017-07
hl7.fhir.us.phcpR4StructureDefinition/PhCP-Encounter PhCP Encounterdraft2021-02
hl7.fhir.us.phcpR4StructureDefinition/PhCP-Instruction-Procedure PhCP Instruction Proceduredraft2017-07
hl7.fhir.us.phcpR4StructureDefinition/PhCP-Intervention-Procedure PhCP Intervention Proceduredraft2021-02
hl7.fhir.us.phcpR4StructureDefinition/PhCP-Medication-Therapy-Condition PhCP Medication Therapy Conditiondraft2021-02
hl7.fhir.us.phcpR4StructureDefinition/PhCP-MedicationDispense PhCP MedicationDispensedraft2017-07
hl7.fhir.us.phcpR4StructureDefinition/PhCP-Organization PhCP Organizationdraft2021-02
hl7.fhir.us.phcpR4StructureDefinition/PhCP-ServiceRequest PhCP ServiceRequestdraft2017-07
hl7.fhir.us.medsR3CapabilityStatement/client US Meds Clientdraft2017-03
hl7.fhir.us.medsR3CapabilityStatement/server US Meds Serverdraft2017-03
hl7.fhir.us.medsR3ImplementationGuide/ig US Medsactive
hl7.fhir.us.medsR3StructureDefinition/medicationadministration MedicationAdministrationProfileactive2016-11
hl7.fhir.us.medsR3StructureDefinition/medicationdispense MedicationDispenseProfileactive2017-03
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/CodeSystem/usdf-CoinsuranceOptionCS Coinsurance Option CSdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/CodeSystem/usdf-CopayOptionCS Copay Option CSdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/CodeSystem/usdf-DrugTierCS Drug Tier CSdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/CodeSystem/usdf-PharmacyTypeCS Pharmacy Type CSdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/ImplementationGuide/hl7.fhir.us.Davinci-drug-formulary DaVinci Payer Data Exchange (PDex) US Drug Formularydraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-CoveragePlan Coverage Plandraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-DrugAlternatives-extension Drug Alternativesdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-DrugTierDefinition-extension Drug Tier Definitiondraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-DrugTierID-extension Drug Tier IDdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-EmailPlanContact-extension Email Plan Contactdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-FormularyDrug Formulary Drugdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-FormularyURL-extension Formulary URLdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-MarketingURL-extension Marketing URLdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-Network-extension Networkdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-PlanID-extension Plan IDdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-PlanIDType-extension Plan ID Typedraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-PriorAuthorization-extension Prior Authorizationdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-QuantityLimit-extension Quantity Limitdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-StepTherapyLimit-extension Step Therapy Limitdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/StructureDefinition/usdf-SummaryURL-extension Summary URLdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/ValueSet/usdf-CoinsuranceOptionVS Coinsurance Option VSdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/ValueSet/usdf-CopayOptionVS Copay Option VSdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/ValueSet/usdf-DrugTierVS Drug Tier VSdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/ValueSet/usdf-PharmacyTypeVS Pharmacy Type VSdraft2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/CapabilityStatement/usdf-server US Drug Formulary Server Capability Statementactive2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/SearchParameter/DrugName DrugNameactive2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/SearchParameter/DrugPlan DrugPlanactive2020-01
hl7.fhir.us.Davinci-drug-formularyR4http://hl7.org/fhir/us/Davinci-drug-formulary/SearchParameter/DrugTier DrugTieractive2020-01
hl7.fhir.us.breastcancerR3CodeSystem/BC-basic-resource-type BC Basic Resource Type CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3CodeSystem/cimi-element-AnatomicalDirectionCS BC AnatomicalDirectionCS CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3CodeSystem/cimi-entity-LanguageQualifierCS BC LanguageQualifierCS CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3CodeSystem/oncology-BreastCarcinomaHistologicTypeCS BC BreastCarcinomaHistologicTypeCS CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3CodeSystem/oncology-BreastSpecimenTypeCS BC BreastSpecimenTypeCS CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3CodeSystem/oncology-RecurrenceRiskScoreInterpretationCS BC RecurrenceRiskScoreInterpretationCS CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3CodeSystem/oncology-StageTimingPrefixCS BC StageTimingPrefixCS CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3CodeSystem/shr-core-PerformanceGradingScaleCS BC PerformanceGradingScaleCS CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3CodeSystem/shr-core-YesNoUnknownCS BC YesNoUnknownCS CodeSystemdraft2018-08
hl7.fhir.us.breastcancerR3ImplementationGuide/1 HL7 FHIR Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment 2) FHIR Profilesdraft
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Abatement-extension BC Abatement Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Abatement-model BC Abatement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-AssertionContext-model BC AssertionContext Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Certainty-extension BC Certainty Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Certainty-model BC Certainty Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ClinicalStatus-model BC ClinicalStatus Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ConditionPresenceContext-model BC ConditionPresenceContext Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ContextCode-extension BC ContextCode Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ContextCode-model BC ContextCode Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-DeltaFlag-model BC DeltaFlag Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ExceptionValue-extension BC ExceptionValue Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ExceptionValue-model BC ExceptionValue Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-FindingContext-model BC FindingContext Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-FindingStatus-model BC FindingStatus Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Interpretation-extension BC Interpretation Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Interpretation-model BC Interpretation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Issued-model BC Issued Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ObservationContext-model BC ObservationContext Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Observer-model BC Observer Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Onset-extension BC Onset Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Onset-model BC Onset Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ParticipationPeriod-model BC ParticipationPeriod Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-PresenceContext-extension BC PresenceContext Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-PresenceContext-model BC PresenceContext Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-PresentOnAdmission-model BC PresentOnAdmission Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-RecordedContext-model BC RecordedContext Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-RelevantTime-model BC RelevantTime Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-ResultValue-model BC ResultValue Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Severity-model BC Severity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-Stage-model BC Stage Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-StageDetail-model BC StageDetail Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-StatementContext-extension BC StatementContext Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-StatementContext-model BC StatementContext Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-VerificationStatus-extension BC VerificationStatus Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-VerificationStatus-model BC VerificationStatus Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-context-WhenClinicallyRecognized-model BC WhenClinicallyRecognized Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-core-Content-model BC Content Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-core-Independent-model BC Independent Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-core-InformationEntry-model BC InformationEntry Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-core-Locatable-model BC Locatable Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-core-NonIndependent-model BC NonIndependent Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-core-PersonOfRecord-extension BC PersonOfRecord Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-core-PersonOfRecord-model BC PersonOfRecord Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-core-RelationshipToPersonOfRecord-model BC RelationshipToPersonOfRecord Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-AnatomicalDirection-model BC AnatomicalDirection Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-AnatomicalLocation-model BC AnatomicalLocation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-AnatomicalLocation BC AnatomicalLocation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-FamilyName-model BC FamilyName Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-GivenName-model BC GivenName Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Identifier-extension BC Identifier Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Identifier-model BC Identifier Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Identifier BC Identifier Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Issuer-model BC Issuer Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Laterality-model BC Laterality Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-MiddleName-model BC MiddleName Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Name-model BC Name Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-NameAsText-model BC NameAsText Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-PartOf-model BC PartOf Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-PersonName-model BC PersonName Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Prefix-model BC Prefix Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Status-model BC Status Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-element-Suffix-model BC Suffix Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-encounter-Encounter-extension BC Encounter Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-encounter-Encounter-model BC Encounter Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-encounter-Encounter BC Encounter Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-encounter-EncounterType-model BC EncounterType Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-AccessionIdentifier-model BC AccessionIdentifier Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-AccessionIdentifier BC AccessionIdentifier Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-ActiveFlag-extension BC ActiveFlag Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-ActiveFlag-model BC ActiveFlag Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-ActiveFlagAsaCodeableConcept-extension BC ActiveFlagAsaCodeableConcept Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-ActiveFlagAsaCodeableConcept-model BC ActiveFlagAsaCodeableConcept Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Actual-model BC Actual Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Additive-extension BC Additive Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Additive-model BC Additive Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-AdministrativeGender-extension BC AdministrativeGender Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-AdministrativeGender-model BC AdministrativeGender Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Brand-model BC Brand Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-BrandName-model BC BrandName Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Capacity-extension BC Capacity Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Capacity-model BC Capacity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-CollectionMethod-model BC CollectionMethod Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-CollectionSite-model BC CollectionSite Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-CollectionSource-model BC CollectionSource Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-CollectionTime-extension BC CollectionTime Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-CollectionTime-model BC CollectionTime Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-DateOfBirth-extension BC DateOfBirth Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-DateOfBirth-model BC DateOfBirth Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Device-model BC Device Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-DeviceUdi-model BC DeviceUdi Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-DoseForm-model BC DoseForm Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Entity-model BC Entity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Entity BC Entity Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-EntityOrRole-model BC EntityOrRole Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-ExcludeFlag-model BC ExcludeFlag Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-ExpirationDate-model BC ExpirationDate Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Group-model BC Group Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Group BC Group Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-GroupCharacteristic-model BC GroupCharacteristic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-GroupCharacteristicCode-model BC GroupCharacteristicCode Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-HandlingRisk-extension BC HandlingRisk Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-HandlingRisk-model BC HandlingRisk Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Headshot-extension BC Headshot Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Headshot-model BC Headshot Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Ingredient-model BC Ingredient Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-IngredientAmount-model BC IngredientAmount Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-IsActiveIngredient-model BC IsActiveIngredient Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-LanguageQualifier-extension BC LanguageQualifier Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-LanguageQualifier-model BC LanguageQualifier Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-LanguageUsed-extension BC LanguageUsed Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-LanguageUsed-model BC LanguageUsed Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-LotNumber-model BC LotNumber Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-ManufactureDate-model BC ManufactureDate Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Manufacturer-model BC Manufacturer Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-ManufacturerName-model BC ManufacturerName Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Medication-model BC Medication Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Medication BC Medication Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-MedicationIngredient-model BC MedicationIngredient Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Member-model BC Member Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-NationalProviderIdentifier-model BC NationalProviderIdentifier Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-NationalProviderIdentifier BC NationalProviderIdentifier Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Organization-model BC Organization Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Organization BC Organization Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-OrganizationAlias-model BC OrganizationAlias Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-OrganizationIdentifier-model BC OrganizationIdentifier Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-OrganizationIdentifier BC OrganizationIdentifier Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-OrganizationName-model BC OrganizationName Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-OverTheCounter-model BC OverTheCounter Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Package-model BC Package Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Patient-model BC Patient Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Person-model BC Person Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Person BC Person Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Practitioner-model BC Practitioner Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Practitioner BC Practitioner Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Qualification-model BC Qualification Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-RelatedPerson-model BC RelatedPerson Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-RelatedPerson BC RelatedPerson Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Role-model BC Role Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SequenceNumber-extension BC SequenceNumber Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SequenceNumber-model BC SequenceNumber Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SourceSpecimen-model BC SourceSpecimen Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecialHandling-extension BC SpecialHandling Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecialHandling-model BC SpecialHandling Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Specimen-model BC Specimen Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Specimen BC Specimen Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecimenContainer-model BC SpecimenContainer Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecimenContainer BC SpecimenContainer Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecimenQuantity-extension BC SpecimenQuantity Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecimenQuantity-model BC SpecimenQuantity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecimenStatus-model BC SpecimenStatus Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecimenTreatment-extension BC SpecimenTreatment Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecimenTreatment-model BC SpecimenTreatment Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpecimenTreatment BC SpecimenTreatment Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpokenLanguageProficiency-extension BC SpokenLanguageProficiency Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-SpokenLanguageProficiency-model BC SpokenLanguageProficiency Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Substance-model BC Substance Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Substance BC Substance Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-Url-model BC Url Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-VendorModelNumber-model BC VendorModelNumber Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-WrittenLanguageProficiency-extension BC WrittenLanguageProficiency Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-entity-WrittenLanguageProficiency-model BC WrittenLanguageProficiency Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-AssertionPresenceStatement-model BC AssertionPresenceStatement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-AssertionPresenceStatement BC AssertionPresenceStatement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-AssertionStatement-model BC AssertionStatement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-AssertionStatement BC AssertionStatement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-ClinicalStatement-model BC ClinicalStatement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-ClinicalStatement BC ClinicalStatement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-CodedLaboratoryObservation-model BC CodedLaboratoryObservation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-CodedLaboratoryObservation BC CodedLaboratoryObservation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-ComponentOnlyNonLaboratoryObservation-model BC ComponentOnlyNonLaboratoryObservation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-ComponentOnlyNonLaboratoryObservation BC ComponentOnlyNonLaboratoryObservation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-ConditionPresenceStatement-model BC ConditionPresenceStatement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-ConditionPresenceStatement BC ConditionPresenceStatement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-FindingStatement-model BC FindingStatement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-FindingStatement BC FindingStatement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-LaboratoryObservation-model BC LaboratoryObservation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-LaboratoryObservation BC LaboratoryObservation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-NonLaboratoryObservation-model BC NonLaboratoryObservation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-NonLaboratoryObservation BC NonLaboratoryObservation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-Observation-model BC Observation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-Observation BC Observation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-SimpleCodedLaboratoryObservation-model BC SimpleCodedLaboratoryObservation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-SimpleCodedLaboratoryObservation BC SimpleCodedLaboratoryObservation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-SimpleLaboratoryObservation-model BC SimpleLaboratoryObservation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-statement-SimpleLaboratoryObservation BC SimpleLaboratoryObservation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-AlleviatingFactor-model BC AlleviatingFactor Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-ApplicableAgeRange-model BC ApplicableAgeRange Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-ApplicableSubpopulation-model BC ApplicableSubpopulation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-AssertionTopic-model BC AssertionTopic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-CodedEvaluationComponent-model BC CodedEvaluationComponent Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-ConditionAssertionTopic-model BC ConditionAssertionTopic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-ConditionCause-model BC ConditionCause Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-DiagnosticService-model BC DiagnosticService Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-EvaluationComponent-model BC EvaluationComponent Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-ExacerbatingFactor-model BC ExacerbatingFactor Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-FindingMethod-extension BC FindingMethod Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-FindingMethod-model BC FindingMethod Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-FindingTopic-extension BC FindingTopic Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-FindingTopic-model BC FindingTopic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-LaboratoryObservationTopic-model BC LaboratoryObservationTopic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-ObservationTopic-model BC ObservationTopic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-PanelMembers-model BC PanelMembers Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-Precondition-model BC Precondition Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-ReferenceRange-model BC ReferenceRange Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-StatementTopic-extension BC StatementTopic Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-StatementTopic-model BC StatementTopic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-TopicCode-extension BC TopicCode Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/cimi-topic-TopicCode-model BC TopicCode Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-AverageCEP17SignalsPerCell-model BC AverageCEP17SignalsPerCell Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-AverageHER2SignalsPerCell-model BC AverageHER2SignalsPerCell Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BRCA1Variant-model BC BRCA1Variant Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BRCA2Variant-model BC BRCA2Variant Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerDistantMetastasesClassification-model BC BreastCancerDistantMetastasesClassification Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerDistantMetastasesClassification BC BreastCancerDistantMetastasesClassification Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerGeneticAnalysisObservation-model BC BreastCancerGeneticAnalysisObservation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerGeneticAnalysisObservation BC BreastCancerGeneticAnalysisObservation Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerHistologicGrade-model BC BreastCancerHistologicGrade Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerHistologicGrade BC BreastCancerHistologicGrade Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerPresenceStatement-model BC BreastCancerPresenceStatement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerPresenceStatement BC BreastCancerPresenceStatement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerPrimaryTumorClassification-model BC BreastCancerPrimaryTumorClassification Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerPrimaryTumorClassification BC BreastCancerPrimaryTumorClassification Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerRegionalNodesClassification-model BC BreastCancerRegionalNodesClassification Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerRegionalNodesClassification BC BreastCancerRegionalNodesClassification Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerStage-model BC BreastCancerStage Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerStage BC BreastCancerStage Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastCancerStageTopic-model BC BreastCancerStageTopic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastClinicalLymphNodeInvolvement-model BC BreastClinicalLymphNodeInvolvement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastClinicalLymphNodeInvolvement BC BreastClinicalLymphNodeInvolvement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastLymphNodeBodySite-model BC BreastLymphNodeBodySite Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastLymphNodeBodySite BC BreastLymphNodeBodySite Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastLymphNodeInvolvement-model BC BreastLymphNodeInvolvement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastPathologicalLymphNodeInvolvement-model BC BreastPathologicalLymphNodeInvolvement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastPathologicalLymphNodeInvolvement BC BreastPathologicalLymphNodeInvolvement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastSite-model BC BreastSite Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastSite BC BreastSite Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastSpecimen-model BC BreastSpecimen Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastSpecimen BC BreastSpecimen Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastTumor-model BC BreastTumor Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-BreastTumor BC BreastTumor Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-ColdIschemiaTime-model BC ColdIschemiaTime Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-CompleteMembraneStainingPercent-model BC CompleteMembraneStainingPercent Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-DCISNuclearGrade-model BC DCISNuclearGrade Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-DCISNuclearGrade BC DCISNuclearGrade Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-DistanceFromBreastSiteToNipple-extension BC DistanceFromBreastSiteToNipple Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-DistanceFromBreastSiteToNipple-model BC DistanceFromBreastSiteToNipple Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-EstrogenReceptorAverageStainingIntensity-model BC EstrogenReceptorAverageStainingIntensity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-EstrogenReceptorNuclearPositivity-model BC EstrogenReceptorNuclearPositivity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-EstrogenReceptorStatus-model BC EstrogenReceptorStatus Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-EstrogenReceptorStatus BC EstrogenReceptorStatus Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-ExtraCapsularExtensionOfNodalTumorStatus-model BC ExtraCapsularExtensionOfNodalTumorStatus Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-HER2ReceptorStatus-model BC HER2ReceptorStatus Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-HER2ReceptorStatus BC HER2ReceptorStatus Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-HER2byFISH-model BC HER2byFISH Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-HER2byFISH BC HER2byFISH Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-HER2byIHC-model BC HER2byIHC Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-HER2byIHC BC HER2byIHC Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-HER2toCEP17Ratio-model BC HER2toCEP17Ratio Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-Ki-67NuclearAntigen-model BC Ki-67NuclearAntigen Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-Ki-67NuclearAntigen BC Ki-67NuclearAntigen Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-Ki-67NuclearAntigenValue-model BC Ki-67NuclearAntigenValue Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-LymphNodeMobility-model BC LymphNodeMobility Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-LymphNodeSamplingMethod-model BC LymphNodeSamplingMethod Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-LymphNodeSize-model BC LymphNodeSize Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-MammaprintRecurrenceScore-model BC MammaprintRecurrenceScore Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-MammaprintRecurrenceScore BC MammaprintRecurrenceScore Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-MitoticCountScore-model BC MitoticCountScore Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-MorphologyBehavior-extension BC MorphologyBehavior Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-MorphologyBehavior-model BC MorphologyBehavior Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-NuclearPleomorphismScore-model BC NuclearPleomorphismScore Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-NumberOfLymphNodesWithIsolatedTumorCells-model BC NumberOfLymphNodesWithIsolatedTumorCells Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-NumberOfLymphNodesWithMacrometastases-model BC NumberOfLymphNodesWithMacrometastases Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-NumberOfLymphNodesWithMicrometastases-model BC NumberOfLymphNodesWithMicrometastases Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-NumberOfRegionalLymphNodes-model BC NumberOfRegionalLymphNodes Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-NumberOfSentinelLymphNodes-model BC NumberOfSentinelLymphNodes Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-OncotypeDxDCISRecurrenceScore-model BC OncotypeDxDCISRecurrenceScore Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-OncotypeDxDCISRecurrenceScore BC OncotypeDxDCISRecurrenceScore Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-OncotypeDxInvasiveRecurrenceScore-model BC OncotypeDxInvasiveRecurrenceScore Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-OncotypeDxInvasiveRecurrenceScore BC OncotypeDxInvasiveRecurrenceScore Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-ProgesteroneReceptorAverageStainingIntensity-model BC ProgesteroneReceptorAverageStainingIntensity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-ProgesteroneReceptorNuclearPositivity-model BC ProgesteroneReceptorNuclearPositivity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-ProgesteroneReceptorStatus-model BC ProgesteroneReceptorStatus Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-ProgesteroneReceptorStatus BC ProgesteroneReceptorStatus Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-ProsignaRecurrenceScore-model BC ProsignaRecurrenceScore Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-ProsignaRecurrenceScore BC ProsignaRecurrenceScore Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-SizeOfGrossTumorBed-model BC SizeOfGrossTumorBed Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-SizeOfLongestDiameter-model BC SizeOfLongestDiameter Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-SizeOfShortAxis-model BC SizeOfShortAxis Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-StageSuffix-model BC StageSuffix Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-StageTimingPrefix-model BC StageTimingPrefix Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TotalNumberOfLymphNodesExamined-model BC TotalNumberOfLymphNodesExamined Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TubuleFormationScore-model BC TubuleFormationScore Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TumorDimensions-model BC TumorDimensions Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TumorDimensions BC TumorDimensions Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TumorIdentifier-extension BC TumorIdentifier Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TumorIdentifier-model BC TumorIdentifier Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TumorMarginDescription-model BC TumorMarginDescription Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TumorMargins-model BC TumorMargins Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/oncology-TumorMargins BC TumorMargins Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-condition-FindingSiteConditionPresenceStatement-model BC FindingSiteConditionPresenceStatement Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-condition-FindingSiteConditionPresenceStatement BC FindingSiteConditionPresenceStatement Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-condition-FindingSiteConditionTopic-model BC FindingSiteConditionTopic Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-condition-FindingSiteIdentifier-model BC FindingSiteIdentifier Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Address-extension BC Address Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Address-model BC Address Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-AddressLine-model BC AddressLine Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Age-model BC Age Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-BinaryData-model BC BinaryData Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Category-extension BC Category Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Category-model BC Category Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-City-model BC City Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-ClockDirection-extension BC ClockDirection Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-ClockDirection-model BC ClockDirection Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-CodeSystem-model BC CodeSystem Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-CodeSystemVersion-model BC CodeSystemVersion Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-CodeableConcept-extension BC CodeableConcept Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Comparator-model BC Comparator Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-ContactPoint-extension BC ContactPoint Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-ContactPoint-model BC ContactPoint Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-ContentType-model BC ContentType Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Count-model BC Count Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Country-model BC Country Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-CreationTime-model BC CreationTime Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Denominator-model BC Denominator Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Details-extension BC Details Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Details-model BC Details Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-DisplayText-model BC DisplayText Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-District-model BC District Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-EffectiveTimePeriod-model BC EffectiveTimePeriod Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-EmbeddedContent-model BC EmbeddedContent Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-GeopoliticalLocation-model BC GeopoliticalLocation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Hash-model BC Hash Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-HumanName-extension BC HumanName Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-HumanName-model BC HumanName Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-IntegerQuantity-model BC IntegerQuantity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Language-extension BC Language Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Language-model BC Language Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-LowerBound-model BC LowerBound Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Media-extension BC Media Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Media-model BC Media Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Numerator-model BC Numerator Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-PostalCode-model BC PostalCode Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-PriorityRank-model BC PriorityRank Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Purpose-model BC Purpose Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Quantity-model BC Quantity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Range-model BC Range Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Ratio-model BC Ratio Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Ratio BC Ratio Profiledraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-ReceivedTime-model BC ReceivedTime Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-ResourceLocation-model BC ResourceLocation Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-ResourceSize-model BC ResourceSize Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-SimpleQuantity-model BC SimpleQuantity Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-State-model BC State Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-TelecomNumberOrAddress-model BC TelecomNumberOrAddress Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-TimePeriod-model BC TimePeriod Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-TimePeriodEnd-model BC TimePeriodEnd Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-TimePeriodStart-model BC TimePeriodStart Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Title-model BC Title Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Type-extension BC Type Extensiondraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Type-model BC Type Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Units-model BC Units Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-UpperBound-model BC UpperBound Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3StructureDefinition/shr-core-Version-model BC Version Logical Modeldraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/cimi-context-DeltaFlagVS BC DeltaFlagVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/cimi-context-PresenceContextVS BC PresenceContextVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/cimi-element-AnatomicalDirectionVS BC AnatomicalDirectionVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/cimi-element-AnatomicalLocationVS BC AnatomicalLocationVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/cimi-entity-LanguageQualifierVS BC LanguageQualifierVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-BreastCancerDetectionVS BC BreastCancerDetectionVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-BreastCarcinomaHistologicTypeVS BC BreastCarcinomaHistologicTypeVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-BreastLymphNodeGroupVS BC BreastLymphNodeGroupVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-BreastSiteVS BC BreastSiteVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-BreastSpecimenCollectionMethodVS BC BreastSpecimenCollectionMethodVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-BreastSpecimenTypeVS BC BreastSpecimenTypeVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-DCISNuclearGradeVS BC DCISNuclearGradeVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-EstrogenReceptorInterpretationTestsVS BC EstrogenReceptorInterpretationTestsVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2FISHMethodVS BC HER2FISHMethodVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2byFISHVSInterpretationTestsVS BC HER2byFISHVSInterpretationTestsVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2byIHCInterpretationTestsVS BC HER2byIHCInterpretationTestsVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2byIHCScoreVS BC HER2byIHCScoreVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-Ki-67NuclearAntigenVS BC Ki-67NuclearAntigenVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-LymphNodeClinicalMethodVS BC LymphNodeClinicalMethodVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-LymphNodeInvolvementVS BC LymphNodeInvolvementVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-LymphNodeMobilityVS BC LymphNodeMobilityVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-LymphNodeSamplingMethodVS BC LymphNodeSamplingMethodVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-MorphologyBehaviorVS BC MorphologyBehaviorVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-ProgesteroneReceptorInterpretationTestsVS BC ProgesteroneReceptorInterpretationTestsVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-RecurrenceRiskScoreInterpretationVS BC RecurrenceRiskScoreInterpretationVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-StageTimingPrefixVS BC StageTimingPrefixVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-StainingIntensityVS BC StainingIntensityVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-TumorMarginDescriptionVS BC TumorMarginDescriptionVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/shr-core-AllUnitsVS BC AllUnitsVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/shr-core-ClockDirectionVS BC ClockDirectionVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/shr-core-PerformanceGradingScaleVS BC PerformanceGradingScaleVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/shr-core-PositiveNegativeEquivocalIndeterminateVS BC PositiveNegativeEquivocalIndeterminateVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/shr-core-PositiveNegativeIndeterminateVS BC PositiveNegativeIndeterminateVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/shr-core-PositiveNegativeVS BC PositiveNegativeVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/shr-core-YesNoUnknownVS BC YesNoUnknownVS ValueSetdraft2018-08
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/admission-amb-type Admission Amb Typedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/admission-imp-type Admission Inpatient Typedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/admission-mvmnt-type Admission Movement Typedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/cml-counseling-patient-state CML Counseling Patient Statedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/cml-counseling-type CML Counseling Type Codedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/cml-medical-record-type Chamileon Record Typedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/consultation-followup-flag consultation Follow Up Flagdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/home-check-in Home Check Indraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/CodeSystem/hospitals-uri Hospitals urisdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ImplementationGuide/il.fhir.r4.dgmc Israel Division of Governmental Hospitals Profilesdraft
fhir.dgmcR4http://fhir.dgmc.health.gov.il/StructureDefinition/consultation-question-flag Extension - Consultation Question Flagdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/StructureDefinition/dgmc-cml-consultation-answer DGMC Consultation Answerdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/StructureDefinition/dgmc-cml-consultation-request DGMC Consultation Requestdraft2024-07
fhir.dgmcR4http://fhir.health.gov.il/StructureDefinition/dgmc-encounter-case DGMC Encounter Namer Casedraft2024-07
fhir.dgmcR4http://fhir.health.gov.il/StructureDefinition/dgmc-encounter-cml DGMC Encounter Chameleondraft2024-07
fhir.dgmcR4http://fhir.health.gov.il/StructureDefinition/dgmc-encounter-movement DGMC Encounter Namer Movementdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/StructureDefinition/dgmc-patient DGMC Patientdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/admission-type Admission Type codesdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/cml-counseling-patient-state CML Counseling Patient Statedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/cml-medical-record-type Chamileon Record Typedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/cml-counseling-type-code Counseling Type Codedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/encounter-diet-pref Hospitals Uris Encounter Diet Preferencedraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/nmr-case-number Hospitals Uris Namer Case Numberdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/nmr2cml-identifier Hospitals Uris Maner to Chameleon Identifierdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/cml-counseling-answer Hospitals Uris Chameleon Answerdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/cml-medical-record Hospitals Uris Chameleon Medical Recorddraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/cml-pat-internal Hospitals Uris Chameleon Patient Internaldraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/cml-counseling-request Hospitals Uris Chameleon Requestdraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/nmr-pat-internal Hospitals Uris Namer Patient Internaldraft2024-07
fhir.dgmcR4http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/nmr-pat-temp Hospitals Uris Namer Patient Tempdraft2024-07
ca.on.dhdr.r4.v4R4http://hl7.org/fhir/ConceptMap/101 FHIR v3 Address Use Mappingdraft2012-06
ca.on.dhdr.r4.v4R4https://ehealthontario.ca/fhir/DHDR/metadata-consumer Digital Health Drug Repository FHIR Capability Statementactive2022-02
ca.on.dhdr.r4.v4R4http://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database-3 Drug Identification Number-DINactive2022-03
ca.on.dhdr.r4.v4R4http://cihi.ca/fhir/CodeSytem/aac-discharge-disposition aac Discharge Dispositionactive2019-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/ValueSet/dhdr-drug-service-coverage Drug Service Coverageactive
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Encounter Encounteractive2023-04
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ValueSet/acCDR-encounter-class Encounter Classactive
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ValueSet/acCDR-encounter-participant-type Encounter Participant Typeactive2019-02
ca.on.dhdr.r4.v4R4http://cihi.ca/fhir/ValueSet/aac-admit-category Encounter Typeactive2019-02
ca.on.dhdr.r4.v4R4http://fhir.infoway-inforoute.ca/io/psca/ValueSet/LicensedNaturalHealthProducts Licensed Natural Health Productsactive2022-03
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Location Locationactive
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ValueSet/acCDR-location-physical-type Location Physical Typeactive
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Medication Medicationactive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Medication-submission Medication (Submission)active
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Medication Medicationactive2022-01
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationAdministration-submission MedicationAdministration (Submission)active
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationAdministration MedicationAdministrationactive
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-MedicationDispense MedicationDispenseactive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationDispense MedicationDispenseactive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/ValueSet/dhdr-dispense-category Dispense Categoryactive
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationDispense-submission MedicationDispense (Submission)active
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationRequest MedicationRequest Prescriptionactive
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-MedicationRequest MedicationRequestPrescriptionactive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-OperationOutcome OperationOutcomeactive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-OperationOutcome OperationOutcomeactive2021-11
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Organization-dispenser OrganizationDispenseractive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Organization Organizationactive2021-11
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Organization-submission Organization (Submission)active
ca.on.dhdr.r4.v4R4http://terminology.hl7.org/CodeSystem/v3-ParticipationType v3 Code System ParticipationTypeactive2018-08
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Patient-dispense Patientactive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Patient-submission Patient (Submission)active2022-09
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Patient Patientactive2021-11
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Practitioner-submission Practitioner (Submission)active2022-09
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Practitioner Practitioneractive
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Practitioner-dispenser PractitionerDispenseractive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Practitioner-prescriber PractitionerPrescriberactive2022-02
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-PractitionerRole PractitionerRoleactive
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-PractitionerRole-submission PractitionerRole (Submission)active
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-acCDR-province-code v2 map for acCDR Province Codedraft2023-03
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/CodeSystem/province-state-code Province State Codeactive2019-10
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/SearchParameter/Bundle-composition-medicationadministration-effective-time composition.medicationadministration.effective-timeactive2023-10
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/SearchParameter/Bundle-composition-medicationdispense-whenprepared composition.medicationdispense.whenpreparedactive2023-10
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/SearchParameter/Bundle-composition-patient-birthDate composition.patient.birthDateactive2023-10
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/SearchParameter/Bundle-composition-patient-gender composition.patient.genderactive2023-10
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/CodeSystem/accdr-bed-desc-code accdr Bed Desc Codeactive2023-08
ca.on.dhdr.r4.v4R4https://ehealthontario.ca/fhir/CapabilityStatement/ca-on-medication-profile-CapabilityStatement-Repository Digital Health Drug Repository FHIR Capability Statementactive2023-10
ca.on.dhdr.r4.v4R4https://ehealthontario.ca/fhir/CapabilityStatement/ca-on-medication-profile-CapabilityStatement-Consumer Digital Health Drug Repository FHIR Capability Statementactive2023-10
ca.on.dhdr.r4.v4R4https://ehealthontario.ca/fhir/CapabilityStatement/ca-on-medication-profile-CapabilityStatement-BundleDocument-Source Digital Health Drug Repository FHIR Capability Statementactive2023-10
ca.on.dhdr.r4.v4R4https://ehealthontario.ca/fhir/DHDR/metadata-query Digital Health Drug Repository FHIR Capability Statementdraft2023-03
ca.on.dhdr.r4.v4R4https://simplifier.net/guide/digitalhealthdrugrepositoryhl7fhirimplementationguide Digital Health Drug Repository HL7 FHIR Implementation Guidedraft
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/SearchParameter/ca-on-medications-patient-gender PatientGenderSearchParameteractive2021-01
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/SearchParameter/ca-on-medications-patient-identifier PatientIdentifierSearchParameteractive2021-01
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/SearchParameter/ca-on-medications-patient-birthDate PatientBirthDateSearchParameteractive2021-01
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/ValueSet/dhdr-medication-repeat-pattern Medication Repeat Patterndraft
ca.on.dhdr.r4.v4R4http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationRequest-submission MedicationRequest Prescription (Submission)active2022-01
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-administrative-gender v2 map for DHDR Administrative Genderdraft2023-03
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-contact-point-use v2 map for DHDR Contact Point Usedraft2023-03
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-CDR-address-type v2 map for DHDR Address Typedraft2023-03
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-CDR-address-use v2 map for DHDR Address Usedraft2023-03
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-contact-point-system v2 map for DHDR Address Typedraft2023-03
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-DHDR-EncounterClass v2 to FHIR map for DHDR Encounter Classdraft2023-02
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-medication-administration-status v2 map for DHDR Medication Administration Statusdraft2023-03
ca.on.dhdr.r4.v4R4http://ontariohealth.ca/fhir/ConceptMap/cm-medication-request-status v2 map for DHDR Medication Request Statusdraft2023-03
fhir.cdc.opioid-mme-r4R4CodeSystem/CDCMMEClinicalConversionFactors CDC MME Clinical Conversion Factorsactive2021-11
fhir.cdc.opioid-mme-r4R4CodeSystem/CDCMMEUsageContextCodes CDC MME Usage Context Codesactive2021-11
fhir.cdc.opioid-mme-r4R4CodeSystem/cfct-example-CDCMMEClinicalConversionFactors Example CDC MME Clinical Conversion Factorsactive2021-11
fhir.cdc.opioid-mme-r4R4ImplementationGuide/fhir.cdc.opioid-mme-r4 CDC MME CQL Calculatoractive2021-11
fhir.cdc.opioid-mme-r4R4StructureDefinition/mmemedicationrequest MMEMedicationRequestdraft2017-04
rapportendoscopiequebec.testR4http://hl7.org/fhir/us/mdi/ValueSet/ValueSet-yes-no-unknown-not-applicable ValueSet - Yes No Unknown NotApplicableactive2023-09
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/VilleEndo VilleEndoactive2024-05
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/VoieAdministrationEndo VoieAdministrationEndoactive2024-05
rapportendoscopiequebec.testR4http://hl7.org/fhir/administrative-gender AdministrativeGenderactive2023-06
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/CodeSystem/CodePostalEndo code postalactive2024-04
rapportendoscopiequebec.testR4http://terminology.hl7.org/CodeSystem/consentscope Consent Scope Codesactive2024-04
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/Etablissement Etablissementactive2024-04
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/InstallationEndo installationactive2024-04
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/OrganisationOrdreEndo Organisation ordreactive2024-04
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/TypeRessource Type ressource endoactive2024-04
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/Villes Villeactive2024-01
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/SearchParameter/identifierPHIN identifierPHINactive
rapportendoscopiequebec.testR4https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/SearchParameter/mothersMaidenName mothersMaidenNameactive
fhir.cqf.commonR4ImplementationGuide/fhir.cqf.common Clinical Quality Framework Common FHIR Assetsdraft2021-11
fhir.cqf.commonR4ValueSet/active-condition CQF Active Conditionactive2019-07
fhir.cqf.commonR4ValueSet/inactive-condition CQF Inactive Conditionactive2019-07
hl7.fhir.us.bulkdataR4ImplementationGuide/ig FHIR Bulk Data Accessactive
hl7.fhir.us.bulkdataR4OperationDefinition/export FHIR Bulk Data Export (Flat FHIR) - System Level Exportactive2019-02
hl7.fhir.us.bulkdataR4OperationDefinition/group-export FHIR Bulk Data Export (Flat FHIR) - System Level Exportactive2019-02
hl7.fhir.us.bulkdataR4OperationDefinition/patient-export FHIR Bulk Data Export (Flat FHIR) - System Level Exportactive2019-02
hl7.fhir.us.vitalsignsR4CodeSystem/APCTemporaryCodeSystem Associated Precondition Temporary Code Systemdraft2019-10
hl7.fhir.us.vitalsignsR4CodeSystem/SolorTemporaryCodeSystem SNOMED CT Solor Extension Temporary Code Systemdraft2019-10
hl7.fhir.us.vitalsignsR4organization-hspc-organizationtype HSPC Organization Type Code Systemdraft2015-05
hl7.fhir.us.vitalsignsR4ImplementationGuide/hl7.fhir.us.vitalsigns Vital Signsactive2020-08
hl7.fhir.us.vitalsignsR4StructureDefinition/AssociatedPreconditionExt Associated Preconditiondraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/AverageBloodPressure Average Blood Pressuredraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/BPDevice BloodPressureDevicedraft2020-04
hl7.fhir.us.vitalsignsR4StructureDefinition/BloodPressureCuffSizeExt Blood Pressure Cuff Sizedraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/BloodPressurePanel Blood Pressure Paneldraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/BodyLength BodyLengthdraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/BodyMassIndex BodyMassIndexdraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/BodyPositionExt Body Positiondraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/BodyTemperature BodyTemperaturedraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/BodyWeight BodyWeightdraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/ClothingWornDuringMeasureExt Clothing Worn During Measure Extensiondraft2019-09
hl7.fhir.us.vitalsignsR4StructureDefinition/ExerciseAssociationExt Exercise Association extensiondraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/HeadOccipitalFrontalCircumference Head Occipital-Frontal Circumferencedraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/HeartRate HeartRatedraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/Height Heightdraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/MeasurementDeviceExt Measurement Devicedraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/MeasurementProtocolExt Measurement Protocoldraft2020-06
hl7.fhir.us.vitalsignsR4StructureDefinition/MeasurementSettingExt Measurement Settingdraft2020-05
hl7.fhir.us.vitalsignsR4StructureDefinition/MethodDeviceExt Method/Devicedraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/OxygenSaturationArterialBlood Oxygen Saturation in Arterial blood, method not specifieddraft2020-01
hl7.fhir.us.vitalsignsR4StructureDefinition/OxygenSaturationArterialBloodPulseOx Oxygen Saturation in Arterial Blood by Pulse Oximeterydraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/RespiratoryRate Respiratory Ratedraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/SensorDescriptionExt Sensor Descriptiondraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/SleepStatusExt Sleep Statusdraft2019-05
hl7.fhir.us.vitalsignsR4StructureDefinition/TwentyFourHourBloodPressure Twenty Four Hour Blood Pressuredraft2020-05
hl7.fhir.us.vitalsignsR4StructureDefinition/VitalSignsPanel Vital Signs Paneldraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/MeasSettingVS Measurement Setting value setdraft2020-05
hl7.fhir.us.vitalsignsR4ValueSet/MeasurementProtocolVS MeasurementProtocolVSdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/abnIntNumericNomVS Abnormal Interpretation Numeric Nominal value setdraft2015-04
hl7.fhir.us.vitalsignsR4ValueSet/bodyPositionVS Body Position value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/bodyTempMeasBodyLocationPrecoordVS Body Temperature Measurement Body Location value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/bodyTempMeasMethodDeviceVS Body Temperature Measurement Method Device value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/bodyWeightMeasurementAssociatedPrecondVS Body Weight Measurement Associated Precondition value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/bpCuffSizeVS Blood Pressure Cuff Size value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/bpMeasDeviceCSVS Blood Pressure Measurement Device and Cuff Size value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/bpMeasDeviceVS Blood Pressure Measurement Device value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/bpMeasMethodVS Blood Pressure Measurement Method value setdraft2018-12
hl7.fhir.us.vitalsignsR4ValueSet/bpmeasbodylocationprecoord Blood Pressure Measurement Body Location Precoodinated value setdraft2015-06
hl7.fhir.us.vitalsignsR4ValueSet/clothingWornDuringMeasureVS Clothing Worn During Measure value setdraft2019-09
hl7.fhir.us.vitalsignsR4ValueSet/definedLimitsVS Defined Limits value setdraft2018-11
hl7.fhir.us.vitalsignsR4ValueSet/exertionPhaseVS Exertion Phase value setdraft2019-10
hl7.fhir.us.vitalsignsR4ValueSet/heartRateMeasBodyLocationPrecoordVS Heart Rate Measurement Body Location Precoordinated value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/heartRateMeasDeviceVS Heart Rate Measurement Device value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/heartRateMeasMethodVS Heart Rate Measurement Method value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/heightBodyPositionVS Height Body Position value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/heightLengthMeasDeviceVS Height Length Measurement Device value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/heightLengthMeasMethodVS Height Length Measurement Method value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/respiratoryRateMeasDeviceVS Respiratory Rate Measurement Device value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/respiratoryRateMeasMethodVS Respiratory Rate Measurement Method value setdraft2019-05
hl7.fhir.us.vitalsignsR4ValueSet/sPO2BodyLocationVS Oxygen Saturation Body Location value setdraft2018-11
hl7.fhir.us.vitalsignsR4ValueSet/sensorDescriptionVS Sensor Description value setdraft2018-12
hl7.fhir.us.vitalsignsR4ValueSet/sleepStatusVS Sleep Status value setdraft2018-12
hl7.fhir.us.vitalsignsR4ValueSet/weightMeasurementDeviceVS Weight Measurement Device value setdraft2019-05
hl7.fhir.us.cqfmeasuresR4CapabilityStatement/authoring-measure-repository CQF Measures Authoring Measure Repository Capability Statementactive2021-03
hl7.fhir.us.cqfmeasuresR4CapabilityStatement/measure-calculation-service-example Measure Calculation Service Capability Statement Exampledraft2016-09
hl7.fhir.us.cqfmeasuresR4CapabilityStatement/publishable-measure-repository CQF Measures Publishable Measure Repository Capability Statementactive2021-03
hl7.fhir.us.cqfmeasuresR4CapabilityStatement/shareable-measure-repository CQF Measures Shareable Measure Repository Capability Statementactive2021-03
hl7.fhir.us.cqfmeasuresR4CodeSystem/intended-venue-codes Intended Venue Codesactive2024-11
hl7.fhir.us.cqfmeasuresR4ConceptMap/aggregate-method Aggregate Method mappingactive2021-02
hl7.fhir.us.cqfmeasuresR4ConceptMap/composite-measure-scoring Composite Measure Scoring mappingactive2021-02
hl7.fhir.us.cqfmeasuresR4ConceptMap/data-usages Data Usage Mappingactive2021-02
hl7.fhir.us.cqfmeasuresR4ConceptMap/improvement-notations Improvement Notation Mappingactive2021-02
hl7.fhir.us.cqfmeasuresR4ConceptMap/measure-populations Measure Population criteria mappingactive2020-05
hl7.fhir.us.cqfmeasuresR4ConceptMap/measure-scoring Measure Scoring mappingactive2021-02
hl7.fhir.us.cqfmeasuresR4ConceptMap/measure-types Measure Type mappingactive2021-02
hl7.fhir.us.cqfmeasuresR4ImplementationGuide/hl7.fhir.us.cqfmeasures Quality Measure Implementation Guidedraft2024-11
hl7.fhir.us.cqfmeasuresR4OperationDefinition/cqfm-package CQFM Packagedraft2019-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/attestation-measure-cqfm CQFM Attestation Measureactive2024-09
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cohort-measure-cqfm CQFM Cohort Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/composite-measure-cqfm CQFM Composite Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/computable-measure-cqfm CQFM Computable Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-aggregateMethod CQFM Aggregate Methodactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-appliesTo CQFM Applies Toactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-component CQFM Componentactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-compositeScoring CQFM Composite Scoringactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-criteriaReference CQFM Criteria Referenceactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-effectivePeriodAnchor CQFM Effective Period Anchoractive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-effectivePeriodDuration CQFM Effective Period Durationactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-groupId CQFM Group Idactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-improvementNotation CQFM Improvement Notationactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-includeInReportType CQFM Include In Report Typeactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-isTestCase CQFM Is Test Caseactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-operation CQFM Operationactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-populationBasis CQFM Population Basisactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-rateAggregation CQFM Rate Aggregationactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-riskAdjustment CQFM Risk Adjustmentactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-scoring CQFM Scoringactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-scoringPrecision CQFM Scoring Precisionactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-scoringUnit CQFM Scoring Unitactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-supplementalDataGuidance CQFM Supplemental Data Guidanceactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-testCaseDescription CQFM Test Case Descriptionactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-type CQFM Typeactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cqfm-weight CQFM Weightactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cql-measure-cqfm CQFM CQL Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/cv-measure-cqfm CQFM Continuous Variable Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/device-softwaresystem-cqfm CQFM Deviceactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/elm-measure-cqfm CQFM ELM Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/executable-measure-cqfm CQFM Executable Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/proportion-measure-cqfm CQFM Proportion Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/publishable-measure-cqfm CQFM Publishable Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/ratio-measure-cqfm CQFM Ratio Measureactive2024-11
hl7.fhir.us.cqfmeasuresR4StructureDefinition/test-case-cqfm CQFM Test Caseactive2024-11
hl7.fhir.us.cqfmeasuresR4ValueSet/chronic-liver-disease-legacy-example Chronic Liver Disease Legacy Exampleactive2019-03
hl7.fhir.us.cqfmeasuresR4ValueSet/intended-venue Intended Venueactive2024-11
hl7.fhir.us.cqfmeasuresR4ValueSet/subject-type Subject Type Value Setactive2024-08
hl7.fhir.us.cqfmeasuresR4Measure/BCSComponent Breast Cancer Screeningactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/CCSComponent Cervical Cancer Screeningactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/EXM108-FHIR EXM108 - Venous Thromboembolism Prophylaxisactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/EXM124-FHIR EXM124 - Cervical Cancer Screeningactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/EXM125-FHIR EXM125 - Breast Cancer Screeningactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/EXM130-FHIR EXM130 - Colorectal Cancer Screening Measureactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/EXM146-FHIR EXM146 - Appropriate Testing for Children with Pharyngitisactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/EXM55-FHIR EXM55 - Median Emergency Department Visit Durationactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/EXMLogic-FHIR EXM Measureactive2022-02
hl7.fhir.us.cqfmeasuresR4http://example.org/fhir/measures/measure-ratio-exm EXM Ratio Measureactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/HBPComponent Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documentedactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/MultiRateExample-FHIR Multi-Rate Example Measuredraft2022-02
hl7.fhir.us.cqfmeasuresR4Measure/PVSComponent Pneumococcal Vaccination Status for Older Adultsactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/PreventiveCareandWellnessAllOrNothingComposite Preventive Care and Wellness All-Or-Nothing Compositedraft2024-11
hl7.fhir.us.cqfmeasuresR4Measure/PreventiveCareandWellnessOpportunityComposite Preventive Care and Wellness Opportunity Compositedraft2024-11
hl7.fhir.us.cqfmeasuresR4Measure/PreventiveCareandWellnessPatientLevelLinearComposite Preventive Care and Wellness Patient-level Linear Compositedraft2024-11
hl7.fhir.us.cqfmeasuresR4Measure/PreventiveCareandWellnessWeightedComposite Preventive Care and Wellness Weighted Compositedraft2024-11
hl7.fhir.us.cqfmeasuresR4Measure/TSCComponent Preventive Care and Screening: Tobacco Use: Screening and Cessation Interventionactive2022-02
hl7.fhir.us.cqfmeasuresR4Measure/Terminology-FHIR Terminology FHIRactive2022-02
hl7.fhir.us.cqfmeasuresR4http://example.org/fhir/measures/measure-pi-exm EXM Promoting Interoperability Measureactive2023-05
hl7.fhir.us.cqfmeasuresR4Measure/measure-risk-adjustment-FHIR2 Risk Adjustment FHIR DSTU2active2019-02
hl7.fhir.us.cqfmeasuresR4SearchParameter/Library-contained-parameter-name LibraryContainedParameterNamedraft2023-05
hl7.fhir.us.cqfmeasuresR4SearchParameter/Library-expansion-identifier LibraryExpansionIdentifierdraft2023-05
hl7.fhir.us.cqfmeasuresR4SearchParameter/ValueSet-keyword ValuesetKeyworddraft2023-06
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/CapabilityStatement/client Argonaut Scheduling Client CapabilityStatementactive2018-03
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/CapabilityStatement/server Argonaut Scheduling Server CapabilityStatementactive2018-03
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/CodeSystem/appt-type Argonaut Appointment Type Codesactive2017-07
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/CodeSystem/status-reason Argonaut Appointment Event Reason Codesactive2017-10
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/CodeSystem/visit-type Argonaut Visit Type Codesactive2017-07
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ConceptMap/visit-appt-map Argonaut Scheduiing Visit Type to Appointment Type Mappingactive2017-11
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ConceptMap/visit-snomed-map Argonaut Scheduiing Visit Type to SNOMED CT Mappingactive2017-10
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ImplementationGuide/ig Argo-Schedulingactive
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/OperationDefinition/appointment-book Appointment_Bookactive2017-08
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/OperationDefinition/appointment-find Appointment_Availability_Operationactive2017-10
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/OperationDefinition/appointment-hold Appointment_Holdactive2017-08
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/OperationDefinition/slot-prefetch Availability_Prefetch_Operationactive2018-02
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/argo-appt Argonaut Appointment Profileactive2017-06
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/argo-coverage Argonaut Coverage Profileactive2017-11
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/argo-sched-notif Argonaut Schedule Notification Profileactive2018-02
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/argo-sub-notif Argonaut Scheduling Subscription Profileactive2018-02
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/avail-bundle Argonaut Appointment Bundle Profileactive2018-01
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/extension-status-reason Reason For Current Statusactive2017-06
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/extension-subscription-eventfocus Subscription Event Focus Extensionactive2018-02
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/extension-subscription-payloadprofile Subscription Payload Profile Extensionactive2018-02
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/extension-subscription-triggerevent Subscription Trigger Event Extensionactive2018-02
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/prefetch-slot Argonaut Prefetch Slot Profileactive2018-01
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/StructureDefinition/slot-bundle Argonaut Slot Bundle Profileactive2018-01
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ValueSet/appt-type Argonaut Appointment Typesactive2017-07
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ValueSet/argo-slot-status Argonaut Slot Status Codesactive2018-03
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ValueSet/sct-services Argonaut Snomed CT Servicesactive2018-03
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ValueSet/slot-bundle-type Argonaut Slot BundleType Codesactive2017-01
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ValueSet/specialty Argonaut Scheduling Specialtiesactive2017-07
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ValueSet/status-reason Argonaut Appointment Event Reason Codesactive2017-10
fhir.argonaut.schedulingR3http://fhir.org/guides/argonaut-scheduling/ValueSet/visit-type Argonaut Visit Typesactive2017-07
fhir.dicomR4http://dicom.nema.org/resources/ontology/DCM DICOM Controlled Terminology Definitionsactive2025-04
fhir.dicomR4http://dicom.nema.org/resources/ValueSet/all All DICOM Controlled Terminology Definitionsactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10.html InterventionalDrugactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_100.html QuantitativeDiagnosticImagingProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1000.html CTTransversePlaneReferenceBasisactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10000.html ScopeofAccumulationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10001.html UIDTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10002.html IrradiationEventTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10003.html EquipmentPlaneIdentificationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10004.html FluoroModeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10005.html XRayRadiationDoseProcedureTypeReportedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10006.html XRayFilterMaterialactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10007.html XRayFilterTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10008.html DoseRelatedDistanceMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10009.html Measured/Calculatedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1001.html AnatomicalReferenceBasisactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10010.html DoseMeasurementDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10011.html EffectiveDoseEvaluationMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10013.html CTAcquisitionTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10014.html CTIVContrastImagingTechniqueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10015.html CTDoseReferenceAuthorityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10016.html AnodeTargetMaterialactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10017.html XRayGridactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1002.html AnatomicalReferenceBasisHeadactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10020.html SourceofProjectionXRayDoseInformationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10021.html SourceofCTDoseInformationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10022.html LabelTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10023.html SizeSpecificDoseEstimationMethodforCTactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10024.html WaterEquivalentDiameterMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10025.html RadiationDoseReferencePointactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1003.html AnatomicalReferenceBasisSpineactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10030.html DetectorTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10031.html CR/DRMechanicalConfigurationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10032.html ProjectionXRayAcquisitionDeviceTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10033.html CTReconstructionAlgorithmactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10034.html ReasonforRepeatingAcquisitionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1004.html AnatomicalReferenceBasisChestactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10040.html RadiopharmaceuticalOrganDoseReferenceAuthorityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10041.html SourceofRadioisotopeActivityInformationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10043.html IntravenousExtravasationSymptomactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10044.html RadiosensitiveOrganactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10045.html RadiopharmaceuticalPatientStateactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10046.html GFRMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10047.html GFRMeasurementMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1005.html AnatomicalReferenceBasisAbdomen/Pelvisactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10050.html SummaryRadiationExposureQuantityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1006.html AnatomicalReferenceBasisExtremityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10060.html OrganforRadiationDoseEstimateactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10061.html AbsorbedRadiationDoseTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10062.html EquivalentRadiationDoseTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10063.html RadiationDoseEstimateDistributionRepresentationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10064.html PatientModelTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10065.html RadiationTransportModelTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10066.html AttenuatorCategoryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10067.html RadiationAttenuatorMaterialactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10068.html EstimateMethodTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10069.html RadiationDoseEstimateParameteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10070.html RadiationDoseTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10071.html RadiationDoseUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10072.html ReportedValueTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10073.html ValueTimingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10074.html RDSRFrameofReferenceOriginactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_101.html ImagingProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1010.html ReferenceGeometryPlaneactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1011.html ReferenceGeometryPointactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1015.html PatientAlignmentMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_108.html DiagnosticImagingProcedurewithoutIVContrastactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_109.html DiagnosticImagingProcedurewithIVContrastactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_11.html AdministrationRouteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_11001.html PhotoacousticIlluminationMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_11002.html AcousticCouplingMediumactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_11003.html UltrasoundTransducerTechnologyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_11004.html SpeedofSoundCorrectionMechanismsactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_11005.html PhotoacousticReconstructionAlgorithmFamilyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_11006.html PhotoacousticImagedPropertyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12.html ImagingContrastAgentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1200.html ContraindicationsForCTImagingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12001.html UltrasoundProtocolTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12002.html UltrasoundProtocolStageTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12003.html OBGYNDateactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12004.html FetalBiometryRatioactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12005.html FetalBiometryMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12006.html FetalLongBonesBiometryMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12007.html FetalCraniumMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12008.html OBGYNAmnioticSacMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12009.html EarlyGestationBiometryMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1201.html ContraindicationsForXAImagingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12010.html FollicleTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12011.html UltrasoundPelvisandUterusMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12012.html OBEquation/Tableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12013.html GestationalAgeEquation/Tableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12014.html OBFetalBodyWeightEquation/Tableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12015.html FetalGrowthEquation/Tableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12016.html EstimatedFetalWeightPercentileEquation/Tableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12017.html GrowthDistributionRankactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12018.html OBGYNSummaryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12019.html OBGYNFetusSummaryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12020.html FetalBiometryAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12021.html FetalLongBoneAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12022.html FetalCraniumAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12023.html PelvisandUterusAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12024.html VascularUltrasoundReportDocumentTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12025.html OBGYNUltrasoundBeamPathUltrasoundBeamPathactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12030.html UltrasoundContrast/BolusAgentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12031.html ProtocolIntervalEventactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12032.html TransducerScanPatternactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12033.html UltrasoundTransducerGeometryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12034.html UltrasoundTransducerBeamSteeringactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12035.html UltrasoundTransducerApplicationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12100.html VascularUltrasoundReportDocumentTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12101.html VascularSummaryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12102.html TemporalPeriodRelatingtoProcedureorTherapyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12103.html VascularUltrasoundAnatomicLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12104.html ExtracranialArteryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12105.html IntracranialCerebralVesselactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12106.html IntracranialCerebralVessel(Unilateral)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12107.html UpperExtremityArteryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12108.html UpperExtremityVeinactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12109.html LowerExtremityArteryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12110.html LowerExtremityVeinactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12111.html AbdominopelvicArtery(Paired)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12112.html AbdominopelvicArtery(Unpaired)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12113.html AbdominopelvicVein(Paired)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12114.html AbdominopelvicVein(Unpaired)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12115.html RenalVesselactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12116.html VesselSegmentModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12117.html VesselBranchModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12118.html MeasurementOrientationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12119.html VascularUltrasoundPropertyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12120.html UltrasoundBloodVelocityMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12121.html VascularIndex/Ratioactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12122.html OtherVascularPropertyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12123.html CarotidRatioactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12124.html RenalRatioactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12125.html AbdominopelvicVesselactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12130.html OrganPart(NonLateralized)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12131.html OrganPart(Lateralized)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12140.html PelvicVasculatureAnatomicalLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12141.html FetalVasculatureAnatomicalLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12200.html EchocardiographyLeftVentricleMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12201.html LeftVentricleLinearMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12202.html LeftVentricleVolumeMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12203.html LeftVentricleOtherMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12204.html EchocardiographyRightVentricleMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12205.html EchocardiographyLeftAtriumMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12206.html EchocardiographyRightAtriumMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12207.html EchocardiographyMitralValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12208.html EchocardiographyTricuspidValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12209.html EchocardiographyPulmonicValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12210.html EchocardiographyPulmonaryArteryMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12211.html EchocardiographyAorticValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12212.html EchocardiographyAortaMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12214.html EchocardiographyPulmonaryVeinMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12215.html EchocardiographyVenaCavaMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12216.html EchocardiographyHepaticVeinMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12217.html EchocardiographyCardiacShuntMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12218.html EchocardiographyCongenitalAnomalyMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12219.html PulmonaryVeinModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12220.html EchocardiographyCommonMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12221.html FlowDirectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12222.html OrificeFlowPropertyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12223.html EchocardiographyStrokeVolumeOriginactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12224.html UltrasoundImageModeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12226.html EchocardiographyImageViewactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12227.html EchocardiographyMeasurementMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12228.html EchocardiographyVolumeMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12229.html EchocardiographyAreaMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12230.html GradientMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12231.html VolumeFlowMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12232.html MyocardiumMassMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12233.html CardiacPhaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12234.html RespirationStateactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12235.html MitralValveAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12236.html EchocardiographyAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12237.html EchocardiographyAnatomicSiteModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12238.html WallMotionScoringSchemeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12239.html CardiacOutputPropertyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12240.html LeftVentricleAreaMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12241.html TricuspidValveFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12242.html AorticValveFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12243.html LeftVentricleFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12244.html CongenitalFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12245.html CardiacUltrasoundReportTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12246.html CardiacUltrasoundIndicationforStudyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12247.html Pediatric,FetalandCongenitalCardiacSurgicalInterventionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12248.html CardiacUltrasoundSummaryCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12249.html CardiacUltrasoundFetalSummaryCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12250.html CardiacUltrasoundCommonLinearMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12251.html CardiacUltrasoundLinearValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12252.html CardiacUltrasoundCardiacFunctionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12253.html CardiacUltrasoundAreaMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12254.html CardiacUltrasoundHemodynamicMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12255.html CardiacUltrasoundMyocardiumMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12257.html CardiacUltrasoundLeftVentricleMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12258.html CardiacUltrasoundRightVentricleMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12259.html CardiacUltrasoundVentriclesMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12260.html CardiacUltrasoundPulmonaryArteryMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12261.html CardiacUltrasoundPulmonaryVeinactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12262.html CardiacUltrasoundPulmonaryValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12263.html CardiacUltrasoundVenousReturnPulmonaryMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12264.html CardiacUltrasoundVenousReturnSystemicMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12265.html CardiacUltrasoundAtriaandAtrialSeptumMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12266.html CardiacUltrasoundMitralValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12267.html CardiacUltrasoundTricuspidValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12268.html CardiacUltrasoundAtrioventricularValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12269.html CardiacUltrasoundInterventricularSeptumMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12270.html CardiacUltrasoundAorticValveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12271.html CardiacUltrasoundOutflowTractMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12272.html CardiacUltrasoundSemilunarValve,AnnulateandSinusMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12273.html CardiacUltrasoundAorticSinotubularJunctionMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12274.html CardiacUltrasoundAortaMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12275.html CardiacUltrasoundCoronaryArteryMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12276.html CardiacUltrasoundAortoPulmonaryConnectionMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12277.html CardiacUltrasoundPericardiumandPleuraMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12279.html CardiacUltrasoundFetalGeneralMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12280.html CardiacUltrasoundTargetSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12281.html CardiacUltrasoundTargetSiteModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12282.html CardiacUltrasoundVenousReturnSystemicFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12283.html CardiacUltrasoundVenousReturnPulmonaryFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12284.html CardiacUltrasoundAtriaandAtrialSeptumFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12285.html CardiacUltrasoundAtrioventricularValveFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12286.html CardiacUltrasoundInterventricularSeptumFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12287.html CardiacUltrasoundVentricleFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12288.html CardiacUltrasoundOutflowTractFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12289.html CardiacUltrasoundSemilunarValve,AnnulusandSinusFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12290.html CardiacUltrasoundPulmonaryArteryFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12291.html CardiacUltrasoundAortaFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12292.html CardiacUltrasoundCoronaryArteryFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12293.html CardiacUltrasoundAortopulmonaryConnectionFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12294.html CardiacUltrasoundPericardiumandPleuraFindingSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12300.html CoreEchoMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12301.html MeasurementSelectionReasonactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12302.html EchoFindingObservationTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12303.html EchoMeasurementTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12304.html CardiovascularMeasuredPropertyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12305.html BasicEchoAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12306.html EchoFlowDirectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12307.html CardiacPhaseandTimePointactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12308.html UltrasoundShearWaveMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12309.html CoreEchoStrainMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12310.html MyocardialStrainMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12311.html EchoMeasuredStrainPropertyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12312.html FetalEchocardiographyImageViewactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12313.html CardiacUltrasoundFetalArrhythmiaMeasurementsactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12314.html CommonFetalEchocardiographyMeasurementsactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12320.html GeneralUltrasoundReportDocumentTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12321.html ElastographySiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12322.html ElastographyMeasurementSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12323.html UltrasoundRelevantPatientConditionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12324.html ShearWaveDetectionMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12325.html LiverUltrasoundStudyIndicationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12331.html StructuralHeartProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12332.html StructuralHeartDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12333.html StructuralHeartMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12334.html AorticValveStructuralMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12335.html MitralValveStructuralMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12336.html TricuspidValveStructuralMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12337.html StructuralHeartEchoMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12338.html LeftAtrialAppendageClosureMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12339.html StructuralHeartProcedureAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12341.html IndicationforStructuralHeartProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12342.html BradycardiacAgentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12343.html TransesophagealEchocardiographyScanPlaneactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12344.html StructuralHeartMeasurementReportDocumentTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12345.html CardiacStructureCalcificationQualitativeEvaluationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_13.html ImagingContrastAgentIngredientactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_18.html RadiopharmaceuticalIsotopeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_19.html PatientOrientationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_2.html AnatomicModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_20.html PatientOrientationModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_21.html PatientEquipmentRelationshipactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_210.html QualitativeEvaluationModifierTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_211.html QualitativeEvaluationModifierValueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_212.html GenericAnatomicLocationModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_217.html VisualExplanationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_218.html QuantitativeImageFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_219.html GeometryGraphicalRepresentationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_220.html SignificanceLevelactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_221.html MeasurementRangeConceptactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_222.html Normalityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_223.html NormalRangeValueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_224.html SelectionMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_225.html MeasurementUncertaintyConceptactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_226.html PopulationStatisticalDescriptoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_227.html SampleStatisticalDescriptoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_228.html EquationorTableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_23.html CranioCaudadAngulationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_230.html YesNoactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_231.html YesNoOnlyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_240.html PresentAbsentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_241.html PresentAbsentOnlyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_242.html NormalAbnormalactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_244.html Lateralityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_245.html LateralitywithMedianactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_246.html RelativeLateralityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_247.html LateralityLeftRightOnlyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_25.html Radiopharmaceuticalactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_250.html PositiveNegativeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_251.html ComplicationSeverityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_252.html SMLSizeDescriptoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_26.html NuclearMedicineProjectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_27.html BasicCardiacViewactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_270.html ObserverTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_271.html ObservationSubjectClassactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_272.html SpecificObservationSubjectClassactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_280.html LongitudinalTemporalEventTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_281.html SimilarityMeasureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_29.html AcquisitionModalityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_30.html DICOMDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_300.html MultienergyRelevantMaterialactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3000.html AudioChannelSourceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3001.html ECGLeadactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3003.html HemodynamicWaveformSourceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3004.html ArterialPulseWaveformactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3005.html RespirationWaveformactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_301.html MultienergyMaterialUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3010.html CardiovascularAnatomicStructureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3011.html ElectrophysiologyAnatomicLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3014.html CoronaryArterySegmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3015.html CoronaryArteryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3016.html MajorCoronaryArteryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3019.html CardiovascularAnatomicStructureModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3020.html AssessmentfromCADRADS™active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3021.html CADRADS™StenosisAssessmentModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3022.html CADRADS™AssessmentModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3030.html EEGLeadactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3031.html LeadLocationNearorinMuscleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3032.html LeadLocationNearPeripheralNerveactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3033.html EOGLeadactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3034.html BodyPositionChannelactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3035.html EEGAnnotation–NeurophysiologicEnumerationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3036.html EMGAnnotation–NeurophysiologicalEnumerationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3037.html EOGAnnotation–NeurophysiologicalEnumerationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3038.html PatternEventactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3039.html DevicerelatedandEnvironmentrelatedEventactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3040.html EEGAnnotationNeurologicalMonitoringMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3041.html NeurophysiologicStimulationModeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3042.html AnalogWaveformFilteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3043.html DigitalWaveformFilteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3044.html WaveformFilterLookupTableInputFrequencyUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3045.html WaveformFilterLookupTableOutputMagnitudeUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3046.html SleepStageactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3047.html WaveformAnnotationClassificationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3048.html WaveformAnnotationsDocumentTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3049.html EEGProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3050.html PatientConsciousnessactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3083.html UnitRadioactivityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3090.html TimeSynchronizationChannelTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_31.html AbstractPrioractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3101.html CardiacProceduralStateValueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3102.html Rest/StressStateactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3104.html CardiacSynchronizationTechniqueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3106.html PETCardiologyProtocolactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3107.html PETCardiologyRadiopharmaceuticalactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3108.html NM/PETProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3110.html NuclearCardiologyProtocolactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3111.html NuclearCardiologyRadiopharmaceuticalactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3112.html AttenuationCorrectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3113.html PerfusionDefectTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3114.html StudyQualityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3115.html StressImagingQualityIssueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3116.html NMExtracardiacFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3117.html AttenuationCorrectionMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3118.html LevelofRiskactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3119.html LVFunctionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3120.html PerfusionFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3121.html PerfusionMorphologyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3122.html VentricularEnlargementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_32.html NonAcquisitionModalityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3200.html StressTestProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3201.html IndicationsforStressTestactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3202.html ChestPainactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3203.html ExerciserDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3204.html StressAgentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3205.html IndicationsforPharmacologicalStressTestactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3206.html NoninvasiveCardiacImagingProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3207.html StressTestProcedurePhaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3208.html ExerciseECGSummaryCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3209.html StressImagingSummaryCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3210.html SpeedofResponseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3211.html BPResponseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3212.html TreadmillSpeedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3213.html StressHemodynamicFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3215.html PerfusionFindingMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3217.html ComparisonFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3220.html StressSymptomactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3221.html StressTestTerminationReasonactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3227.html QTcMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3228.html ECGTimingMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3229.html ECGAxisMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3230.html ECGFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3231.html STSegmentFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3232.html STSegmentLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3233.html STSegmentMorphologyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3234.html EctopicBeatMorphologyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3235.html PerfusionComparisonFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3236.html ToleranceComparisonFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3237.html WallMotionComparisonFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3238.html StressScoringScaleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3239.html PerceivedExertionScaleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3240.html ElectrophysiologyMeasurementFunction/Techniqueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3241.html HemodynamicMeasurementTechniqueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3250.html CatheterizationProcedurePhaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3254.html ElectrophysiologyProcedurePhaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3261.html StressProtocolactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3262.html ECGPatientStateValueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3263.html ElectrodePlacementValueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3271.html HemodynamicPhysiologicalChallengeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_33.html Modalityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3335.html ECGAnnotationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3337.html HemodynamicAnnotationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3339.html ElectrophysiologyAnnotationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_34.html WaveformAcquisitionModalityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3400.html ProcedureLogTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3401.html LogNoteTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3402.html PatientStatusandEventactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3403.html PercutaneousEntryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3404.html StaffActionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3405.html ProcedureActionValueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3406.html NoncoronaryTranscatheterInterventionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3407.html ObjectReferencePurposeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3408.html ConsumableActionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3409.html Drug/ContrastAdministrationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3410.html Drug/ContrastNumericParameteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3411.html IntracoronaryDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3412.html InterventionAction/Statusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3413.html AdverseOutcomeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3414.html ProcedureUrgencyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3415.html CardiacRhythmactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3416.html RespirationRhythmactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3418.html LesionRiskactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3419.html FindingTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3421.html ProcedureActionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3422.html DeviceUseActionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3423.html NumericDeviceCharacteristicactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3425.html InterventionParameteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3426.html ConsumablesParameteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3427.html EquipmentEventactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3428.html CardiovascularImagingProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3429.html CatheterizationDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3430.html DateTimeQualifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3440.html PeripheralPulseLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3441.html PatientAssessmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3442.html PeripheralPulseMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3446.html SkinConditionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3448.html AirwayAssessmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3451.html CalibrationObjectactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3452.html CalibrationMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3453.html CardiacVolumeMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3455.html IndexMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3456.html SubsegmentMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3458.html ContourRealignmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3460.html CircumferentialExtentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3461.html RegionalExtentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3462.html ChamberIdentificationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3463.html VentricleIdentificationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3465.html QAReferenceMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3466.html PlaneIdentificationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3467.html EjectionFractionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3468.html EDVolumeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3469.html ESVolumeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3470.html VesselLumenCrosssectionalAreaCalculationMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3471.html EstimatedVolumeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3472.html CardiacContractionPhaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3480.html IVUSProcedurePhaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3481.html IVUSDistanceMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3482.html IVUSAreaMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3483.html IVUSLongitudinalMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3484.html IVUSIndex/Ratioactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3485.html IVUSVolumeMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3486.html VascularMeasurementSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3487.html IntravascularVolumetricRegionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3488.html Min/Max/Meanactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3489.html CalciumDistributionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3491.html IVUSLesionMorphologyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3492.html VascularDissectionClassificationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3493.html IVUSRelativeStenosisSeverityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3494.html IVUSNonMorphologicalFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3495.html IVUSPlaqueCompositionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3496.html IVUSFiducialPointactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3497.html IVUSArterialMorphologyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3500.html PressureUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3502.html HemodynamicResistanceUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3503.html IndexedHemodynamicResistanceUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3510.html CatheterSizeUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3515.html SpecimenCollectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3520.html BloodSourceTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3524.html BloodGasPressureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3525.html BloodGasContentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3526.html BloodGasSaturationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3527.html BloodBaseExcessactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3528.html BloodpHactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3529.html Arterial/VenousContentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3530.html OxygenAdministrationActionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3531.html OxygenAdministrationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3550.html CirculatorySupportActionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3551.html VentilationActionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3552.html PacingActionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3553.html CirculatorySupportactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3554.html Ventilationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3555.html Pacingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3560.html BloodPressureMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3600.html RelativeTimeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3602.html HemodynamicPatientStateactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3604.html ArterialLesionLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3606.html ArterialSourceLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3607.html VenousSourceLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3608.html AtrialSourceLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3609.html VentricularSourceLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3610.html GradientSourceLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3611.html PressureMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3612.html BloodVelocityMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3613.html HemodynamicTimeMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3614.html NonmitralValveAreaactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3615.html ValveAreaactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3616.html HemodynamicPeriodMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3617.html ValveFlowactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3618.html HemodynamicFlowactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3619.html HemodynamicResistanceMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3620.html HemodynamicRatioactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3621.html FractionalFlowReserveactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3627.html MeasurementTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3628.html CardiacOutputMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3629.html ProcedureIntentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3630.html CardiovascularAnatomicLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3640.html Hypertensionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3641.html HemodynamicAssessmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3642.html DegreeFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3651.html HemodynamicMeasurementPhaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3663.html BodySurfaceAreaEquationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3664.html OxygenConsumptionEquation/Tableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3666.html P50Equationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3667.html FraminghamScoreactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3668.html FraminghamTableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3670.html ECGProcedureTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3671.html ReasonforECGStudyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3676.html LeadMeasurementTechniqueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3677.html SummaryCodesECGactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3678.html QTCorrectionAlgorithmactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3680.html ECGLeadNoiseDescriptionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3687.html ElectrophysiologyWaveformDurationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3688.html ElectrophysiologyWaveformVoltageactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3689.html ECGGlobalWaveformDurationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3690.html ECGControlNumericVariableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3691.html ECGControlTextVariableactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3700.html CathDiagnosisactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3701.html CardiacValve/Tractactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3703.html WallMotionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3704.html MyocardiumWallMorphologyFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3705.html ChamberSizeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3706.html OverallContractilityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3707.html VSDDescriptionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3710.html CoronaryDominanceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3711.html ValvularAbnormalityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3712.html VesselDescriptoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3713.html TIMIFlowCharacteristicactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3714.html Thrombusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3715.html LesionMarginactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3716.html Severityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3717.html LeftVentricleMyocardialWall17SegmentModelactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3718.html MyocardialWallSegmentsinProjectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3719.html CanadianClinicalClassificationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3721.html CardiovascularSurgeryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3722.html DiabeticTherapyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3723.html MITypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3724.html SmokingHistoryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3726.html CoronaryInterventionIndicationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3727.html CatheterizationIndicationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3728.html CathFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3729.html AdmissionStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3730.html InsurancePayoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3733.html PrimaryCauseofDeathactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3735.html AcuteCoronarySyndromeTimePeriodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3736.html NYHAClassificationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3737.html IschemiaNoninvasiveTestactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3738.html PreCathAnginaTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3739.html CathProcedureTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3740.html ThrombolyticAdministrationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3741.html LabVisitMedicationAdministrationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3742.html PCIMedicationAdministrationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3743.html Clopidogrel/TiclopidineAdministrationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3744.html EFTestingMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3745.html CalculationMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3746.html PercutaneousEntrySiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3747.html PercutaneousClosureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3748.html AngiographicEFTestingMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3749.html PCIProcedureResultactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3750.html PreviouslyDilatedLesionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3752.html GuidewireCrossingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3754.html VascularComplicationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3755.html CathComplicationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3756.html CardiacPatientRiskFactoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3757.html CardiacDiagnosticProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3758.html CardiovascularFamilyHistoryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3760.html HypertensionTherapyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3761.html AntilipemicAgentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3762.html AntiarrhythmicAgentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3764.html MyocardialInfarctionTherapyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3769.html ConcernTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3770.html ProblemStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3772.html HealthStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3773.html UseStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3774.html SocialHistoryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3777.html CardiovascularImplantactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3778.html Stageactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3779.html ImplantedDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3781.html LeftVentricleMyocardialWall18SegmentModelactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3782.html LeftVentricleBasalWall6Segmentsactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3783.html LeftVentricleMidlevelWall6Segmentsactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3784.html LeftVentricleApicalWall4Segmentsactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3785.html LeftVentricleApicalWall6Segmentsactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3802.html PlaqueStructureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3804.html StenosisMeasurementMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3805.html StenosisTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3806.html StenosisShapeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3807.html VolumeMeasurementMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3808.html AneurysmTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3809.html AssociatedConditionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3810.html VascularMorphologyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3813.html StentFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3814.html StentCompositionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3815.html SourceofVascularFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3817.html VascularSclerosisTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3820.html NoninvasiveVascularProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3821.html PapillaryMuscleIncluded/Excludedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3823.html RespiratoryStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3826.html HeartRhythmactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3827.html VesselSegmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3829.html PulmonaryArteryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3831.html StenosisLengthactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3832.html StenosisGradeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3833.html CardiacEjectionFractionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3835.html CardiacVolumeMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3836.html TimebasedPerfusionMeasurementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3837.html FiducialFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3838.html DiameterDerivationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3839.html CoronaryVeinactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3840.html PulmonaryVeinactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3843.html MyocardialSubsegmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3850.html ContrastBolusSubstanceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4.html AnatomicRegionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_400.html AuditEventIDactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4005.html PartialViewSectionforMammographyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4009.html DXAnatomyImagedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_401.html AuditEventTypeCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4010.html DXViewactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4011.html DXViewModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4012.html ProjectionEponymousNameactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4013.html AnatomicRegionforMammographyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4014.html ViewforMammographyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4015.html ViewModifierforMammographyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4016.html AnatomicRegionforIntraoralRadiographyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4017.html AnatomicRegionModifierforIntraoralRadiographyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4018.html PrimaryAnatomicStructureforIntraoralRadiography(PermanentDentitionDesignationofTeeth)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4019.html PrimaryAnatomicStructureforIntraoralRadiography(DeciduousDentitionDesignationofTeeth)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_402.html AuditActiveParticipantRoleIDCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4020.html PETRadionuclideactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4021.html PETRadiopharmaceuticalactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4025.html PrimaryAnatomicStructureforIntraoralRadiography(SupernumeraryDentitionDesignationofTeeth)active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4026.html PrimaryAnatomicStructureforIntraoralandCraniofacialRadiographyTeethactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4028.html CraniofacialAnatomicRegionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4029.html DermatologyAnatomicSiteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_403.html SecurityAlertTypeCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4030.html CT,MRandPETAnatomyImagedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4031.html CommonAnatomicRegionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4032.html MRSpectroscopyMetaboliteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4033.html MRProtonSpectroscopyMetaboliteactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_404.html AuditParticipantObjectIDTypeCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4040.html EndoscopyAnatomicRegionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4042.html XA/XRFAnatomyImagedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_405.html MediaTypeCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4050.html DrugorContrastAgentCharacteristicactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4051.html GeneralDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4052.html PhantomDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4053.html CTDIPhantomDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4061.html HeadandNeckPrimaryAnatomicStructureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4062.html VLViewactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4063.html VLDentalViewactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4064.html VLViewModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4065.html VLDentalViewModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4066.html OrthognathicFunctionalConditionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4067.html OrthodonticFindingbyInspectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4068.html OrthodonticObservableEntityactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4069.html DentalOcclusionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4070.html OrthodonticTreatmentProgressactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4071.html GeneralPhotographyDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4072.html DevicesforthePurposeofDentalPhotographyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4100.html T1MeasurementMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4101.html TracerKineticModelactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4102.html PerfusionMeasurementMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4103.html ArterialInputFunctionMeasurementMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4104.html BolusArrivalTimeDerivationMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4105.html PerfusionAnalysisMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4106.html QuantitativeMethodUsedforPerfusionandTracerKineticModelactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4107.html TracerKineticModelParameteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4108.html PerfusionModelParameteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4109.html ModelIndependentDynamicContrastAnalysisParameteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4110.html TracerKineticModelingCovariateactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4111.html ContrastCharacteristicactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_42.html NumericValueQualifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4200.html OphthalmicImagingAgentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4201.html PatientEyeMovementCommandactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4202.html OphthalmicPhotographyAcquisitionDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4203.html OphthalmicPhotographyIlluminationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4204.html OphthalmicFilteractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4205.html OphthalmicLensactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4206.html OphthalmicChannelDescriptionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4207.html OphthalmicImagePositionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4208.html MydriaticAgentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4209.html OphthalmicAnatomicStructureImagedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4210.html OphthalmicTomographyAcquisitionDeviceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4211.html OphthalmicOCTAnatomicStructureImagedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4214.html OphthalmicHorizontalDirectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4215.html OphthalmicVerticalDirectionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4216.html OphthalmicVisualAcuityTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4220.html VisualFixationQualityDuringAcquisitionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4221.html VisualFixationQualityProblemactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4222.html OphthalmicMacularGridProblemactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4230.html OphthalmicUltrasoundAxialMeasurementsTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4231.html LensStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4232.html VitreousStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4233.html OphthalmicAxialLengthMeasurementsSegmentNameactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4234.html RefractiveSurgeryTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4235.html KeratometryDescriptoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4236.html IOLCalculationFormulaactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4237.html LensConstantTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4238.html RefractiveErrorTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4239.html AnteriorChamberDepthDefinitionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4240.html OphthalmicMeasurementorCalculationDataSourceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4241.html OphthalmicAxialLengthSelectionMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4242.html CorneaMeasurementMethodDescriptoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4243.html OphthalmicQualityMetricTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4244.html OphthalmicAgentConcentrationUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4245.html WideFieldOphthalmicPhotographyTransformationMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4250.html VisualFieldStaticPerimetryTestPatternactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4251.html VisualFieldStaticPerimetryTestStrategyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4252.html VisualFieldStaticPerimetryScreeningTestModeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4253.html VisualFieldStaticPerimetryFixationStrategyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4254.html VisualFieldStaticPerimetryTestAnalysisResultactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4255.html VisualFieldIlluminationColoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4256.html VisualFieldProcedureModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4257.html VisualFieldGlobalIndexNameactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4260.html OphthalmicMappingUnitforRealWorldValueMappingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4261.html OphthalmicMappingAcquisitionMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4262.html RetinalThicknessDefinitionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4263.html OphthalmicThicknessMapValueTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4264.html OphthalmicMapPurposeofReferenceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4265.html OphthalmicThicknessDeviationCategoryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4266.html OphthalmicAnatomicStructureReferencePointactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4267.html CornealTopographyMappingUnitforRealWorldValueMappingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4268.html CornealTopographyMapValueTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4270.html OCTAProcessingAlgorithmFamilyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4271.html EnFaceImageTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4272.html OPTScanPatternTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4273.html RetinalSegmentationSurfaceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4274.html EnFaceProcessingAlgorithmFamilyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4275.html AnteriorEyeSegmentationSurfaceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_43.html NumericValueFailureQualifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_44.html NumericValueUnknownQualifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4401.html FitzpatrickSkinTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4402.html HistoryofMalignantMelanomaactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4403.html HistoryofMelanomainSituactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4404.html HistoryofNonMelanomaSkinCanceractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4405.html SkinDisorderactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4406.html PatientReportedLesionCharacteristicactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4407.html LesionPalpationFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4408.html LesionVisualFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4409.html SkinProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4410.html TopicalTreatmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4411.html LesionColoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4412.html SpecimenStainforConfocalMicroscopyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_5.html TransducerApproachactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_50.html InstanceAvailabilityStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_501.html VolumetricViewDescriptionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_502.html VolumetricViewModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6.html TransducerOrientationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_60.html ImagingAgentAdministrationAdverseEventactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6000.html OverallBreastCompositionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6001.html OverallBreastCompositionfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6002.html ChangeSinceLastMammogramorPriorSurgeryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6003.html ChangeSinceLastMammogramorPriorSurgeryfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6004.html MammographyShapeCharacteristicactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6005.html ShapeCharacteristicfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6006.html MammographyMarginCharacteristicactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6007.html MarginCharacteristicfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6008.html DensityModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6009.html DensityModifierfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_601.html BiosafetyLevelactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6010.html MammographyCalcificationTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6011.html CalcificationTypefromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6012.html CalcificationDistributionModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6013.html CalcificationDistributionModifierfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6014.html MammographySingleImageFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6015.html SingleImageFindingfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6016.html MammographyCompositeFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6017.html CompositeFeaturefromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6018.html ClockfaceLocationorRegionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6019.html ClockfaceLocationorRegionfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_602.html BiosafetyControlReasonactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6020.html QuadrantLocationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6021.html QuadrantLocationfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6022.html Sideactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6023.html SidefromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6024.html Depthactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6025.html DepthfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6026.html MammographyAssessmentactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6027.html AssessmentfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6028.html MammographyRecommendedFollowupactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6029.html RecommendedFollowupfromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_603.html AnimalRoomTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6030.html MammographyPathologyCodeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6031.html BenignPathologyCodefromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6032.html HighRiskLesionPathologyCodefromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6033.html MalignantPathologyCodefromBIRADS®active2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6034.html CADOutputIntendedUseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6035.html CompositeFeatureRelationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6036.html FeatureScopeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6037.html MammographyQuantitativeTemporalDifferenceTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6038.html MammographyQualitativeTemporalDifferenceTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6039.html NippleCharacteristicactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_604.html DeviceReuseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6040.html NonlesionObjectTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6041.html MammographyImageQualityFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6042.html ResultStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6043.html MammographyCADAnalysisTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6044.html ImageQualityAssessmentTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6045.html MammographyQualityControlStandardTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6046.html FollowupIntervalUnitactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6047.html CADProcessingandFindingSummaryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6048.html CADOperatingPointAxisLabelactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_605.html AnimalBeddingMaterialactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6050.html BreastProcedureReportedactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6051.html BreastProcedureReasonactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6052.html BreastImagingReportSectionTitleactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6053.html BreastImagingReportElementactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6054.html BreastImagingFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6055.html BreastClinicalFindingorIndicatedProblemactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6056.html AssociatedFindingforBreastactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6057.html DuctographyFindingforBreastactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6058.html ProcedureModifiersforBreastactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6059.html BreastImplantTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_606.html AnimalShelterTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6060.html BreastBiopsyTechniqueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6061.html BreastImagingProcedureModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6062.html InterventionalProcedureComplicationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6063.html InterventionalProcedureResultactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6064.html UltrasoundFindingforBreastactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6065.html InstrumentApproachactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6066.html TargetConfirmationactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6067.html FluidColoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6068.html TumorStagesFromAJCCactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6069.html NottinghamCombinedHistologicGradeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_607.html AnimalFeedTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6070.html BloomRichardsonHistologicGradeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6071.html HistologicGradingMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6072.html BreastImplantFindingactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_608.html AnimalFeedSourceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6080.html GynecologicalHormoneactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6081.html BreastCancerRiskFactoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6082.html GynecologicalProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6083.html ProceduresforBreastactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6084.html MammoplastyProcedureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6085.html TherapiesforBreastactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6086.html MenopausalPhaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6087.html GeneralRiskFactoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6088.html OBGYNMaternalRiskFactoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6089.html Substanceactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_609.html AnimalFeedingMethodactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6090.html RelativeUsage/ExposureAmountactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6091.html RelativeFrequencyofEventValueactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6092.html Usage/ExposureQualitativeConceptactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6093.html Usage/Exposure/AmountQualitativeConceptactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6094.html Usage/Exposure/FrequencyQualitativeConceptactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6095.html ProcedureNumericPropertyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6096.html PregnancyStatusactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6097.html SideofFamilyactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6098.html ClinicalCourseofDiseaseactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6099.html RacialGroupactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_610.html WaterTypeactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6100.html ChestComponentCategoryactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6101.html ChestFindingorFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6102.html ChestFindingorFeatureModifieractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6103.html AbnormalLinesFindingorFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6104.html AbnormalOpacityFindingorFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6105.html AbnormalLucencyFindingorFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6106.html AbnormalTextureFindingorFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6107.html WidthDescriptoractive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6108.html ChestAnatomicStructureAbnormalDistributionactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6109.html RadiographicAnatomyFindingorFeatureactive2025-04
fhir.dicomR4http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_611.html AnesthesiaCategoryCodeTypeforSmallAnimalAnesthesiaactive2025-04
fhir.dicomR4StructureDefinition/rtpbc-pharmacy-organization RTPBC Pharmacy Organizationactive2020-05
hl7.fhir.us.carin-rtpbcR4StructureDefinition/rtpbc-request-bundle RTPBC Request Bundleactive2020-05
hl7.fhir.us.carin-rtpbcR4StructureDefinition/rtpbc-request-claim RTPBC Request Using Claimactive2020-05
hl7.fhir.us.carin-rtpbcR4StructureDefinition/rtpbc-request-messageheader RTPBC Request MessageHeaderactive2020-05
hl7.fhir.us.carin-rtpbcR4StructureDefinition/rtpbc-response-bundle RTPBC Response Bundleactive2020-05
hl7.fhir.us.carin-rtpbcR4StructureDefinition/rtpbc-response-claimresponse RTPBC Response Using ClaimResponseactive2020-05
hl7.fhir.us.carin-rtpbcR4StructureDefinition/rtpbc-response-messageheader RTPBC Response MessageHeaderactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-benefit-restriction RTPBC Benefit Restriction Value Setactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-billing-unit RTPBC Billing Unit Value Setactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-country-code RTPBC Country Code Value Setactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-error-code RTPBC Error Code Value Setactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-event-type RTPBC Event Type Value Setactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-patient-pay-type RTPBC Patient Pay Type Value Setactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-pharmacy-type RTPBC Pharmacy Type Value Setactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-prescribable-product-code RTPBC Prescribable Product Code Value Setactive2020-05
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-state-and-province-code RTPBC Two Letter State and Province Code Value Setactive2020-05
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/qualification Qualificationactive2022-04
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/region SignalRegiondraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceReferred SignalServiceReferreddraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestAuthorizedAmount SignalServiceRequestAuthorizedAmountdraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestDateOfReferral SignalServiceRequestDateOfReferraldraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestGuardian SignalServiceRequestGuardiandraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestNoOfUnits SignalServiceRequestNoOfUnitsdraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestParentFee SignalServiceRequestParentFeedraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestParentFlatRate SignalServiceRequestParentFlatRatedraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestPatient SignalServiceRequestPatientdraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestProvider SignalServiceRequestProviderdraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestReferringOrg SignalServiceRequestReferringOrgdraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsClientID SignalServiceRequestTrailsClientIDdraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsCountyHouseholdID SignalServiceRequestTrailsCountyHouseholdIDdraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsID SignalServiceRequestTrailsIDdraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/StateActivityStatus SurveyStateActivityStatusdraft
signal.core.r4R4http://hl7.org/fhir/StructureDefinition/patient-adoptionInfo Patient Adoption Infodraft2023-06
signal.core.r4R4http://hl7.org/fhir/StructureDefinition/no-fixed-address Patient No Fixed Addressdraft2023-05
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/documentreference DocumentReference Profiledraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/account Account Profiledraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/encounter Encounter Profileactive
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/episodeofcare EpisodeOfCare Profileactive
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/healthcareservice HealthcareService Profiledraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/invoice Invoicedraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/location Location Profiledraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/organization Organization Profiledraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/patient Patient Profiledraft2023-06
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/practitionerrole PractitionerRole Profiledraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/SignalQuestionnaireResponse SignalQuestionnaireResponsedraft
signal.core.r4R4https://signalbhn.org/fhir/StructureDefinition/servicerequest ServiceRequest Profiledraft
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/omb-race-category OMB Race Categoriesactive2022-09
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/contact-attempt-results Contact Attempt Resultsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/signal-healthcare-service-category Signal Healthcare Service Categorydraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/signal-program Signal Programdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/signal-healthcare-service-type Signal Healthcare Service Typedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/signal-organization-license Signal Organization Licenseactive2019-11
signal.core.r4R4https://signalbhn.org/fhir/us/core/CodeSystem/signal-organization-type Signal Organization Typedraft2019-11
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/place-of-service Place Of Servicedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/progress-made-towards-goals Progress Made Towards Goalsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/provider-taxonomy-na Provider Taxonomy NAdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-action-types Questionnaire CCARS Action Typesdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-activity-involvement-rating Questionnaire CCARS Overall Activity Involvement Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-aggression-danger-to-others-rating Questionnaire CCARS Aggression Danger To Others Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-alcohol-use-rating Questionnaire CCARS Alcohol Use Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-cognition-rating Questionnaire CCARS Cognition Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-considerations-for-providers Questionnaire CCARS Considerations For Providersdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-issues Questionnaire CCARS Current Issuesdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-living-arrangement Questionnaire CCARS Current Living Arrangementdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-non-prescription-substance-use Questionnaire CCARS Current Non-Prescription Substance Usedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-primary-role Questionnaire CCARS Current Primary Roledraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-depressive-issues-rating Questionnaire CCARS Depressive Issues Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-disabilities Questionnaire CCARS Disabilitiesdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-drug-use-rating Questionnaire CCARS Drug Use Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-empowerment-rating Questionnaire CCARS Empowerment Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-enrollment-payer Questionnaire CCARS Enrollment Payerdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-ethnicity Questionnaire CCARS Ethnicitydraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-existence-presenting-problem Questionnaire CCARS Existence Presenting Problemdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-family-rating Questionnaire CCARS Family Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-gender Questionnaire CCARS Genderdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-highest-education-level Questionnaire CCARS Highest Education Leveldraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-current-victimization Questionnaire CCARS History Current Victimizationdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-of-issues Questionnaire CCARS History Of Issuesdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-of-mental-health-services Questionnaire CCARS History Of Mental Health Servicesdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-hope-rating Questionnaire CCARS Hope Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-interpersonal-rating Questionnaire CCARS Interpersonal Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-legal-rating Questionnaire CCARS Legal Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-legal-status Questionnaire CCARS Legal Statusdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-marital-status Questionnaire CCARS Marital Statusdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-medication-psychiatric-service Questionnaire CCARS Medication Psychiatric Servicedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-mental-health-services-program Questionnaire CCARS Mental Health Services Programdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-multiple-issues-rating Questionnaire CCARS Multiple Issues Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-level-of-functioning-rating Questionnaire CCARS Overall Level Of Functioning Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-recovery-rating Questionnaire CCARS Overall Recovery Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-symptom-severity-rating Questionnaire CCARS Overall Symptom Severity Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-physical-health-rating Questionnaire CCARS Physical Health Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-place-of-residence Questionnaire CCARS Place Of Residencedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-previous-concurrent-services Questionnaire CCARS Previous Concurrent Servicesdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-psychosis-rating Questionnaire CCARS Psychosis Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-race Questionnaire CCARS Racedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-rae-aso-identification-codes Questionnaire CCARS RAE ASO Identification Codesdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-reason-for-discharge Questionnaire CCARS Reason For Dischargedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-role-performance-rating Questionnaire CCARS Role Performance Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-school-development Questionnaire CCARS School Developmentdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-school-problems Questionnaire CCARS School Problemsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-security-supervision-rating Questionnaire CCARS Security Supervision Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-self-care-basic-needs-rating Questionnaire CCARS Self Care Basic Needs Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-sexual-orientation Questionnaire CCARS Sexual Orientationdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-social-support-rating Questionnaire CCARS Social Support Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-socialization-rating Questionnaire CCARS Socialization Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-suicide-danger-to-self-rating Questionnaire CCARS Suicide Danger To Others Ratingdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-tobacco-use Questionnaire CCARS Tobacco Usedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-type-of-discharge Questionnaire CCARS Type Of Dischargedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-type-of-update Questionnaire CCARS Type Of Updatedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no-na Questionnaire CCARS Yes No NAdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no-unable-to-assess Questionnaire CCARS Yes No Unable To Assessdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no Questionnaire CCARS Yes Nodraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-admission-route-of-administration Questionnaire DACODS Admission Route Of Administrationdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-client-disability Questionnaire DACODS Client Disabilitydraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-clinician-diagnostic-impression Questionnaire DACODS Clinician Diagnostic Impressiondraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goalsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-route-of-administration Questionnaire DACODS Discharge Route Of Administrationdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-status Questionnaire DACODS Discharge Statusdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-drug-type-code Questionnaire DACODS Drug Type Codedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-education-employment-problems Questionnaire DACODS Education Employment Problemsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-employment-status Questionnaire DACODS Employment Statusdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-family-issues-and-problems Questionnaire DACODS Family Issues And Problemsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-health-insurance-status Questionnaire DACODS Health Insurance Statusdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-living-situation Questionnaire DACODS Living Situationdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-marital-status Questionnaire DACODS Marital Statusdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-medical-physical-problems Questionnaire DACODS Medical Physical Problemsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-reason-for-discharge Questionnaire Dacods Reason For Dischargedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-secondary-tertiary-drug-type-code Questionnaire DACODS Secondary Tertiary Drug Type Codedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-sexual-orientation Questionnaire DACODS Sexual Orientationdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-socialization-problems Questionnaire DACODS Socialization Problemsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-illicit-drugs Questionnaire DACODS Source Of Illicit Drugsdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-income Questionnaire DACODS Source Of Incomedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-payment-for-treatment Questionnaire DACODS Source Of Payment For Treatmentdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-statutory-commitment Questionnaire DACODS Statutory Commitmentdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-tobacco-use Questionnaire DACODS Tobacco Usedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-transfer-referral-source Questionnaire DACODS Transfer Referral Sourcedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-na Questionnaire DACODS Yes No NAdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-unable-to-assess Questionnaire DACODS Yes No Unable To Assessdraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-unknown Questionnaire DACODS Yes No Unknowndraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no Questionnaire DACODS Yes Nodraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/reason-for-discharge Reason For Dischargedraft2023-08
signal.core.r4R4https://signalbhn.org/fhir/us/core/CodeSystem/signal-filerepo-classification Signal FileRepo Classificationdraft2019-11
signal.core.r4R4http://signalbhn.org/fhir/us/core/CodeSystem/signal-filerepo-docreviewstatus Signal FileRepo Doc Review DocStatusdraft2019-11
signal.core.r4R4https://signalbhn.org/fhir/CodeSystem/signal-region Signal Regionactive2023-09
signal.core.r4R4https://signalbhn.org/fhir/us/core/CodeSystem/signal-state-activity-status Signal State Activity Statusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-observation-category US Core Screening Assessment Observation Categoryactive2023-03
signal.core.r4R4http://hl7.org/fhir/ValueSet/account-status AccountStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/account-type Account Typesdraft2019-11
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/fips-county-co CO FIPS Countiesdraft2023-06
signal.core.r4R4http://hl7.org/fhir/ValueSet/address-type AddressTypeactive2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/address-use AddressUseactive2019-11
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/birthsex Birth Sexactive2022-09
signal.core.r4R4http://hl7.org/fhir/ValueSet/chargeitem-status ChargeItemStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/composition-status CompositionStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/condition-clinical Condition Clinical Status Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/condition-severity Condition/Diagnosis Severitydraft
signal.core.r4R4http://hl7.org/fhir/ValueSet/condition-ver-status ConditionVerificationStatusdraft2019-11
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/contact-attempt-results Contact Attempt Resultsdraft
signal.core.r4R4http://hl7.org/fhir/ValueSet/coverage-class Coverage Class Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/coverage-copay-type Coverage Copay Type Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/coverage-financial-exception Example Coverage Financial Exception Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/data-absent-reason DataAbsentReasonactive2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/days-of-week DaysOfWeekactive2019-11
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/detailed-ethnicity Detailed ethnicityactive2022-09
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/detailed-race Detailed Raceactive2022-09
signal.core.r4R4http://hl7.org/fhir/ValueSet/device-action Procedure Device Action Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/device-kind FHIR Device Typesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/diagnosis-role DiagnosisRoledraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/document-classcodes Document Class Value Setactive2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/document-reference-status DocumentReferenceStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/document-relationship-type DocumentRelationshipTypedraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/encounter-admit-source Admit sourcedraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/encounter-diet Dietdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/encounter-location-status EncounterLocationStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/encounter-participant-type Participant typedraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/encounter-special-arrangements Special arrangementsdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/encounter-special-courtesy Special courtesydraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/encounter-status EncounterStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/episode-of-care-status EpisodeOfCareStatusdraft2019-10
signal.core.r4R4http://hl7.org/fhir/ValueSet/episodeofcare-type Episode of care typedraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/event-status EventStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/c80-facilitycodes Facility Type Code Value Setactive2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/fm-status Financial Resource Status Codesdraft2019-10
signal.core.r4R4http://hl7.org/fhir/ValueSet/formatcodes DocumentReference Format Code Setactive2019-11
signal.core.r4R4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.32 Gender Identityactive2022-03
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-category Signal Healthcare Service Categorydraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/healthcare-service-procedure-code-cpt HealthCare Service Procedure Code CPTdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/signal-program Signal Programdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-type Signal Healthcare Service Typedraft
signal.core.r4R4http://hl7.org/fhir/ValueSet/identifier-use IdentifierUsedraft2019-10
signal.core.r4R4http://hl7.org/fhir/ValueSet/invoice-priceComponentType InvoicePriceComponentTypedraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/invoice-status InvoiceStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/languages Common Languagesdraft2016-08
signal.core.r4R4http://hl7.org/fhir/ValueSet/location-mode LocationModedraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/location-physical-type Location typedraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/location-status LocationStatusdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/observation-category Observation Category Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/observation-status ObservationStatusactive2019-11
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/omb-ethnicity-category OMB Ethnicity Categoriesactive2022-09
signal.core.r4R4http://hl7.org/fhir/ValueSet/organization-role Organization Affiliation Roledraft2019-11
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/signal-organization-license Signal Organization Licensedraft2023-07
signal.core.r4R4https://signalbhn.org/fhir/us/core/ValueSet/signal-organization-type Signal Organization Typedraft2023-07
signal.core.r4R4http://hl7.org/fhir/ValueSet/performer-role Procedure Performer Role Codesdraft2019-11
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/place-of-service Place Of Servicedraft
signal.core.r4R4http://hl7.org/fhir/ValueSet/procedure-category Procedure Category Codes (SNOMED CT)draft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/procedure-followup Procedure Follow up Codes (SNOMED CT)draft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/procedure-not-performed-reason Procedure Not Performed Reason (SNOMED-CT)active2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/procedure-outcome Procedure Outcome Codes (SNOMED CT)draft2019-11
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/progress-made-towards-goals Progress Made Towards Goalsdraft
signal.core.r4R4http://hl7.org/fhir/ValueSet/provider-taxonomy Provider Taxonomy Codesdraft2023-03
signal.core.r4R4http://terminology.hl7.org/ValueSet/v2-2.7-0360 v2 table 0360, Version 2.7active
signal.core.r4R4http://hl7.org/fhir/ValueSet/questionnaire-answers-status QuestionnaireResponseStatusdraft2019-10
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-action-types Questionnaire CCARS Action Typesdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-activity-involvement-rating Questionnaire CCARS Overall Activity Involvement Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-aggression-danger-to-others-rating Questionnaire CCARS Aggression Danger To Others Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-alcohol-use-rating Questionnaire CCARS Alcohol Use Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-cognition-rating Questionnaire CCARS Cognition Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-considerations-for-providers Questionnaire CCARS Considerations For Providersdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-issues Questionnaire CCARS Current Issuesdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-living-arrangement Questionnaire CCARS Current Living Arrangementdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-non-prescription-substance-use Questionnaire CCARS Current Non-Prescription Substance Usedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-primary-role Questionnaire CCARS Current Primary Roledraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-depressive-issues-rating Questionnaire CCARS Depressive Issues Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-disabilities Questionnaire CCARS Disabilitiesdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-drug-use-rating Questionnaire CCARS Drug Use Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-empowerment-rating Questionnaire CCARS Empowerment Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-enrollment-payer Questionnaire CCARS Enrollment Payerdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-ethnicity Questionnaire CCARS Ethnicitydraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-existence-presenting-problem Questionnaire CCARS Existence Presenting Problemdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-family-rating Questionnaire CCARS Family Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-gender Questionnaire CCARS Genderdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-highest-education-level Questionnaire CCARS Highest Education Leveldraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-current-victimization Questionnaire CCARS History Current Victimizationdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-issues Questionnaire CCARS History Of Issuesdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-mental-health-services Questionnaire CCARS History Of Mental Health Servicesdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-hope-rating Questionnaire CCARS Hope Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-interpersonal-rating Questionnaire CCARS Interpersonal Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-rating Questionnaire CCARS Legal Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-status Questionnaire CCARS Legal Statusdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-marital-status Questionnaire CCARS Marital Statusdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-medication-psychiatric-service Questionnaire CCARS Medication Psychiatric Servicedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-mental-health-services-program Questionnaire CCARS Mental Health Services Programdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-multiple-issues-rating Questionnaire CCARS Multiple Issues Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-level-of-functioning-rating Questionnaire CCARS Overall Level Of Functioning Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-recovery-rating Questionnaire CCARS Overall Recovery Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-symptom-severity-rating Questionnaire CCARS Overall Symptom Severity Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-physical-health-rating Questionnaire CCARS Physical Health Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-place-of-residence Questionnaire CCARS Place Of Residencedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-previous-concurrent-services Questionnaire CCARS Previous Concurrent Servicesdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-psychosis-rating Questionnaire CCARS Psychosis Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-race Questionnaire CCARS Racedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-rae-aso-identification-codes Questionnaire CCARS RAE ASO Identification Codesdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-reason-for-discharge Questionnaire CCARS Reason For Dischargedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-role-performance-rating Questionnaire CCARS Role Performance Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-development Questionnaire CCARS School Developmentdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-problems Questionnaire CCARS School Problemsdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-security-supervision-rating Questionnaire CCARS Security Supervision Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-self-care-basic-needs-rating Questionnaire CCARS Self Care Basic Needs Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-sexual-orientation Questionnaire CCARS Sexual Orientationdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-social-support-rating Questionnaire CCARS Social Support Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-socialization-rating Questionnaire CCARS Socialization Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-suicide-danger-to-self-rating Questionnaire CCARS Suicide Danger To Others Ratingdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-tobacco-use Questionnaire CCARS Tobacco Usedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-type-of-discharge Questionnaire CCARS Type Of Dischargedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-type-of-update Questionnaire CCARS Type Of Updatedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no-na Questionnaire CCARS Yes No NAdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no-unable-to-assess Questionnaire CCARS Yes No Unable To Assessdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no Questionnaire CCARS Yes Nodraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-admission-route-of-administration Questionnaire DACODS Admission Route Of Administrationdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-client-disability Questionnaire DACODS Client Disabilitydraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-clinician-diagnostic-impression Questionnaire DACODS Clinician Diagnostic Impressiondraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goalsdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-route-of-administration Questionnaire DACODS Discharge Route Of Administrationdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-status Questionnaire DACODS Discharge Statusdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-drug-type-code Questionnaire DACODS Drug Type Codedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-education-employment-problems Questionnaire DACODS Education Employment Problemsdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-employment-status Questionnaire DACODS Employment Statusdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-family-issues-and-problems Questionnaire DACODS Family Issues And Problemsdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-health-insurance-status Questionnaire DACODS Health Insurance Statusdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-living-situation Questionnaire DACODS Living Situationdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-marital-status Questionnaire DACODS Marital Statusdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-medical-physical-problems Questionnaire DACODS Medical Physical Problemsdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-reason-for-discharge Questionnaire Dacods Reason For Dischargedraft2023-09
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-secondary-tertiary-drug-type-code Questionnaire DACODS Secondary Tertiary Drug Type Codedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-sexual-orientation Questionnaire DACODS Sexual Orientationdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-socialization-problems Questionnaire DACODS Socialization Problemsdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-illicit-drugs Questionnaire DACODS Source Of Illicit Drugsdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-income Questionnaire DACODS Source Of Incomedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-payment-for-treatment Questionnaire DACODS Source Of Payment For Treatmentdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-statutory-commitment Questionnaire DACODS Statutory Commitmentdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-tobacco-use Questionnaire DACODS Tobacco Usedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-transfer-referral-source Questionnaire DACODS Transfer Referral Sourcedraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-na Questionnaire DACODS Yes No NAdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-unable-to-assess Questionnaire DACODS Yes No Unable To Assessdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-unknown Questionnaire DACODS Yes No Unknowndraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no Questionnaire DACODS Yes Nodraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/reason-for-discharge Reason For Dischargeactive2023-06
signal.core.r4R4http://hl7.org/fhir/ValueSet/referencerange-appliesto Observation Reference Range Applies To Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/referencerange-meaning Observation Reference Range Meaning Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/service-provision-conditions ServiceProvisionConditionsdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/service-referral-method ReferralMethoddraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/request-intent RequestIntentdraft2019-10
signal.core.r4R4http://hl7.org/fhir/ValueSet/servicerequest-orderdetail Service Request Order Details Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/request-priority RequestPrioritydraft2016-07
signal.core.r4R4http://hl7.org/fhir/ValueSet/request-status RequestStatusdraft2019-10
signal.core.r4R4http://hl7.org/fhir/ValueSet/service-type Service typedraft2019-11
signal.core.r4R4https://signalbhn.org/fhir/us/core/ValueSet/signal-filerepo-classification Signal FileRepo Classificationdraft2023-09
signal.core.r4R4http://signalbhn.org/fhir/us/core/ValueSet/signal-filerepo-docreviewstatus Signal FileRepo DocStatusdraft2023-09
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/signal-organization-qualification Signal Organization Qualificationdraft
signal.core.r4R4https://signalbhn.org/fhir/ValueSet/signal-region Signal Regiondraft
signal.core.r4R4https://signalbhn.org/fhir/us/core/ValueSet/signal-state-activity-status Signal State Activity Statusdraft2023-09
signal.core.r4R4http://hl7.org/fhir/ValueSet/subscriber-relationship SubscriberPolicyholder Relationship Codesdraft2019-11
signal.core.r4R4http://hl7.org/fhir/ValueSet/contact-point-system ContactPointSystemdraft2019-10
signal.core.r4R4http://hl7.org/fhir/ValueSet/contact-point-use ContactPointUsedraft2019-10
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/us-core-discharge-disposition US Core Discharge Dispositionactive2022-09
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/us-core-encounter-type US Core Encounter Typeactive2022-09
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/us-core-problem-or-health-concern US Core Problem or Health Concernactive2022-09
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-condition-category US Core Screening Assessment Condition Categoryactive2023-04
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category US Core ServiceRequest Category Codesactive2022-09
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/us-core-simple-observation-category US Core Simple Observation Categoryactive2022-09
signal.core.r4R4http://hl7.org/fhir/us/core/ValueSet/us-core-usps-state USPS Two Letter Alphabetic Codesactive2022-09
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/CapabilityStatement/client Argonaut Provider Directory Clientdraft2016-11
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/CapabilityStatement/server Argonaut Provider Directory Serverdraft2017-04
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/ImplementationGuide/ig Argonaut Provider Directory Implementation Guidedraft
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-endpoint Argonaut Provider Directory Endpointdraft2016-11
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-location Argonaut Provider Directory Locationdraft2016-11
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-organization Argonaut Provider Directory Organizationdraft2016-11
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-practitioner Argonaut Provider Directory Practitionerdraft2016-11
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-practitionerrole Argonaut Provider Directory PractitionerRoledraft2016-11
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/ValueSet/provider-role Argonaut Provider Directory Provider Role (NUCC)draft2016-08
fhir.argonaut.pdR3http://fhir.org/guides/argonaut-pd/ValueSet/provider-specialty Argonaut Provider Directory Provider Speciality (NUCC)draft2016-08
hl7.fhir.us.patient-reported-outcomesR4CapabilityStatement/server Serverdraft2017-03
hl7.fhir.us.patient-reported-outcomesR4ImplementationGuide/ig Patient Reported Outcomesdraft
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ConceptMap/ndc-cvx Argonaut NDC to CVX Code Mappingactive2016-06
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ImplementationGuide/ig Implementation Guide Templatedraft
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/OperationDefinition/docref Argonaut Get DocumentReferencesdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/SearchParameter/ethnicity ArgonautEthnicitydraft2016-12
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/SearchParameter/race ArgonautRacedraft2016-12
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-allergyintolerance Argonaut AllergyIntolerance Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-birthsex Sex of patient assigned at birthdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-careplan Argonaut CarePlan Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-careteam Argonaut CareTeam Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-condition Argonaut Condition Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-device Argonaut Device Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-diagnosticreport Argonaut DiagnosticReport Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-documentreference Argonaut DocumentReference Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-ethnicity Argonaut ethnicity Extensiondraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-goal Argonaut Goal Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-immunization Argonaut Immunization Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-medication Argonaut Medication Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-medicationorder Argonaut MedicationOrder Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-medicationstatement Argonaut MedicationStatement Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-observationresults Argonaut Observation Results Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-patient Argonaut Patient Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-procedure Argonaut Procedure Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-profile-link Profile-Resource Associationdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-race Argonaut Race Extensiondraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-resource-documentation Resource level Documentationdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-smokingstatus Argonaut Smoking Status Observation Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/StructureDefinition/argo-vitalsigns Argonaut Vital Signs Observation Profiledraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/argo-codesystem Argonaut Extension Codesdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/condition-category Argonaut Condition Category Codesdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/detailed-ethnicity US-Core Detailed ethnicitydraft2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/detailed-race US-Core Detailed Racedraft2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/device-kind Argonaut Device Typesdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/languages All Languagesdraft2016-11
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/medication-codes Medication Clinical Drug (RxNorm)draft2016-05
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/narrative-status Narrative Statusdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/ndc-vaccine-codes Vaccine National Drug Code (NDC)draft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/observation-ccdasmokingstatus Smoking Statusactive2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/observation-ccdavitalsignresult Argonaut Vital Sign Codesactive2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/observation-value-codes Observation Value Codes (SNOMED-CT)draft2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/omb-ethnicity OMB Ethnicity Categoriesdraft2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/omb-race OMB Race Categoriesactive2016-05
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/procedure-icd10pcs Argonaut Procedure Type ICD-10-PCS Codesdraft2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/procedure-type Argonaut ProcedureTypedraft2016-05
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/provider-role Care Team Provider Rolesdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/substance-ndfrt DAF Substance ND-FRT codesdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/substance-rxnorm DAF Substance RxNorm Codesdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/substance-sct DAF SNOMED CT Substances Other Than Clinical Drugsdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/substance Argonaut Substance-Reactant for Intolerance and Negation Codesdraft2016-10
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/ucum-vitals-common Argonaut Vital Signs Unitsdraft2016-05
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/ucum UCUM unitsdraft2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/usrealm-birthsex USRealm Birth Sex Value Setactive2016-08
fhir.argonaut.r2R2http://fhir.org/guides/argonaut/ValueSet/vacc-status Argonaut Immunization Statusdraft2016-10
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-datamart Data Martdraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-datasource Data Sourcedraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-research-queryrequester Research Query Requesterdraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-research-queryresponder Research Query Responderdraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/CodeSystem/daf-research-data-models DAF Research Data Modelsdraft2017-04
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/CodeSystem/daf-research-query-formats DAF Research Query Formatsdraft2017-04
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/ImplementationGuide/ig Implementation Guide Templatedraft
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-execute-query Execute Querydraft2016-07
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-extract Extract Datadraft2016-07
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-load Load Datadraft2016-07
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-capabilitystatement U.S. Data Access Framework (DAF) Capability Statement Profiledraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-data-model Data Modelsdraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-operationdefinition U.S. Data Access Framework (DAF) OperationDefinition Profiledraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-provenance U.S. Data Access Framework (DAF) Provenancedraft2014-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-query-format Query Formatsdraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-queryresults U.S. Data Access Framework (DAF) Query Resultsdraft2014-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-task U.S. Data Access Framework (DAF) Task Profiledraft2016-08
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/ValueSet/daf-research-data-models DAF Research Data Modelsactive2016-07
hl7.fhir.us.dafR3http://hl7.org/fhir/us/daf-research/ValueSet/daf-research-query-formats DAF Research Query Formatsactive2016-07
fhir.tx.support.r4R4urn:oid:2.16.840.1.113883.3.1937.98.5.8 TemplateStatusCode LifeCycleactive2013-12
fhir.tx.support.r4R4https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats Australian Immunisation Register Vaccineactive2021-03
fhir.tx.support.r4R4http://cap.org/eCP College of American Pathologists Electronic Cancer Protocol (eCP) Codesactive2023-03
fhir.tx.support.r4R4http://terminology.hl7.org/CodeSystem/ICHContextOfUse ICH Context of Useactive2025-05
fhir.tx.support.r4R4http://devices.fhir.org/CodeSystem/MDC-concept-status MDC Concept Statusactive
fhir.tx.support.r4R4http://devices.fhir.org/CodeSystem/MDC-designation-use MDC Designation Useactive
fhir.tx.support.r4R4http://standardterms.edqm.eu EDQM Standard Termsactive2019-03
fhir.tx.support.r4R4http://terminology.hl7.org/CodeSystem/hl7-document-format-codes HL7 Document Format Codesactive2019-07
fhir.tx.support.r4R4urn:oid:2.16.840.1.113883.2.9.6.2.7 International Standard Classification of Occupations (ISCO)active2007-12
fhir.tx.support.r4R4http://hl7.org/fhir/spdx-license SPDXLicensedraft2021-01
fhir.tx.support.r4R4https://www.usps.com/ US State Codesactive2013-12
fhir.tx.support.r4R4http://hl7.org/fhir/resource-names-r2-r3 Resource Names R2 to R3active2019-01
fhir.tx.support.r4R4http://hl7.org/fhir/resource-names-r2-r4 Resource Names R2 to R4active2019-01
fhir.tx.support.r4R4http://hl7.org/fhir/resource-names-r3-r2 Resource Names R3 to R2active2019-01
fhir.tx.support.r4R4http://hl7.org/fhir/resource-names-r3-r4 Resource Names R3 to R4active2019-01
fhir.tx.support.r4R4http://hl7.org/fhir/resource-names-r4-r2 Resource Names R4 to R2active2019-01
fhir.tx.support.r4R4http://hl7.org/fhir/resource-names-r4-r3 Resource Names R4 to R3active2019-01
fhir.tx.support.r4R4http://fhir.org/packages/fhir.tx.support.r4/ImplementationGuide/fhir.tx.support.r4 FHIR Terminology Support Packageactive
fhir.tx.support.r4R4http://devices.fhir.org/ValueSet/MDC-dimension MDC Unit of Measurementactive
fhir.tx.support.r4R4http://devices.fhir.org/ValueSet/MDC-metric MDC Metric nomenclatureactive
fhir.tx.support.r4R4http://devices.fhir.org/ValueSet/MDC-object MDC Object infrastructure and Device nomenclatureactive
fhir.tx.support.r4R4http://devices.fhir.org/ValueSet/MDC-partition MDC Partition codesactive
fhir.tx.support.r4R4http://devices.fhir.org/ValueSet/MDC MDC Nomenclatureactive
fhir.tx.support.r4R4http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-gps-uv-ips Allergy-intolerance substance-product - GPS - IPSactive2021-05
fhir.tx.support.r4R4http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-snomed-extended-uv-ips Allergy intolerance substance product - SNOMED CT extended - IPSactive2021-05
fhir.tx.support.r4R4http://hl7.org/fhir/ValueSet/covid-19-cond COVID-19 related Condition codesdraft2020-03
fhir.tx.support.r4R4http://hl7.org/fhir/ValueSet/covid-19-obs COVID-19 related Observation codesdraft2020-03
fhir.tx.support.r4R4http://hl7.org/fhir/ValueSet/jurisdiction-common Common Jurisdiction Codesactive2020-09
fhir.tx.support.r4R4http://terminology.hl7.org/ValueSet/snomed-intl-ips SNOMED CT® International Patient Set (IPS)active2022-06
fhir.tx.support.r4R4https://www.iana.org/time-zones IANA Timezonesdraft2021-01
hl7.fhir.us.sdcdeR3CapabilityStatement/sdc-de-curator SDC Data Element Curatordraft2014-07
hl7.fhir.us.sdcdeR3CapabilityStatement/sdc-de-registry SDC Data Element Managerdraft2014-07
hl7.fhir.us.sdcdeR3ImplementationGuide/sdcde Structured Data Capture - Data Element Exchangedraft
hl7.fhir.us.sdcdeR3StructureDefinition/sdcde-codesystem Structured Data Capture Code Systemdraft2014-07
hl7.fhir.us.sdcdeR3StructureDefinition/sdcde-dataelement Structured Data Capture Data Element Exchangedraft2014-04
hl7.fhir.us.sdcdeR3StructureDefinition/sdcde-valueset Structured Data Capture Data Element Exchange Value Setdraft2014-07
hl7.fhir.us.sdcdeR3ValueSet/dataelement-sdccode DataElement SDC Conceptdraft2017-04
hl7.fhir.us.immdsR4CodeSystem/ForecastReason Forecast Reasonactive2021-06
hl7.fhir.us.immdsR4CodeSystem/ForecastStatus Forecast Statusactive2021-06
hl7.fhir.us.immdsR4CodeSystem/StatusReason Evaluation Status Reasonactive2021-06
hl7.fhir.us.immdsR4ImplementationGuide/hl7.fhir.us.immds Immunization Decision Support Forecast (ImmDS) Implementation Guideactive2021-06
hl7.fhir.us.immdsR4OperationDefinition/ImmDSForecastOperation Immunization Decision Support Forecastdraft2021-06
hl7.fhir.us.immdsR4StructureDefinition/immds-immunization ImmDS Immunizationactive2021-06
hl7.fhir.us.immdsR4StructureDefinition/immds-immunizationevaluation ImmDS Immunization Evaluationactive2021-06
hl7.fhir.us.immdsR4StructureDefinition/immds-immunizationrecommendation ImmDS Immunization Recommendationactive2021-06
hl7.fhir.us.immdsR4StructureDefinition/immds-patient ImmDS Patientactive2021-06
hl7.fhir.us.immdsR4ValueSet/ForecastReason Forecast Reasonactive2021-06
hl7.fhir.us.immdsR4ValueSet/ForecastStatus Forecast Statusactive2021-06
hl7.fhir.us.immdsR4ValueSet/StatusReason Evaluation Status Reasonactive2021-06
hl7.fhir.us.immdsR4ValueSet/targetDisease Vaccine Target Diseaseactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.12009.10.2.5 LOINC Imaging Document Codesactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45 Comfort Measuresactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1 Selected non pharmaceutical therapies for moderate to severe chronic painactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3 selected first line medications for pain controlactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3 selected muscle relaxants for pain controlactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3 Selected topical agents for pain controlactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2 selected non opioids for moderate to severe painactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2 Selected opioids for moderate to severe painactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1 pain medication action planactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1 Selected urine drug screens for opioids indicating testing is completeactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1 selected follow up visit intervals for opioid monitoringactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2 Selected urine screening for patients receiving opioid therapyactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.1 Opioids used for pain controlactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.2 All prescribable opioids used for pain control including Inactive Medicationsactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.1 malignant neoplasms and cancer painactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.2 malignant neoplasms and cancer painactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.7 malignant neoplasms and cancer painactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.9 malignancy or cancer related painactive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150 Cerumen on Otoscopyactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151 Cerumen on Otoscopyactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152 Cerumen on Otoscopyactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172 Hearing Lossactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173 Hearing Lossactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174 Hearing Lossactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175 Tinnitusactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176 Tinnitusactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177 Tinnitusactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178 Ear Congestionactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179 Ear Pruritusactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180 Otalgiaactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181 Otalgiaactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182 Otalgiaactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96 Initial Encounter with Otolaryngologist or undefined clinicianactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204 Hearing Aidsactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205 Hearing Aidsactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206 Hearing Aidsactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81 Cerumen Impactionactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82 Cerumen Impactionactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188 Radiotherapyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.189 Radiotherapyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190 Radiotherapyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191 Head and Neck Anatomic Locationsactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192 Conditions Associated with Head and Neck Radiotherapyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193 Conditions Associated with Head and Neck Radiotherapyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194 Ear Canal Stenosisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195 Ear Canal Stenosisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196 Ear Canal Stenosisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197 Exostosesactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198 Exostosesactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199 Exostosesactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200 Non intact Tympanic Membraneactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201 Non Intact Tympanic Membraneactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202 Non Intact Tympanic Membraneactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246 Hearing Aidsactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250 DO NOT USEactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251 Cerumenolyticsactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252 Irrigationactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253 Irrigationactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288 Otoscopy performed on examactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291 Otolaryngologist as a Clinician or Serviceactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123 Cerumen Impactionactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275 Dermatologic Diseases of the Earactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20 Keratoses Obturansactive2017-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221 Tympanoplastyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222 Tympanoplastyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223 Myringoplastyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224 Myringoplastyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225 Mastoidectomyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229 Mastoidectomyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227 Ear Surgery, Otheractive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228 Ear Surgery, Otheractive2018-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334 Sleep Apneaactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.335 Sleep Apneaactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336 Sleep Apneaactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237 Allergic Rhinitisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238 Allergic Rhinitisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239 Allergic Rhinitisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263 Uncontrolled or severe asthmaactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264 Uncontrolled or severe asthmaactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265 Uncontrolled or severe asthmaactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300 Rhinosinusitisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301 Rhinosinusitisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302 Rhinosinusitisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303 Nasal Polyposisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304 Nasal Polyposisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305 Nasal Polyposisactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306 Suspected Nasal Neoplasmactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307 Suspected Nasal Neoplasmactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308 Suspected Nasal Neoplasmactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309 Other sinus conditions potentially requiring imagingactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310 Other sinus conditions potentially requiring imagingactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319 Intranasal Antihistaminesactive2017-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320 Mast Cell Stabilizersactive2017-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321 Ophthalmic Antihistaminesactive2017-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215 Sneezing as a findingactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216 Sneezing as a Clinical Conditionactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217 Pruritus Unspecified or Other Locationactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218 Pruritus Unspecified or Other Locationactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272 Specific IgE Testing for Allergiesactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273 Immunoglobulin G Testingactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274 Total IgE Testingactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290 Clinicians who perform allergy testingactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279 Radiography of face, head or neckactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315 Intranasal Corticosteroidsactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316 Eustachian Tube Dysfunctionactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317 Eustachian Tube Dysfunctionactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318 Eustachian Tube Dysfunctionactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287 Oral Second Generation and Less Sedating Antihistaminesactive2017-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266 Leukotriene antagonistactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267 Immunotherapy that is not Identified as Subcutaneousactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268 Immunotherapyactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653 Fidaxomicinactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654 Proton Pump Inhibitors not including for H. pylori treatmentactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655 Clostridium difficile infectionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656 Clostridium difficile infectionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657 Clostridium difficile infectionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594 Complete Blood Count (with Diff)active2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662 Metronidazole Systemicactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663 Vancomycin non injectableactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665 Creatinineactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722 Ileus due to infectionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723 Ileus due to infectionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724 Ileus due to infectionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725 Vomiting potentially due to CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726 Vomiting potentially due to CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727 Vomiting potentially due to CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728 Toxic Megacolon in adultsactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729 Toxic Megacolon in adultsactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730 Toxic Megacolon in adultsactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731 Abdominal Distensionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732 Abdominal Distensionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688 Septic Shock due to C. Diffactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689 Septic Shock due to C. Diffactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690 Septic Shock due to C. Diffactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658 Antiperistaltic agents to avoid in C. diffactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734 Systemic Antimicrobial Medications not used for CDIactive2019-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659 Recurrent Clostridium difficile infectionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660 History of CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661 Consult Infectious Diseaseactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691 Abdominal Xrays for CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692 CT of abdomen with contrast for fulminant CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693 Surgical consult for CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694 Fecal microbiota transplantationactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645 Hospitalistactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697 Positive result indicatoractive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698 Clostridium Difficile Testactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646 Body Temperatureactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647 Body Temperatureactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648 Diarrhea Potentially due to CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649 Diarrhea Potentially due to CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650 Diarrhea Potentially due to CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651 Leukocyte countactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652 Inpatient Settingactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1 ONC Administrative Sexactive2015-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.1 Substance Reactant for Intoleranceactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.2 Clinical Substanceactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.4 Medication Clinical Drugactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.5 Medication Clinical Brand specific Drugactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6 CVX Vaccines Administered Vaccine Setactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.7 Clinical Drug Ingredientactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.8 Vaccine Clinical Drugactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9 Substance Other Than Clinical Drugactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.240 SNOMED CT CORE Problem Listactive2024-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98 Route of Administrationactive2019-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.101 Gender Identity USCDI coreactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.102 Unknown or did not answeractive2021-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.103 Other or unknown or refused to answeractive2021-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12 Low Molecular Weight Heparin for VTE prophylaxis ingredient specificactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.120 Patient Sex for Quality Measurementactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.121 Federal Administrative Sexactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.14 Published test VSactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.24 Birth Sexactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.30 AdministrationUnitDoseFormactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.33 Sexual Orientationactive2021-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.40 MDP Test Intensionalactive2019-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.41 MDP Test HL7 Intensionalactive2019-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.46 Device Magnetic resonance (MR) Safetyactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.47 Device Latex Safetyactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.48 Implantable Device Statusactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.56 Medical Reason Not Done SCTactive2019-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.119 Phototherapyactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.120 Phototherapyactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.121 Phototherapyactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.122 Neonatal Jaundiceactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.123 Neonatal Jaundiceactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.124 Neonatal Jaundiceactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125 Maternal Drug Useactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126 Maternal Drug Useactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127 Maternal Drug Useactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.128 Fetal Conditionsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.129 Fetal Conditionsactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.130 Fetal Conditionsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.131 Congenital Malformationsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.132 Congenital Malformationsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.133 Congenital Malformationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.134 Social Indicationsactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.135 Social Indicationsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.136 Social Indicationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.137 Neonatal Severe Birth Traumaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.138 Neonatal Severe Birth Traumaactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.139 Neonatal Severe Birth Traumaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.140 Neonatal Severe Hypoxia or Asphyxiaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.141 Neonatal Severe Hypoxia or Asphyxiaactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.142 Neonatal Severe Hypoxia or Asphyxiaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.143 Neonatal Severe Shock and Resuscitationactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.144 Neonatal Severe Shock and Resuscitationactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.145 Neonatal Severe Shock and Resuscitationactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.146 Neonatal Severe Respiratory Complicationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.147 Neonatal Severe Respiratory Complicationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.148 Neonatal Severe Respiratory Complicationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.149 Neonatal Severe Infectionactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.150 Neonatal Severe Infectionactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.151 Neonatal Severe Infectionactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.152 Neonatal Severe Neurological Complicationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.153 Neonatal Severe Neurological Complicationsactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.154 Neonatal Severe Neurological Complicationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.155 Neonatal Severe Shock and Resuscitation Proceduresactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.156 Neonatal Severe Shock and Resuscitation Proceduresactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.157 Neonatal Severe Shock and Resuscitation Proceduresactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.158 Neonatal Severe Respiratory Proceduresactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.159 Neonatal Severe Respiratory Proceduresactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.160 Neonatal Severe Respiratory Proceduresactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.161 Neonatal Severe Neurological Proceduresactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.162 Neonatal Severe Neurological Proceduresactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.163 Neonatal Severe Neurological Proceduresactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.164 Neonatal Severe Septicemiaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.165 Neonatal Severe Septicemiaactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.166 Neonatal Severe Septicemiaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.167 Neonatal Moderate Birth Traumaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.168 Neonatal Moderate Birth Traumaactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.169 Neonatal Moderate Birth Traumaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.170 Neonatal Moderate Respiratory Complicationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.171 Neonatal Moderate Respiratory Complicationsactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.172 Neonatal Moderate Respiratory Complicationsactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.173 Neonatal Moderate Respiratory Complications Proceduresactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.174 Neonatal Moderate Respiratory Complications Proceduresactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.175 Neonatal Moderate Respiratory Complications Proceduresactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.176 Neonatal Moderate Birth Trauma with LOSactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177 Neonatal Moderate Birth Trauma with LOSactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178 Neonatal Moderate Birth Trauma with LOSactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.179 Neonatal Moderate Respiratory Complications with LOSactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180 Neonatal Moderate Respiratory Complications with LOSactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181 Neonatal Moderate Respiratory Complications with LOSactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.182 Moderate Neurological Complications with LOS Proceduresactive2019-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.183 Neonatal Moderate Neurological Complications with LOS Proceduresactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.184 Neonatal Moderate Neurological Complications with LOS Proceduresactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.185 Neonatal Moderate Respiratory complications with LOS Proceduresactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186 Neonatal Moderate Respiratory complications with LOS Proceduresactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187 Neonatal Moderate Respiratory complications with LOS Proceduresactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.188 Single Liveborn Newborn Vaginalactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189 Single Liveborn Newborn Vaginalactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190 Single Liveborn Newborn Vaginalactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.191 Single Liveborn Newborn Cesareanactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192 Single Liveborn Newborn Cesareanactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193 Single Liveborn Newborn Cesareanactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.194 Birth Weightactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.195 Neonatal Moderate Infection with LOSactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196 Neonatal Moderate Infection with LOSactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197 Neonatal Moderate Infection with LOSactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.203 Neonatal Intensive Care Unitactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.204 Intensive Care Unitactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205 Neonatal Intensive Care Unitactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206 Intensive Care Unitactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.208 Blood Transfusion Administrationactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209 Blood Transfusion Administrationactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213 Blood Transfusionactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.214 Acute Respiratory Distress Syndromeactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.217 Amniotic Fluid Embolismactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.219 Aortic Aneurysmactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.220 Aortic Aneurysmactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.221 Cardiac Arrest Ventricular Fibrillationactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.223 Disseminated Intravascular Coagulationactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.225 Eclampsiaactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.227 Heart Failure Cardiac Arrest Related to Procedure or Surgeryactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.228 Heart Failure Cardiac Arrest Related to Procedure or Surgeryactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.229 Puerperal Cerebrovascular Disorderactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.231 Pulmonary Edemaactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.233 Acute Heart Failureactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.235 Severe Anesthesia Complicationsactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.237 Sepsisactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.239 Shockactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24 Blood Transfusion Administrationactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.241 Sickle Cell Disease with Crisisactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.243 Air and Thrombotic Embolismactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.245 Blood Transfusionactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246 Blood Transfusionactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.247 Conversion of Cardiac Rhythmactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248 Conversion of Cardiac Rhythmactive2021-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.249 Hysterectomyactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250 Hysterectomyactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.251 Tracheostomyactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252 Tracheostomyactive2021-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.253 Ventilationactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254 Ventilationactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.255 Severe Maternal Morbidity Diagnosesactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256 Severe Maternal Morbidity Proceduresactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.267 Gestational Diabetesactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.269 Gestational Diabetesactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.271 HIV in Pregnancy Childbirth and Puerperiumactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.272 HIV in Pregnancy Childbirth and Puerperiumactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.274 Preexisting Diabetesactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.275 Preexisting Diabetesactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.277 Previous Cesareanactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.278 Previous Cesareanactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.279 Pulmonary Hypertensionactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.281 Pulmonary Hypertensionactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.282 Multiple Pregnancyactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.284 Multiple Pregnancyactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.286 Bleeding Disorderactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.287 Bleeding Disorderactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.289 Morbid or Severe Obesityactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.290 Morbid or Severe Obesityactive2022-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.291 Economic Housing Instabilityactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.292 Economic Housing Instabilityactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.295 Thyrotoxicosisactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.296 Thyrotoxicosisactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.297 Preterm Birthactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.299 Preterm Birthactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.300 Placenta Accretaactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.302 Placenta Accretaactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.303 Placental Abruptionactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.305 Placental Abruptionactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.306 Neuromuscular Diseaseactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.308 Neuromuscular Diseaseactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.309 Autoimmune Diseaseactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.311 Autoimmune Diseaseactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.312 Mental Health Disorderactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.314 Mental Health Disorderactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.315 Bariatric Surgeryactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.317 Bariatric Surgeryactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.318 Substance Abuseactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.320 Substance Abuseactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.321 Anemiaactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.323 Anemiaactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.324 Severe Preeclampsiaactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.326 Mild or Moderate Preeclampsiaactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.327 Severe Preeclampsiaactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.329 Mild or Moderate Preeclampsiaactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.330 Hypertensionactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.332 Hypertensionactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.333 Renal Diseaseactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.335 Renal Diseaseactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.336 Gastrointestinal Diseaseactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.338 Gastrointestinal Diseaseactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.339 Cardiac Diseaseactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.341 Cardiac Diseaseactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.344 Aortic Aneurysmactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357 Conversion of Cardiac Rhythmactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358 Hysterectomyactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359 Tracheostomyactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360 Ventilationactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.361 Venous Thromboembolism in Pregnancyactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.363 Venous Thromboembolism in Pregnancyactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.364 Long Term Anticoagulant Useactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.366 Long Term Anticoagulant Useactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368 Preadmission Observation Undelivered Motheractive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369 ED Visit and OB Triageactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.370 Present on Admission is No or Unable To Determineactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.371 COVID 19 Confirmedactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372 COVID 19 Confirmedactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373 COVID 19 Confirmedactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.374 Respiratory Conditions Related to COVID 19active2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375 Respiratory Conditions Related to COVID 19active2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376 Respiratory Conditions Related to COVID 19active2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.377 Respiratory Support Proceduresactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378 Respiratory Support Proceduresactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379 Respiratory Support Procedures Related to COVID 19active2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.387 Placenta Increta or Percretaactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.388 Placenta Increta or Percretaactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67 Other Health Care Facilityactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10 Non essential Hypertension SNOMEDCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102 Suicide Attemptactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.11 Cirrhosis ICD9CMactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.12 Cirrhosis ICD10CMactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13 Cirrhosis SNOMEDCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14 Cirrhosisactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151 Polycystic Ovary Syndromeactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.16 Low Intensity Statin Therapy/Brandedactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.17 Moderate Intensity Statin Therapy/Brandedactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18 High Intensity Statin Therapy/Brandedactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.21 ALTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230 Gestational Diabetes SNOMED CTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.231 Gestational Diabetes ICD10CMactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233 All Results of High Risk HPV Testactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234 High Risk HPV Positive Resultsactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248 Suicide Attempt SNOMED CTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.26 Nonopioid pain medicationsactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263 High Risk Positive HPV Results Without HPV16 or HPV18active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264 CDS Pregnancyactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.265 CDS Pregnancy Intensionalactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266 Rhabdomyolysis Intensionalactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267 CDS Rhabdomyolysisactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268 HPV Negative Resultsactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.27 Non pharmacologic treatments for chronic pain ICD10PCSactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.28 Urine drug screen for pain managementactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29 Non pharmacologic treatments for chronic pain SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.292 Non pharmacologic treatments for chronic pain NCIactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296 SCT Findings 202209active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.298 Cervical Cytology Testactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.299 HPV 16 Testsactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.300 HPV 18 Testsactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302 Test Cervical Excision Proceduresactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.303 Statin Combinationsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.305 Counseling for Physical Activity CPTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.306 Counseling for Physical Activity ICD10CMactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307 Counseling for Physical Activity CDSactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.308 Cardiovascular disease 10Y riskactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309 SCT Findings 202309active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311 SCT Procedures 202209active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312 SCT Procedures 202309active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313 Statin Allergen Groupingactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.319 Steward Transfer Testactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.320 Opioids ATCPROD N02Aactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.322 Test 123active2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.34 Opioid pain medicationsactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36 Non pharmacologic treatments for chronic painactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.40 Suicide attemptactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.42 Naloxone and Nalmefene medicationsactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.43 Benzodiazepine medicationsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.44 Stool softeners and laxativesactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.47 Anxietyactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48 Anxietyactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.50 Sleep disordered breathingactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51 Sleep disordered breathingactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52 Anxietyactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53 Sleep disordered breathingactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.54 Adjuvant pain medicationsactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.55 Risk assessments relevant to pain managementactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.6 Non essential Hypertension ICD9CMactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.7 Non essential Hypertension ICD10CMactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79 Behavioral Counseling for Nutrition and Activity Referralactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85 Impaired Glucose Toleranceactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.87 Fasting Plasma Glucoseactive2023-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.88 Waist Circumferenceactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9 Hypertensionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90 Gestational Diabetesactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.92 First Degree Family Memberactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.94 Glucose Tolerance Test Resultsactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96 Dependence on dialysisactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.99 Gestational Diabetesactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.460 Cluster Headache (ICD10CM)active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.461 Cluster Headache (ICD9CM)active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464 Cluster Headacheactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.467 Medication Therapy for Cluster Headache (RXNORM)active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555 Patient Declines Treatment for Cluster Headache (SNOMEDCT)active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.558 Acute Cluster Headache Medication (RXNORM)active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.559 Long Term Preventive Medication for Cluster Headacheactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.561 Oral Steroid for Cluster Headacheactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.569 Migraine Preventive Medicationactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.601 Acute Migraine Attack Medicationactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.605 NSAID OTC Migraine Attack Medicationactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.606 NSAID Prescribable Migraine Attack Medicationactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.640 Neurologic Disordersactive2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641 Neuromodulation for migraineactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642 No pain with headacheactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.643 Antiplateletsactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.644 Anticoagulantsactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.645 Statin Medicationsactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646 Anxiety Disorders (ICD10 and SNOMED)active2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648 Depression Diagnosis (ICD10 and SNOMED)active2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649 Psychosis (ICD10 and SNOMED)active2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650 Cluster Headache (SNOMED)active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651 Galcanezumab (RxNorm)active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.652 Lithium (RxNorm)active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.653 Verapamilactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.654 Long term preventive medications for cluster headacheactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.655 Short term preventive medication for cluster headacheactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.656 Zolmitriptanactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.657 Sumatriptanactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.658 Dihydroergotamineactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.659 Acute cluster headache medicationactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660 Acute cluster headache treatmentactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.661 Short term preventive treatment for cluster headacheactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662 Long term preventive treatment for cluster headacheactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.663 Migraine diagnosis (ICD)active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.664 Prescribable NSAIDs and Acute Migraine Attack Medicationactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.103 Abnormal Presentationactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105 Abnormal Presentationactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.114 Hematocrit Lab Testactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.117 Potassium Lab Testactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.119 Sodium Lab Testactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.127 Platelet Count Lab Testactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.129 White Blood Cells Count Lab Testactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.130 Respiratory Rateactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.134 Glucose Lab Testactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.139 Bicarbonate Lab Testactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15 Intravenous Thrombolytic tPA Therapyactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.151 Oxygen Saturation by Pulse Oximetryactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.152 Body Temperatureactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.159 Body Weightactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16 Intraarterial Thrombolytic tPA Therapyactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.163 Systolic Blood Pressureactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171 Abnormal Presentationactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173 Delivery of Singletonactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21 Intravenous or Intraarterial Thrombolytic tPA Therapyactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.26 Estimated Gestational Age at Deliveryactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27 Cornual Ectopic Pregnancyactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.38 General Or Neuraxial Anesthesiaactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.39 Low Dose Unfractionated Heparin for VTE Prophylaxisactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41 Glycoprotein IIb IIIa Inhibitorsactive2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.55 Oxytocinactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.56 Dinoprostoneactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.58 Delivery Proceduresactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59 Delivery Proceduresactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.66 PCIactive2017-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67 PCIactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.68 Endotracheal Intubationactive2018-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69 Endotracheal Intubationactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.98 Delivery of Singletonactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99 Delivery of Singletonactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225 Opioid Medication Assisted Treatment (MAT) SNOMEDactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.241 Schedule II, III and IV Opioid Medicationsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.242 Opioid Use Disorderactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243 Opioid Use Disorderactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.265 Inpatient, Emergency, and Observation Locationsactive2022-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269 Medications for Opioid Use Disorder (MOUD)active2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.274 NHSN Inpatient Encounter Class Codesactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.277 Emergency Department Locationactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.278 Emergency Department Treatment Locationactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279 Triageactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283 Emergency Department Locationactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284 Emergency Department Locationactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285 Mental Health Diagnosis without Substance Use Disordersactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286 Decision to Transferactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.35 Healthcare Agent or Proxy Choicesactive2022-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10 Breastfeedingactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100 Familial Hypercholesterolemiaactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102 Rhabdomyolysisactive2017-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.107 Low Intensity Statin Therapyactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12 Liver Diseaseactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13 Rhabdomyolysisactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.19 Atherosclerosis and Peripheral Arterial Diseaseactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20 Atherosclerosis and Peripheral Arterial Diseaseactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21 Atherosclerosis and Peripheral Arterial Diseaseactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.22 Liver Disease ICD9active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.37 Stable and Unstable Anginaactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.39 Cerebrovascular Disease Stroke or TIAactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.41 Ischemic Heart Disease or Related Diagnosesactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.42 Liver Diseaseactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.43 Liver Diseaseactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.44 Cerebrovascular Disease Stroke or TIAactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.46 Ischemic Heart Disease or Related Diagnosesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.47 Stable and Unstable Anginaactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.501 Overweight or Obeseactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.502 Overweight or Obeseactive2018-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.512 Elevated Blood Pressure Readingactive2019-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.513 Elevated Blood Pressure Readingactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.514 Finding of Elevated Blood Pressure or Hypertensionactive2019-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.515 Bariatric Proceduresactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.517 Age related macular degeneration intermediate dryactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.518 Ophthalmologist visitactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.519 Posterior vitreous detachment (PVD)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.521 Ophthalmoscopic examactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.523 Opthalmoscopic exams with Scleral Depressionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.525 Referral (ophthalmology)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.526 Retina Ultrasoundactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.527 Retina visualization inadequateactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.528 Refusal or Noncompliance with treatmentactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.529 Vitreous hemorrhageactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.530 Vitreous hemorrhageactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.536 Macula examinationactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.539 Fluorescein angiographyactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.541 Optical coherence tomography (OCT)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.542 Intravitreal injectionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543 Bevacizumab injectionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.544 Ranibizumab injectionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.545 Aflibercept injectionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.552 Uveitisactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.553 Uveitisactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.554 Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edemaactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.555 Macular edemaactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.556 Corticosteroids for Injectionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.557 Corticosteroids for Injectionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.560 Tonometryactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.561 Intraocular pressureactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.571 Retinal Vein Occlusion Related Macular Edemaactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.576 Vitreous hemorrhageactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.580 Intravitreal and Periocular Injectionsactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.581 Intravitreal and Periocular Injectionsactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.582 Corticosteroids for Injectionactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.583 Endophthalmitis in the Right Eyeactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.584 Endophthalmitis in the Left Eyeactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.585 Panophthalmitis in the Right Eyeactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.586 Panophthalmitis in the Left Eyeactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.587 Lost to follow upactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.588 Uveitisactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.610 Scleral depressed examactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.611 3 Mirror Goldmann examactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.612 Scleral depressed examactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.615 Physical Disabilityactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.616 Financial difficultyactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.617 Vitreous exam findingsactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.619 Scleral depressed examactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.629 Post operative follow upactive2020-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.67 Breastfeedingactive2017-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.69 Stable and Unstable Anginaactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.70 Ischemic Heart Disease or Related Diagnosesactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.71 Cerebrovascular Disease Stroke or TIAactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.73 Breastfeedingactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.85 Familial Hypercholesterolemiaactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.89 Rhabdomyolysisactive2017-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.9 Outpatient Encounters for Preventive Careactive2019-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.91 Familial Hypercholesterolemiaactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.93 Hypercholesterolemia ICD 9active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.97 High Intensity Statin Therapyactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.98 Moderate Intensity Statin Therapyactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.50 HIV Lab Testsactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.51 Indicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.52 Indicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.53 Indicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.71 Human Immunodeficiency Virus (HIV) Viral Loadactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.10 ARBs (Angiotensin Receptor Blockers)active2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1000 OIA_V2_GLP1s_RxNormsactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1001 OIA_V2_PCSK9s_RxNormsactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1002 OIA_RFs_Secondary_Prevention_ICD10active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1003 OIA_RFs_Secondary_Prevention_SNOMEDactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1004 OIA_RFs_Secondary_Prevention_CPTactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1005 OIA_RFs_Secondary_Prevention_ICD_SM_CPTactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1006 OIA_Asthma_COPD_Combo_Medsactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1007 OIA_Asthma_COPD_Combo_Meds_SABA_SAMAactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1008 OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICSactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1009 PAE_Patient_Conditionsactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1012 PAE Conditions Shortactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1016 OIA_TEST_VSactive2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1017 Triptan Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1018 NSAID Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1019 Statin Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1021 Penicillin Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1022 Macrolide Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1023 Quinolone Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1025 Beta blocker Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1026 ACE inhibitor Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1027 ARB Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1028 Sulfonylurea Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1030 DPP4i Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1031 GLP1RA Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1032 Beta blocker allergy intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1033 SGLT2i Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1034 MRA Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1036 Meglitinide Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1037 Alpha glucosidase inhibitor Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1038 TZD Allergy NDFRTactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1041 Hemoglobinactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1042 Hematocritactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1043 Anemia for Erythropoesis Simulating Agents I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1044 Anemia for Erythropoesis Simulating Agents SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1045 Anemia for Erythropoesis Simulating Agentsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1046 AZT Medsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1047 Ferritinactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1048 Knee pain I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1049 Knee pain SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.105 conditions_heartfailureactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1050 Knee painactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1051 Knee decreased ROM SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1052 Knee effusion I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1054 Knee effusionactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1055 Knee crepitus SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1056 OIA_Antiemeticsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1057 OIA_PDE5isactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1058 OIA_Vitaminsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1059 OIA_Plavixactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1061 OIA_Oral_Contraceptivesactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1063 OIA_Topical_Steroidsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1064 OIA_Cough_Cold_Medsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1065 Antiperspirant aluminum saltsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1066 Antiperspirant anticholinergicsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1067 Antieplieptic medicationsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1068 Antidepressant medicationsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1069 Urinary incontinence SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1070 Urinary incontinence I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1071 Urinary incontinenceactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1073 Hemifacial spasm SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1074 Hemifacial spasm I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1075 Hemifacial spasmactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1076 Spasmodic dysphonia SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1077 Physical therapy procedure SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1078 Occupational therapy SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1079 Hyperhidrosis SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1080 Hyperhidrosis I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1081 Hyperhidrosisactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1082 Tic disorder I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1083 Tic disorder SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1084 Tic disorderactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1085 Esophageal achalasia SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1086 Esophageal achalasia I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1087 Esophageal achalasiaactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1088 ET propanolol or primidoneactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1089 ET topiramate alprazolam or gabapentinactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.109 CKD stage4above I10active2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1090 Blephraospasm SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1091 Blepharospasm I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1092 Blepharospasmactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1093 Strabismus SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1094 Strabismus I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1095 Strabismusactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1096 Overactive bladder SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1097 Overactive bladder I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1098 Overactive bladderactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1099 Movement disorders SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.110 CKD stage4above SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1100 Movement disorders I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1101 Movement disordersactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1102 Lateral epicondylitis SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1103 Lateral epicondyltisis I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1104 Lateral epicondylitisactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1105 Plantar fasciitis SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1106 Plantar fasciitis I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1107 Plantar fasciititsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1108 Cardiac CT SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1109 Cardiac CT CPTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.111 CKD stage4aboveactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1111 Cardiac CTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1112 Cardiac MRI SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1113 Cardiac MRI CPTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1114 Cardiac MRIactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1115 CT Angiography of Coronary Artery SCTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1116 CT Angiography of Coronary Artery CPTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1117 CT Angiography of Coronary Arteryactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.112 Chronic kidney disease I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.113 Chronic kidney disease SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.116 DigTx Cognitive Impairment I10active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.117 DigTx Cognitive Impairment SCTactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.120 Diabetic ketoacidosis SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.121 Diabetic ketoacidosisactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.124 DKDactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.146 Long Acting Muscarinic Antagonists (LAMA)active2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.147 HFrEF SCTactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.148 HFrEF I10active2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.15 Kidney tansplantactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.150 History of Hypoglycemia I10active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.151 History of Hypoglycemia SCDactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.153 Hyperlipidemiaactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.159 conditions_COPD I10active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.168 medications_COPDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.17 Atrial fibrillationactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.173 Asthma I10active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.175 Asthmaactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.184 DigTx Virtual Reality Contraindications Visual Impairmentactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.186 Beta blockers GDMT for heart failureactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.188 medications_heart failureactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.189 SGLT2iactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.193 relatedconditions_COPD I10active2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.197 Blood (Serum and Plasma) Potassiumactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.202 Serum Creatinineactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.21 Thoracic aorta diseaseactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.214 Type 1 Diabetes Mellitus SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.224 Systolic Heart Failure I10active2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.226 Systolic Heart Failureactive2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.238 MRA mineralocorticoid receptor antagonistsactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.244 MRA Mineralocorticoid Receptor Antagonist Allergyactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.252 relatedconditions_Heart failure I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.260 UACR SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.263 Pregnancy I10active2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.281 Statins Allergy SCTactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.282 Statin Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.292 Metabolic syndrome I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.3 Delivery I10active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.314 relatedconditions_hyperlipidemia I10active2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.322 Angina I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.325 Tachyarrhythmia I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.337 Migraine I10active2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.34 Blood pressure panelactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.35 Systolic Blood Pressureactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.350 Coronary artery disease I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.367 Trandolaprilactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.369 Candesartanactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.37 relatedconditions_hypertension SCTactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.377 Valsartanactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.38 relatedconditions_hypertension I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.397 eGFRactive2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.409 Hypertension I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.412 Statin Moderate Intensityactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.415 LDL Cholesterolactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.43 Urinalysisactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.434 Insulinactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.437 TZD Thiazolidinedionesactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.438 medications_T2DMactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.439 relatedconditions_T2DM I10active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.440 relatedconditions_T2DM SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.442 Blood Glucoseactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.45 ACE inhibitor allergy RXNORMactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.455 Metabolic acidosis I10active2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.459 Liver canceractive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.47 ACE inhibitor allergy SCTactive2022-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.473 Tetanus toxoid, diphtheria (Td) Vaccineactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.474 Allergy to Tdap Vaccineactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.475 Allergy to Td Vaccineactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.476 Allergy To Vaccine Componentactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.478 Allergy to HPV Vaccineactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.481 medications_hypertensionactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.492 Inhaled Corticosteroids Allergyactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.498 Metformin AllergyIntolerance SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.5 Delivery - Procedureactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.508 Abdominal aortic imaging CPTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.516 Allergy to Herpes Zoster Vaccine SCTactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.517 Hemoglobin A1cactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.518 Drug hypersensitivity I10active2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.519 Drug hypersensitivity SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.520 Drug hypersensitivityactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.521 Diabetic Kidney Disease I10active2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.523 Diabetic kidney diseaseactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.524 Chronic Hepatitis SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.525 Chronic Hepatitisactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.527 OCS_Prednisoneactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.528 High Dose Non Combo ICS Adultactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.529 Medium Dose Non Combo Asthma ICS Adultactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.530 Low Dose Non Combo ICSactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.531 Anti IgE Medicationsactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532 IL5 Antagonistsactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.533 Mast cell stabilizers for asthmaactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.534 Vasospastic disease I10active2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.535 Vasospastic disease SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.536 Vasospastic diseaseactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.537 Hemiplegic and basilar migraine I10active2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.538 Hemiplegic and basilar migraine SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.539 Hemiplegic and basilar migraineactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.540 Peptic ulcer disease I10active2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.541 Peptic ulcer disease SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.542 Peptic ulcer diseaseactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.544 Bleeding disorder I10active2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.545 Bleeding disorder SCTactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.548 Electronic cigarettes or Vapingactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.549 Bleeding disorderactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.551 Heart Rateactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.552 Triptansactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.553 CGRP receptor antagonistsactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554 Ditansactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.555 Ergotsactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.556 Migraine specific NSAIDsactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.557 OTC migraine analgesicsactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.558 Butalbital analgesicsactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.559 medications_migraine_acuteactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.560 relatedconditions_migraine I10active2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.561 conditions_migraineactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.562 relatedconditions_migraine SCTactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.563 relatedconditions_migraineactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.564 Triptan Allergy Intolerance SCTactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565 Triptan Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.566 Ischemic bowel disease SCTactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.567 Ischemic bowel disease I10active2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.568 Ischemic bowel diseaseactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.569 Allergen Immunotherapyactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.570 Allergy to house dust mites SCTactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.571 Allergy to house dust mites I10active2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.572 Allergy to house dust mitesactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.573 conditions_hyperlipidemia I10active2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.574 conditions_hyperlipidemia SCTactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.575 conditions_hyperlipidemiaactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.578 PIM_Schedule Vactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.580 PIM_Acarboseactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581 PIM_Avandametactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.582 PIM_Dulaglutideactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.583 PIM_Glimepirideactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.585 PIM_Glucophageactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.587 PIM_Glucovanceactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.588 Glyburide PIMactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.590 Alpha glucosidase inhibitorsactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.592 Azotemiaactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.594 Intolerance to ARB SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.595 ICS Lowactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.596 ICS Mediumactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.597 ICS Highactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.598 Low Dose ICS Formoterolactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.599 PIM_Vitamin B12 Level_LOINC_CPTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.600 PIM_Vitamin B12 Level_LOINCactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.601 PIM_Vitamin B12 Level_CPTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.604 PIM_Glyburideactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.605 PIM_Pioglitazoneactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.606 PIM_Semaglutideactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.607 PIM_Linagliptinactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.609 Macrolide_Azithromycinactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.61 Secondary antihypertensivesactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.610 Long Acting Beta Agonists (LABA) Non_Formoterolactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.611 relatedconditions_Asthma I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.612 Wolff Parkinson White SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.613 Wolff Parkinson White I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.614 Wolff Parkinson Whiteactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.615 medications_Asthmaactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.617 HighICS_LABA_NonFormoterolactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.618 relatedconditions_Asthma SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.619 ICS_LABA_LAMAactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.620 Low Dose ICS_LABA_Non Formoterolactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.621 Medium ICS_LABA Non Formoterolactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.622 relatedconditions_Asthmaactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.623 LAMA Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.624 LABA Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.625 BetaBlock NonCS Secondary Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.626 Eplerenone Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.627 Spironolactone Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.628 SGLT2 Inhibitors Allergy SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.629 PIM_Refill_Request_Antilipemics_LFTsactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.630 Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.631 Pneumococcal Vaccine Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.632 Meglitinides Allergy SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.633 DPP4i Allergy SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.635 Alpha_glucosidase inhibitors allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.636 Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.637 Insulins Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.638 TZD Allergy SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.639 T2DM_Medications Allergy SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.642 T2DM_Medications Allergy RXNORMactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.643 T2DM_Medications Allergy SNOMEDactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646 T2DM_Medication Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647 Statins Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649 ACE Inhibitors Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650 ARB Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652 Long Acting Muscarinic Antagonists (LAMA) Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653 Long Acting Beta Agonists (LABA) Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654 BetaBlocker NonCS Secondary Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656 MRA Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657 Eplerenone Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658 Spironolactone Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659 SGLT2i Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660 Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661 Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665 Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666 Human Papillomavirus (HPV) vaccine Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.667 Herpes Zoster Vaccine Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670 Pneumococcal Vaccine Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671 Inhaled Corticosteroids(ICS) Allergy Intoleranceactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.672 LABA(Formoterol only)active2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.674 PIM_Tirzepatideactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675 GLP1RA Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.676 PIM_Diabetes_Testing_Suppliesactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.677 PIM_H2_Antagonistsactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.678 SGLT2i DM CKDactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.679 SGLT2i DM ASCVDactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.680 GLP1RA DM ASCVDactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.683 OIA_Gout_Medicationsactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.684 GlumetzaSubstitutionactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.685 MetforminER500mgactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.686 PIM_Metforminactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.687 PIM_Glipizideactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.689 PIM_Glipizide_Glyburide_Glimepirideactive2024-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.690 PIM_Insulin_Meglitinidesactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691 PIM_Glyxambiactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.692 PIM_Farxigaactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.693 PIM_Invokanaactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.694 PIM_Jardianceactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.695 PIM_Invokana_Jardianceactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696 Reclastactive2023-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.697 LAMA_LABA Combination 1 Inhaleractive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.698 PIM_Contraceptivesactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.699 Selected Oral Antiemetics for Migraineactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.700 PIM_DEXA_Scanactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.701 PIM_DEXA_Scan_CPT_LOINCactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.702 PIM_SSRIsactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.703 PIM_SNRIsactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.704 PIM_NRIsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.705 PIM_TCAsactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.706 PIM_Citalopramactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.707 PIM_Hydroxyzineactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.708 PIM_Buspironeactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.709 PIM_Bupropionactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.710 PIM_Mirtazapineactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.711 PIM_Trazodoneactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.712 PIM_IHD_CHD_CAD_ICD10active2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.713 PIM_IHD_CHD_CAD_SNOMEDactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.714 PIM_Gabapentinactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.715 PIM_Allergy_Nasal_Spraysactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.716 PIM_Allergy_Oral_Medsactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.717 PIM_Allergy_Nasal_Oralactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.719 OCS_Prednisoloneactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.72 Inhaled corticosteroids (IC)active2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.720 COPD_Ofloxacinactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.721 COPD_Ciprofloxacinactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.722 COPD_Doxycyclineactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.723 Macrolide Allergy SCTactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724 Macrolide Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.725 Prednisone Allergy SCTactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.727 Tetracycline Allergy SCTactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728 Tetracycline Allergy Intoleranceactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.729 Fluoroquinolones Allergy SCTactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730 Fluoroquinolone Allergy Intoleranceactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.731 Penicillin Allergy RXNORMactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.732 Penicillin Allergy SCTactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733 Penicillin Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.734 PIM_Metformin_Single_Ingredient_Onlyactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.735 PIM_Metformin_Combo_Ingredient_Onlyactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.736 Pneumonia I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.737 Pneumonia SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.738 Pneumoniaactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.739 Pulmonary Embolism I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.742 Pulmonary Embolism SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.743 Pulmonary Embolismactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.744 Influenza I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.745 Influenza SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.746 Influenza (Tests for influenza A or B virus Antigen)active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.747 Influenzaactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.748 COVID 19 I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.749 COVID19 SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.750 COVID19active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.752 RSV I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.753 RSV SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.754 RSVactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.755 Respiratory Rate SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.756 Respiratory Rate LOINCactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.757 Respiratory Rateactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.758 Acute Respiratory Failure I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.759 Acute Respiratory Failure SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.760 Acute Respiratory Failureactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.761 Dyspnea SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.762 Dyspnea I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.763 Dyspneaactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.764 Confusion I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.765 Confusion SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.766 Confusionactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.767 Drowsiness SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.768 Drowsiness I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.769 Drowsinessactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.770 Cyanosis I10active2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.771 Cyanosis SCTactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.772 Cyanosisactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.775 Arterial oxygen saturation LOINCactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.776 Arterial oxygen saturation SCTactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.777 Arterial oxygen saturationactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.779 PIM_Potassium_Supplementsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.780 PIM_PPIsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.781 PIM_Migraine_Medications_Abortiveactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.782 PIM_Migraine_Medications_Preventiveactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.783 PIM_Bisphosphonatesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.784 PIM_BPH_Medicationsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.785 PIM_Thyroid_Replacement_Medicationsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.786 PIM_Overactive_Bladder_Medicationsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.787 PIM_Topical_Acne_Medicationsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.788 PIM_Antidepressant_Anxiolytic_Medicationsactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.789 Simple Knee Pain I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.790 Simple Knee Pain SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.791 Simple Knee Painactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.792 Simple Left Knee Pain SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.793 Simple Right Knee Pain SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.794 Simple Right Knee Pain I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.795 Simple Left Knee Pain I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.796 Simple Right Knee Painactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.797 Simple Left Knee painactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.798 Knee joint surgery CPTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.799 Knee joint surgery SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.800 Knee joint surgeryactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.801 Knee Osteoarthritis I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.802 Knee Osteoarthritis SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.803 Knee Osteoarthritisactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.804 Osteoarthritis of right knee SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.805 Osteoarthritis of left knee SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.806 Osteoarthritis of right knee I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.807 Osteoarthritis of left knee I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.808 Osteoarthritis of right kneeactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.809 Osteoarthritis of left kneeactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.810 Hip Osteoarthritis SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.811 Hip Osteoarthritis I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.812 Hip Osteoarthritisactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.813 Hip joint surgery CPTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.814 Hip joint surgery SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.815 Hip joint surgeryactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.816 Osteoarthritis of right hip I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.817 Osteoarthritis of left hip I10active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.818 Osteoarthritis of right hip SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.819 Osteoarthritis of left hip SCTactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.820 Osteoarthritis of right hipactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.821 Osteoarthritis of left hipactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.822 DigTx RelieVR inclusions I10active2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.823 Aminoglycosidesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.824 Carbapenemsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.826 Monobactamsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.827 Penicillinsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.828 Antimycobacterialsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.829 Beta_lactamaseactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.830 Cyclic lipopeptidesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.831 Lincosamidesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.832 Macrolidesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.833 Amphenicolactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.834 Oxazolidinonesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.835 Fluoroquinolonesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.836 Sulfonamidesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.837 Tetracyclinesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.838 Phosphonicsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.839 Pleuromutilinactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.840 Streptograminsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.841 Lipoglycopeptidesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.842 Nitroimidazolesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.843 PIM_Hyd_Bus_Mir_Traactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.844 Nitrofuransactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.845 Rifamycinsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.846 Glycylcyclineactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.847 Pyrimidinesactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.849 Antibiotics oral and parenteralactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.85 PCSK9iactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.850 Medications_hyperkalemiaactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.852 Hyperkalemia_ICD10active2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.853 Hyperkalemia_SCTactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.854 Hyperkalemia Conditionsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.855 Medications_Chronic Hyperkalemiaactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.858 PIM_Alpha_Blockers_2active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.860 PIM_Ambulatory_Visits_CPTsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.862 PIM_Ambulatory_Visits_SNOMEDactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.863 PIM_Thyroid_Stimulating_Hormone_(TSH)active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.864 PIM_Triiodothyronine_(T3)active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.865 PIM_Thyroxine_(T4)active2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.866 PIM_Magnesium_LOINCactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.867 PIM_BMP_CMP_LOINCactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.868 PIM_URIC_ACID_LOINCactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.869 PIM_Migraine_Medicationsactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.870 PIM_Triptansactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.871 ICS_SABA Relieveractive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.873 PIM_Asthma_COPD_Medsactive2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.874 PIM_Lipid_Panel_CPTsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.875 PIM_Hepatic_Function_Panel_CPTsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.876 Alpha Glucosidase Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.877 Inflammatory bowel disease I10active2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.878 Inflammatory bowel disease SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.879 Inflammatory bowel diseaseactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.88 DEPRECATED Diabetesactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.880 Gastrointestinal obstruction SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.881 Gastrointestinal obstruction I10active2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.882 Gastrointestinal obstructionactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.883 DPP4i Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.884 Multiple endocrine neoplasia type 2 (MEN II) SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.885 Multiple endocrine neoplasia type 2 (MEN II) I10active2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.886 Multiple endocrine neoplasia type 2 (MEN II)active2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.887 Gastroparesis SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.888 Gastroparesis I10active2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.889 Gastroparesisactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.890 Meglitinide Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.891 Sulfonylurea Allergy Intoleranceactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.892 Peripheral edema I10active2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.893 Peripheral edema SCTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.894 Peripheral edemaactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.895 TZD Allergy Intoleranceactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.896 PIM_Beta_Blockersactive2024-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.897 PIM_CCB_DHPsactive2024-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.898 PIM_Loop_Diureticsactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.899 PIM_Inhaled_Corticosteroids_(ICS)active2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.9 ACE inhibitorsactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.90 ASCVD I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.900 PIM_Leukotrienesactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.901 OIA_Asthma_COPD_Meds_Inhalersactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.902 OIA_Asthma_COPD_Meds_Nebulizersactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.903 OIA_Asthma_COPD_Meds_Oralactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.904 OIA_GLP1_Injectablesactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.905 OIA_Insulin_Injectablesactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.906 OIA_Oral_Hypoglycemicsactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.907 OIA_DM1_DM2_Medsactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.908 Medium Dose ICS Formoterolactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.909 High Dose ICS Formoterolactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.910 CKD stage5OrESRD I10active2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.911 CKD stage5OrESRD SCTactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.912 CKD stage5OrESRDactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.914 Anxiety_I10active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.915 Anxiety_SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.916 Anxietyactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.918 Stress_SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.919 Stress_I10active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.92 ASCVDactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.920 Stressactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.921 PBH_Anxiety_SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.922 PBH_Depression_SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.923 PBH_Stress_SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.924 PBH_Insomnia_SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.925 PIM_CMP_CPTsactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.926 Canagliflozin medsactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.927 Empagliflozin medsactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.928 Dapagliflozin medsactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.929 Ertugliflozin medsactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.93 Albuminuria I10active2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.930 Dulaglutide medsactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931 Liraglutide medsactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.932 Semaglutide SC medsactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.933 T2DM meds benefitting ASCVDactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.934 T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/minactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.935 T2DM meds benefitting CKD stage 5active2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.936 T2DM meds benefitting HF with eGFR >= 20 mL/minactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.938 Crohn disease SCTactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.939 Crohn disease I10active2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.94 Albuminuria SCTactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.940 Crohn diseaseactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.941 Celiac disease SCTactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.942 Celiac disease I10active2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.943 Celiac diseaseactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.944 OIA_Bisoprololactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.945 OIA_PVD_ICD10active2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.946 Vibration Controlled Transient Elastography (VCTE)active2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.947 OIA_Antihypertensive_Medicationsactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.95 Albuminuriaactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.950 OIA_CAD_ICD10active2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.951 OIA_DM_ICD10active2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.952 OIA_Creatinine_Levels_LOINCactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.953 OIA_DM_SNOMEDCTactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.954 OIA_CAD_SNOMEDCTactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.955 OIA_PVD_SNOMEDCTactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.956 OIA_DM_ICD10_SNOMEDCTactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.957 OIA_CAD_ICD10_SNOMEDCTactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.958 OIA_PVD_ICD10_SNOMEDCTactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.959 ACEi for HFrEFactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.96 AlcoholicLiverDisease I10active2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.960 ARB for HFrEFactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.961 OIA_AntiHTN_Meds_Inclusion_Listactive2024-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.962 OIA_Thiazide_Diureticsactive2024-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.963 OIA_RFs_ACS_ICD10active2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.964 OIA_RFs_ACS_SNOMEDactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.965 OIA_RFs_ACS__ICD10_SNOMEDactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.966 OIA_Aortic_Calcifications_ICD10active2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.967 OIA_Aortic_Calcifications_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.968 OIA_Aortic_Calcifications_ICD10_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.969 OIA_Microalbuminactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.97 Sulfonylurea AllergyIntolerance SCTactive2023-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.970 OIA_LDL_Cholesterolactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.971 Pioglitazoneactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.972 MASLD I10active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.973 MASLD SCTactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.974 MASLDactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.975 OIA_Sulfonylureasactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.976 Ensifentrineactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.977 Dupilumabactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.978 OIA_RFs_ASCVD_ICD10active2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.979 OIA_RFs_ASCVD_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.98 BMI LOINCactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.980 OIA_RFs_ASCVD_ICD10_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.981 OIA_TIA_ICD10active2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.982 OIA_TIA_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.983 OIA_TIA_ICD10_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.984 OIA_Angina_ICD10active2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.985 OIA_Angina_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.987 OIA_Angina_ICD10_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.988 OIA_Ischemic_Hemorrhagic_Stroke_ICD10active2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.989 OIA_Ischemic_Hemorrhagic_Stroke_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.99 BMI SCTactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.990 OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.991 OIA_Myocardial_Infarction_ICD10active2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.992 OIA_Myocardial_Infarction_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.993 OIA_Myocardial_Infarction_ICD10_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.995 OIA_PAD_ICD10active2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.996 OIA_PAD_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.997 OIA_PAD_ICD10_SNOMEDactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.998 OIA_Coronary_Arterial_Revascularizationactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.5 Contact or Office Visitactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.6 Contact or Office Visitactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.7 Contact or Office Visitactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.10 Nutrition Diagnosis SNOMED CTactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.101 Hospice Statusactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.11 Nutrition Focused Physical Findings SNOMED CTactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.14 Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CTactive2020-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.17 Pediatric Enteral Formulas SNOMED CTactive2021-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.18 Modified Amino Acid Formulas SNOMED CTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.19 Nutrition Counseling Approach and Strategies SNOMED CTactive2020-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.2 Food and Nutrient Delivery SNOMED CTactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.20 Enteral Nutrition Management SNOMED CTactive2020-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.21 Nutrition Assessmentactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.24 Malnutrition Assessmentactive2015-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.25 Nutritional Status Severely Malnourishedactive2016-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.29 Malnutrition Assessmentactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.30 Malnutrition Risk Screeningactive2015-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.31 Malnutrition At Riskactive2015-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.32 Malnutrition Risk Screeningactive2016-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.33 Nutrition Assessment Procedureactive2015-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.34 Malnutrition Screening Finding of Not At Risk Resultactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.35 Malnutrition Screening Not at Riskactive2015-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.38 Malnutrition Screening Finding of At Risk Resultactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.39 Malnutrition Risk Screeningactive2016-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.40 Malnutrition Risk Screeningactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.41 Nutritional Status Severely Malnourishedactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.42 Nutrition Assessment Status Finding of Severely Malnourishedactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.43 Nutrition Assessment Status Finding of Severely Malnourishedactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.44 Nutrition Assessment Status Finding of Moderately Malnourishedactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.45 Nutritional Status Moderately Malnourishedactive2015-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.46 Nutritional Status Moderately Malnourishedactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.47 Nutrition Assessment Status Finding of Moderately Malnourishedactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.48 Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourishedactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.49 Nutrition Focused Physical Findings Groupingactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.5 Adult Enteral Formulas SNOMED CTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.50 Enteral Nutrition Composition SNOMED CTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.51 Enteral Nutrition Composition Groupingactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.52 Parenteral Nutrition Management SNOMED CTactive2020-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.53 Malnutrition Diagnosisactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.54 Malnutrition Diagnosisactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.55 Malnutrition Diagnosisactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.56 Malnutrition Diagnosisactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.58 Nutrition Order Item Groupingactive2018-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.59 Diet Item Groupingactive2018-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.60 Edible Substancesactive2021-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.61 Feeding Device SNOMED CTactive2021-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.65 Nutrition Recommendation Groupingactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.7 Modular Nutrition Formulas SNOMED CTactive2021-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.70 Nutrition Education SNOMED CTactive2020-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.71 Coordination of Care by a Nutrition Professional SNOMED CTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.73 Nutrition Anthropometric Measurement SNOMED CTactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.74 Nutrition Anthropometric Measure Panel LOINCactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.75 Nutrition Anthropometric Measurements Groupingactive2018-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.76 Manage Feeding Environmentactive2021-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.77 Special Food Items and Regime/Therapy for Special Food Items SNOMED CTactive2021-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.78 Food and Nutrition Related History LOINCactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.79 Nutrition Encounter Individual and Group CPTactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.80 Nutrition Encounters HCPCSactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.81 Nutrition Encounter Codes Groupingactive2018-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.82 Food and Nutrition Related History Groupingactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.84 Food and Nutrition Related History SNOMED CTactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.85 Nutrition Diagnosis Groupingactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.87 Feeding Device Groupingactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.88 Nutrition Intervention Care Planningactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.89 Malnutrition Screening Finding of At Risk Resultactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.90 Medical Nutrition Therapy Proceduresactive2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.91 Dietitian Referralactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.92 Malnutrition Risk Screeningactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.93 Nutrition Care Planactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.94 Malnutrition Screening Finding of At Risk Resultactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.95 Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourishedactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.96 Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourishedactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.97 Nutrition Assessment Status Finding of Severely Malnourishedactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.98 Nutrition Assessment Status Finding of Moderately Malnourishedactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.99 Nutrition Diagnosis SNOMED CT (2)active2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.1 Findings Related to Medication Management, Referral Sourceactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.100 Recommendations Related to Medication Regimenactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.101 Interventions Related to Medication Regimen, Initiate Medicationactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.102 Interventions Related to Medication Regimen, Change Medicationactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.103 Interventions Related to Medication Regimen, Change Medication Doseactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.104 Interventions Related to Medication Regimen, Change Medication Dosage Formactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.105 Interventions Related to Medication Regimen, Change Medication Courseactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.106 Interventions Related to Medication Regimen, Change Medication Dosing Intervalactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.107 Interventions Related to Medication Regimen, Discontinue Medicationactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.109 Interventions Related to Medication Regimenactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.11 Interventions Related to Medication Management, Medication Reconciliationactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.110 Interventions Related to Education, Medicationsactive2020-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.111 Interventions Related to Education, Medical Equiptment and Devicesactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.112 Interventions Related to Medication Management, Notificationsactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.113 Interventions Related to Medication Management, Refill Synchronizationactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.114 Status of Patient Conditionactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.115 Interventions Related to Education, Diseases and Disordersactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.116 Interventions Related to Educationactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.118 Interventions Related to Medication Managementactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.119 Interventions Related to Medication Management, Targeted Medication Reviewactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.120 Interventions Related to Medication Management, Discussionactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.121 Reasons for Interventions Related to Medication Management, Costactive2019-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.122 Interventions Related to Education, Immunizationsactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.123 Status of Recommendationsactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.124 Interventions Related to Medication Management, Provision of Documentsactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.125 Status of Compliance Abilityactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.126 Status of Interventionsactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.127 Status of Disease Controlactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.128 Status of Complianceactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.129 Occupations of Providersactive2019-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.130 Environments of Careactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.131 Findings Related to Medication Management, Body Mass Indexactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.132 Findings Related to Medication Management, Alcohol Useactive2019-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.133 Findings Related to Medication Management, Caffeine Useactive2019-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.134 Interventions Related to Education, Dietactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.136 Findings Related to Medication Management, Exerciseactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.137 Interventions Related to Education, Behavioractive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.138 Findings Related to Medication Management, Dietactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.139 Status of Care Goalactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.140 Findings Related to Medication Management, Illicit Drug Useactive2020-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.141 Interventions Related to Administration, Immunizationsactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.142 Interventions Related to Care Coordination, Communication Needsactive2020-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.144 Findings Related to Medication Management, Life Eventactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.145 Interventions Related to Medication Management, Device or Equipment Fittingactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.146 Findings Related to Medication Management, Immunizationsactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.148 Findings Related to Medication Management, Cultural Beliefsactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.149 Findings Related to Medication Management, Tobacco Useactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.150 Interventions Related to Medication Regimen, Continue Medicationactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.151 Encounter Typeactive2020-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.152 Encounter Classactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.156 Allergy/Intolerance Severityactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.16 Reasons for Interventions Related to Medication Managementactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.160 Allergy/Intolerance Manifestationactive2019-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.162 Allergy/Intolerance Substance & Negationactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.163 Allergy/Intolerance Negationactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.165 Interventions Related to Care Coordination, Benefit Managementactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.166 Interventions Related to Administrationactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.167 Interventions Related to Administration, Medicationsactive2020-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.168 Findings Related to Medication Management, Eating Habitsactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.169 Findings Related to Medication Management, Tobacco Exposureactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.170 Interventions Related to Care Coordinationactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.176 Interventions Related to Medication Management, Information Gatheringactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.177 Interventions Related to Medication Management, Care Planningactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.178 Interventions Related to Medication Management, Documentationactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.179 Allergy/Intolerance Substance, Foodactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.180 Allergy/Intolerance Substance, Environmentalactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.181 PharmacyEncounterReasonactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.182 Encounter Reasonactive2020-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.183 Findings Related to Medication Management, Medication relatedactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.197 PharmacyAllergiesactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.198 PharmacyInterventionsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.200 PharmacyReasonsForInterventionsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.201 PharmacyInterventionStatusactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.202 PharmacyCareCoordinationactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.203 PharmacyReferralsToactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.204 PharmacyGoalStatusOutcomeactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.205 PharmacyTypeOfProfessionactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.207 PharmacyEnvironmentsOfCareactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.208 PharmacyEncounterTypeactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.209 PharmacytEncounterClassactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.211 PharmacyAllergyIntoleranceTypeactive2018-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.212 PharmacyAllergyIntoleranceManifestationactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.213 PharmacyReasonForMedicationChangeactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.214 PharmacyEducationactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.215 PharmacyEducationStatusactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.216 PharmacyReferralsFromactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.218 Reasons for Interventions Related to Medication Management, Discontinue Medicationactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.224 Social Determinants of Health Problem Observationactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.225 Laboratory results that are used in medication managementactive2020-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.227 Findings Related to Medication Management, Infectious Disease Symptomsactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.229 COVID19 Related Disease, Test, or Exposureactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.230 Maternity Health Interventions Value Setactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.231 Social Determinants of Health Interventionsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.232 Maternity Health Findingsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.233 Reason Medication Discontinued Lack of Indicationactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.234 Reason Medication Discontinued Lack of Effectivenessactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.235 Reason Medication Discontinued Safety Issue Occurredactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.236 Reason Medication Discontinued Compliance Issue other than costactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.237 Recommendation to Resolve Medication Therapy Problemactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.239 Reason Medication Discontinued Patient Unable to Affordactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.240 Medication Listsactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.3 Findings Related to Medication Management, Transitions Between Health Care Settingsactive2019-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.35 Interventions Related to Medication Management, Comprehensive Medication Reviewactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.5 Reasons for Interventions Related to Medication Management, Unnecessary Therapyactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.53 Reasons for Interventions Related to Medication Management, Adverse Eventsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.55 Reasons for Interventions Related to Medication Management, Adherenceactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.56 Findings Related to Medication Management, Multiple Providersactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.58 Findings Related to Medication Management, Chronic Disease Presentactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.59 Findings Related to Medication Management, Taking Medication for Chronic Diseaseactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.6 Reasons for Interventions Related to Medication Management, New or Additional Therapy Requiredactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.60 Findings Related to Medication Management, Health Literacyactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.61 Findings Related to Medication Managementactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.7 Reasons for Interventions Related to Medication Management, Ineffective Therapyactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.8 Reasons for Interventions Related to Medication Management, Dose Too Lowactive2019-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.83 Assessments Related to Medication Management, General Assessmentsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.84 Assessments Related to Medication Managementactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.85 Assessments Related to Medication Management, Assessments Using Assessment Scalesactive2020-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.86 Interventions Related to Medication Regimen, Monitoringactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.87 Interventions Related to Care Coordination, Consultationsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.88 Interventions Related to Care Coordination, Referrals to Other Providersactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.89 Interventions Related to Care Coordination, Referrals for Specific Servicesactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.9 Reasons for Interventions Related to Medication Management, Dose Too Highactive2019-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.90 Recommendations Related to Medication Regimen, Continue Medicationactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.91 Recommendations Related to Medication Regimen, Initiate Medicationactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.92 Recommendations Related to Medication Regimen, Change Medicationactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.93 Recommendations Related to Medication Regimen, Change Medication Doseactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.94 Recommendations Related to Medication Regimen, Change Medication Dosage Formactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.95 Recommendations Related to Medication Regimen, Change Medication Courseactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.97 Recommendations Related to Medication Regimen, Change Medication Dosing Intervalactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.98 Recommendations Related to Medication Regimen, Discontinue Medicationactive2017-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.99 Recommendations Related to Medication Regimen, Monitoringactive2021-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.10 Care Plan Document Typeactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.11 Medication Statusactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.12 Medication Routeactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.24 Extended Pregnancy Statusactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.27 Care Team Member Function (SNOMEDCT)active2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.28 Problem Type (LOINC)active2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.29 Allergy Clinical Statusactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.30 Care Team Member Functionactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.33 External Cause of Injury/Morbidityactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.35 Arthritis Feedback Types (SNOMED)active2019-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.36 Arthritis Feedback Types (LOINC)active2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.4 DIRSectionTypeCodes LOINCactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.45 Bidirectional Services eReferral Typeactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.46 Bidirectional Services eReferral Reasonactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.49 Disability Status Assessmentactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.50 Transport vehicle typeactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.53 Sexactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.54 Specimen typeactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.55 At Home In Vitro Patient Questionsactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.57 Advance Directives Content Typeactive2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.58 Acute COVID 19 Diagnosisactive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.59 Medication Adherence SCTactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.1 Case Management for Behavioral Healthactive2021-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.63 Case Management for Behavioral Healthactive2021-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.64 Case Management for Behavioral Healthactive2021-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.10 Medicare FFS Payeractive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.12 Medicare Advantage Payeractive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.101 Myocardial Infarctionactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.124 Follow Up Within 6 Monthsactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.125 Follow Up Within 6 Monthsactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.126 Bone Scanactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.127 Bone Scanactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15 Hospice Care Ambulatoryactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.175 Office and Wellness Visits for General Screeningactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.176 Office and Wellness Visits for General Screeningactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.177 Office and Wellness Visits for General Screeningactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.178 Office and Wellness Visits for General Screeningactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.179 Hypertensive disorders in pregnancyactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.180 Outpatient Prenatal Visitactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.182 Eclampsiaactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.183 Gestational Hypertensionactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.184 Preexisting Hypertension in Pregnancyactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.185 Postpartum Encounteractive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.186 Postpartum Encounteractive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.187 Postpartum Encounteractive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.188 Preexisting Hypertension in Pregnancyactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.189 Spontaneous or Elective Abortionactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.190 Spontaneous or Elective Abortionactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.191 Preeclampsia or Eclampsiaactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.192 Spontaneous or Elective Abortion Procedureactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.193 Spontaneous or Elective Abortionactive2024-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.28 Non Acute Encounter Codes CPTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.29 Non Acute Encounter Codes HCPCSactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.31 Bleeding Event Diagnosis Codes ICD9active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.78 Statin Associated Muscle Symptomsactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.84 Statin Associated Muscle Symptomsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.85 Statin Associated Muscle Symptomsactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.99 Underweightactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.11 Cornual Ectopic Pregnancyactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.12 Cornual Ectopic Pregnancyactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.13 Perforation of Uterusactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.14 Perforation of Uterusactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.15 Uterine Ruptureactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.16 Uterine Ruptureactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.17 Transabdominal Cerclageactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.18 Transabdominal Cerclageactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.2 Transabdominal Cerclageactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.21 Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrivalactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.23 Intensive Care Unitactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.24 Uterine Hornactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.25 Metroplastyactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.3 Medical Induction of Laboractive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.35 Placenta Previaactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.36 Placenta Accreta Spectrum Previa or Vasa Previaactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.37 Placenta Accreta Spectrum Previa or Vasa Previaactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.38 Outpatient Surgery Serviceactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.41 Statin Allergenactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.42 Statin Allergenactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50 Rivaroxaban for VTE Prophylaxisactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.51 Prasugrelactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52 Pharmacological Contraindications For Antithrombotic Therapyactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.53 Acute Renal Failureactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.54 Total Parenteral Nutritionactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.55 Intravenous Thrombolytic tPA Therapyactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.56 Intraarterial Thrombolytic tPA Therapyactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.57 Ischemic Stroke Thrombosisactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.58 Ischemic Stroke Thrombosisactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.59 Ischemic Stroke Otheractive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.60 Ischemic Stroke Otheractive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.61 Antithrombotic Therapy Antiplateletactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62 Antithrombotic Therapy for Ischemic Strokeactive2021-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.63 Present On Admission is Yes or Exemptactive2022-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.64 Application of Venous Foot Pumpsactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.65 Application of Intermittent Pneumatic Compression Devicesactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.66 Application of Graduated Compression Stockingsactive2022-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.67 20 to 42 Plus Weeks Gestationactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.68 37 to 42 Plus Weeks Gestationactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.69 37 to 38 Weeks Gestationactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.70 20 to 42 Plus Weeks Gestationactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.71 20 to 42 Plus Weeks Gestationactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.72 37 to 42 Plus Weeks Gestationactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.73 37 to 42 Plus Weeks Gestationactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.74 37 to 38 Weeks Gestationactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.75 37 to 38 Weeks Gestationactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.76 History of Atrial Ablationactive2022-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.77 Placenta Accreta Spectrum Previa or Vasa Previaactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.78 Placenta Previaactive2023-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.126 Hospital Settingsactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143 Observation Servicesactive2021-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.146 Buprenorphineactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.159 All Primary and Secondary Canceractive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161 All Primary and Secondary Canceractive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.163 Emergency Department Evaluationactive2020-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.164 Admit Inpatientactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.166 Codeine Schedule II and IIIactive2023-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.167 Alfentanilactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.168 Remifentanilactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.169 Sufentanilactive2021-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.171 Opioid Use Disorderactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.173 Sickle Cell Disease with and without Crisis SNOMEDactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.174 Sickle Cell Disease with and without Crisis ICDactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.175 Sickle Cell Disease with and without Crisisactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.176 Opioid Medication Assisted Treatment (MAT) HCPCSactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.177 Opioid Medication Assisted Treatment (MAT)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.178 Cancer Related Pain ICD 10active2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.179 Cancer Related Pain SNOMEDactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.180 Cancer Related Painactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1114.14 Medication drug class for allergen intolerance SCTactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.10 Care Experience Preferences at End of Life LOINCactive2024-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.11 Care Experience Preferences Groupingactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.12 Healthcare Agent Ordinalityactive2020-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.13 Healthcare Agent Powers or Limitations Indicatoractive2024-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.14 ADIClauseTypeVSactive2022-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.15 Upon Death Preferencesactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.17 Preconditions for Treatment Preferencesactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.18 Treatment Intervention Preferences at End of Life Ordinal LOINCactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.19 Obligation or Prohibition Instruction Type Groupingactive2023-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.2 InstructionActStatusactive2017-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.20 Advance Healthcare Directive Witness roleCodeactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.21 Witness Categoriesactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.22 Advance Directive Document Typesactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.23 AD Conditions and Prognosis Scenariosactive2023-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.26 Healthcare Agent or Advisor Indicatoractive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.27 Initial Treatment portable medical order optionsactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.28 Cardiopulmonary Resuscitation Order Optionsactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.30 Cardiopulmonary Resuscitation Order Proceduresactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.31 Cardiopulmonary Resuscitation Procedures Groupingactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.32 Additional Portable Medical Order Proceduresactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.33 Initial Treatment Portable Medical Order Procedures Groupingactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.34 Additional portable medical order Procedures Groupingactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.35 Medically Assisted Nutrition Order Optionsactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.36 Medically Assisted Nutrition Portable Medical Order Procedures Groupingactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.37 Healthcare Agent Powersactive2024-11
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.38 Personal Health Goal Options LOINCactive2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.39 Personal Health Goal Options Groupingactive2025-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.40 Portable Medical Order Document Typesactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.41 Advance Healthcare Directive Document Types Grouperactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.5 Advance Directive Content Type SCTactive2022-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.6 Personal Health Goals LOINCactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.7 Health Goals Groupingactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.8 Treatment Intervention Preferences at End of Life LOINCactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.9 Treatment Intervention Preferences Groupingactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.1 Rituximab Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.100 Pathological M Stage M1cactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.101 Pathological N Stage N3active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.102 N Stage pN1aactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.103 N Stage pN1bactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.105 Pathological N Stage pN1miactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.106 Pathological N Stage N2bactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.107 Pathological N Stage N2aactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.108 Pathological N Stage N2active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.109 Pathological N Stage N1bactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.110 Pathological N Stage N1aactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.112 Pathological N Stage N0active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.114 Pathological T Stage T4dactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.115 Pathological T Stage T4cactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.116 Pathological T Stage T4bactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.117 Pathological T Stage T4aactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.118 Pathological T Stage T4active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.120 N Stage N2Cactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.121 T Stage T3cactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.122 T Stage T3bactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.123 T Stage T3aactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.124 Pathological T Stage T3active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.125 T Stage T2cactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.126 T Stage T2bactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.127 T Stage T2aactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.128 Pathological T Stage T2active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.129 Pathological T Stage T1cactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.132 Pathological T Stage T1bactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.135 Pathological T Stage T1aactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.136 Pathological T Stage T1active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.137 Pathological T Stage T1micactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.139 Pathological T Stage T0active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.142 Cancer Stage IIIactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.143 Cancer Stage IIIAactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.144 Cancer Stage IIIBactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.145 Cancer Stage IIICactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.146 Cancer Stage IVactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.147 Cancer Stage IVAactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.148 Cancer Stage IVBactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.149 Cancer Stage IVCactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.151 Cisplatin Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.153 Vinorelbine Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.154 Gemcitabine Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.155 Docetaxelactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.156 Pemetrexed Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.158 Vinblastine Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.160 ECOG Performance Statusactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.161 ECOG Performance Statusactive2020-10
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.162 ECOG Performance Statusactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.164 Karnofsky Performance Statusactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.165 Carboplatin Injectableactive2020-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.166 Paclitaxelactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168 Doxorubicin Injectableactive2022-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169 Irinotecan Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179 Bevacizumab Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.181 Methotrexateactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.184 Breast Canceractive2022-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.185 Breast Canceractive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.191 Cancer Stage IIactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.192 Cancer Stage IIAactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.193 Cancer Stage IIBactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.194 Pertuzumab Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.196 Ixabepilone Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.197 Goserelinactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200 Epirubicin Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.202 Ramucirumab Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.204 Letrozoleactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.206 Exemestaneactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.209 Fluorouracilactive2024-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210 Capecitabine Oralactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222 Aprepitant Oralactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223 Fosaprepitant Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.255 Colorectal Canceractive2021-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.256 Colorectal Canceractive2021-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.257 Colorectal Cancer Chemotherapyactive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.280 Cancer Stage IAactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.281 Cancer Stage IBactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.286 Cancer Stage IICactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.291 Positive Resultactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.292 Negative Resultactive2015-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.300 Pathological N Stage N1Cactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332 Daunorubicin Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.336 Palonosetron Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.341 External Beam Radiotherapyactive2024-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.349 Metastatic Canceractive2023-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.365 Hospice Care Referral or Admissionactive2025-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.439 T Categoryactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.440 N Categoryactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.441 M Categoryactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.442 TNM Stage Groupactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.449 Opioidsactive2024-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.492 Pharmacological interventions for depressionactive2024-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.535 Ovarian Canceractive2023-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.536 Ovarian Canceractive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.537 Fallopian Tube Canceractive2022-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.539 Fallopian Tube Canceractive2022-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.541 Peritoneal Canceractive2022-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.542 Peritoneal Canceractive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.547 Cancer Stage 1Cactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.555 Gender Femaleactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.556 Gender Maleactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.557 Pathological N Stage N3aactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.558 Pathological N Stage N3bactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560 Rolapitant Oralactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.599 Obinutuzumab Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.600 Ofatumumab Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602 Neurokinin 1 Receptor Antagonistactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604 Serotonin Receptor Antagonistactive2025-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61 Cetuximab Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.63 Panitumumab Injectableactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81 Palonosetron Oralactive2024-12
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.88 Lung Canceractive2015-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.89 Lung Canceractive2023-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.95 M Stage M0active2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.97 Pathological M Stage M1active2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.98 Pathological M Stage M1aactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.99 Pathological M Stage M1bactive2024-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.5 Most/Moderately Effective Contraceptive Proceduresactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.6 Most/Moderately Effective Contraceptive SNOMED Findingsactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.1 Schedule IV Benzodiazepinesactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.7 PROMIS Depression Assessmentactive2023-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.11 Sleep Apneaactive2018-05
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.12 Toxic Megacolon in adultsactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.13 Septic Shock due to C. Diffactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.15 Body Temperatureactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.16 Diarrhea Potentially due to CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.17 Abdominal Distensionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.18 Vomiting potentially due to CDIactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.19 Ileus due to infectionactive2019-04
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.20 Clostridium difficile infectionactive2019-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.3 Radiation Therapy Indicators from CPTactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.4 Diagnostic Radiology Surrounding Face and Sinusactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.5 Ear Surgery Affecting the Tympanic Membraneactive2017-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.6 Allergic Rhinitis Immunotherapyactive2017-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.8 Radiology to Head and Sinusactive2017-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.9 Immunotherapy For Allergic Rhinitisactive2022-03
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1136.63 Aortic Dissection or Ruptured Aortic Aneurysmactive2024-07
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.564 CABG or PCI Procedureactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.565 CABG or PCI Procedureactive2025-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.566 CABG or PCI Procedureactive2018-08
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.1 C2S Alcohol Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.11 C2S Amphetamine Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.12 C2S Cannabis Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.13 C2S Cannabis Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.14 C2S Cannabis Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.15 C2S Cannabis Use DIsordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.16 C2S Cocaine Use Disorderactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.17 C2S Cocaine Use Disorderactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.18 C2S Cocaine Use Disorderactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.19 C2S Hallucinogensactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.2 C2S Alcohol Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.20 C2S Hallucinogensactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.21 C2S Hallucinogensactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.22 C2S Hallucinogensactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.23 C2S HIV/AIDS Information Sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.24 C2S HIV/AIDS Information Sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.25 C2S HIV/AIDS Information Sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.26 C2S HIV/AIDS Information Sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.27 C2S HIV/AIDS Information Sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.28 C2S Inhalantsactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.29 C2S Inhalantsactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.3 C2S Alcohol Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.30 C2S Inhalantsactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.32 C2S Mental Health Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.33 C2S Mental Health Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.34 C2S Mental Health Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.35 C2S Mental Health Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.36 C2S Mental Health Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.38 C2S Opioidsactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.39 C2S Opioidsactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.4 C2S Alcohol Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.40 C2S Opioidsactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.42 C2S Opioidsactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.43 C2S Other Psychoactive Substance Use Disorderactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.44 C2S Other Psychoactive Substance Use Disorderactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.45 C2S Other Psychoactive Substance Use Disorderactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.46 C2S Sedative Hypnotic, or anxiolytic related disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.47 C2S Sedative Hypnotic, or anxiolytic related disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.48 C2S Sedative Hypnotic, or anxiolytic related disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.49 C2S Sexuality and reproductive health information sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.5 C2S Alcohol Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.51 C2S Tobacco Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.52 C2S Tobacco Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.53 C2S Tobacco Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.54 C2S Tobacco Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.55 C2S Substance Use Information Sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.56 C2S Substance Use Information Sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.58 C2S Sensitive Categoriesactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.59 C2S Opioidsactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.6 C2S Amphetamine Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.60 C2S HIV/AIDS information Sensitivityactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.65 Test C2S Alcohol Use Disordersactive2019-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.67 Test C2S HIV/AIDS Information Sensitivityactive2019-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.7 C2S Amphetamine Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.8 C2S Amphetamine Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.9 C2S Amphetamine Use Disordersactive2016-09
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.10 Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1002 Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1012 S. Typhi Infection (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1016 S. Paratyphi Infection (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1017 S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1021 Dark Urine (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1022 Acute Onset [Qualifier Value] (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1024 Acute Viral Hepatitis (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1027 Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1029 Listeriosis [Listeria species] (Organism or Substance in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1030 Meningitis [Unspecified Cause] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1032 Encephalitis [Unspecified Cause] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1033 Encephalitis [Unspecified Cause] (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1035 Indeterminate or Equivocal Lab Result Valueactive2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1037 Smoking Status [Current Nonsmoker] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1040 Organisms (Tests by Unspecified Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1041 Organisms (Tests by Culture and Identification)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1044 Candida auris Infection (Tests for Candida auris by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1045 Candida auris Infection (Tests for Candida auris Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1047 Parkinson’s disease (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1048 Parkinson’s disease (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1049 Parkinsonism [Secondary] (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1050 Parkinsonism [Secondary] (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1053 Carbidopa Levodopa Combination (RXNORM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1065 Consciousness [Decreased Level] (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1071 Drug Use [IV Evidence] (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1072 Miosis (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1076 Opioid Overdose and Poisoning (Tests for Opioids [Quantitative])active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1077 Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1078 Opioid Overdose and Poisoning (Naloxone) (RxNorm)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1083 Rash [Pustular Vesicular] (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1084 Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1090 Syphilis [Congenital] (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1091 Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1092 Congenital heart disease (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1093 Hearing impairment (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1095 Microcephaly (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1096 Developmental delay (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1099 Congenital heart disease (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1100 Hearing impairment (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1104 Developmental delay (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1106 Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.112 Tetanus (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1123 COVID_19 (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1124 COVID_19 (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1130 Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1131 Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassayactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1138 Staphylococcus Aureus (Tests by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1139 VISA/VRSA (Tests for Vancomycin Resistance Gene)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1142 COVID_19 (Tests for SARS_CoV_2 Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1143 COVID_19 (Organism or Substance in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1145 Resistant Lab Result Valueactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1148 Tests for Vancomycin Susceptibility [Ord]active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1149 Proteinuria (Tests for Total Protein in 24H Urine)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.115 Mumps (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1150 Thrombocytopenia (Tests for Platelets [#/volume] in Blood)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1156 Staphylococcus aureus (Organism or Substance in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1158 COVID_19 (Tests for SARS_CoV_2 Antigen)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1169 Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.117 Mumps (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1180 Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative])active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1186 Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative])active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1188 Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative])active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1189 California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative])active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1196 Anthrax (Tests for Bacillus cereus by Culture and Identification Method)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1197 Cervical Lymphadenitis (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1207 CRE (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1210 Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1212 Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1213 NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1214 Carbapenemase resistance mechanism (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1215 Tests for carbapenemase productionactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1216 Tests for carbapenemase resistance mechanismactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1217 Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem]active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1218 Tests for carbapenem susceptibility [Ertapenem]active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1219 Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Methodactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1220 NU_Tests for Enterobacteriaceae species by Culture and Identification Methodactive2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1224 Therapeutic Response to Medication [Improved]active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1225 Altered Mental Status (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1230 Eschar (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1231 Hypotension (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1233 Localized Edema (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1234 Localized Edema (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1237 Tachycardia (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1238 Tachycardia (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1239 RCKMS Conditions (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.124 Poliomyelitis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1240 Maternal Condition Puerperium (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1242 Non pestis Yersiniosis Infection (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1244 Blastomycosis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1246 Blastomycosis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1249 Blastomycosis (Tests for Blastomyces species by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1250 Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1251 Blastomycosis (Tests for Blastomyces species Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1252 Blastomycosis (Tests for Blastomyces species Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1253 Blastomycosis (Tests for Blastomyces species Antigen)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1265 Fatigue (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1269 Tuberculosis [Latent Infection] (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1274 Histoplasmosis (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1275 Histoplasmosis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1281 Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1294 Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1295 Seizure [Unspecified Cause] (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1298 Abscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1299 Seizure [Unspecified Cause] (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.130 Influenza (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1304 Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1305 Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1306 Body Temperature (Vital Sign)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1307 Respiratory Rate (Vital Sign)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1309 RSV (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1310 RSV (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1312 RSV (Tests for RSV Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1314 Wheezing (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1317 Bronchiolitis (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1325 Tobacco Use and Exposure (Social History)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1330 Tobacco Smoking Status [Current] (Social History) (LOINC)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1335 Hospitalized [Inpatient] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1336 Creutzfeldt Jakob Disease (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1337 Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1340 Prion Disease (Tests for 14_3_3 Protein)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1341 Prion Disease (Tests for Abnormal Prion Protein)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1349 Cerebrospinal Fluid (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.135 Chronic Hepatitis B Virus Infection (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1350 Endocervical (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1351 Tissue (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1352 Specimen from a Normally Sterile Site (Specimen Type)(SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1353 Urethral Swab (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1355 Wound (Specimen Type) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1359 Hepatitis E (Tests for hepatitis E virus IgM Antibody)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.136 Invasive Pneumococcal Disease (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1360 Hepatitis E (Tests for hepatitis E virus Antibody)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1363 Epiglottitis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1364 Organisms (Tests by Microscopic Observation by Gram Stain)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1369 Serum (Specimen Type) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1378 Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimenactive2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1379 Fish Poisoning (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1388 Occupational Asthma (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1389 Asthma (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1390 Asthma (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1391 Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1393 WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1400 Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative])active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1402 Cancer [Malignant Neoplasms] (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1403 Cancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1404 Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1405 Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1407 Cancer [Malignant Neoplasms] (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1409 COVID_19 (Tests for SARS_CoV_2 Genomic Sequence)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1418 Alpha gal syndrome (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1420 Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative])active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1422 Ptosis of Eyelid [Unspecified Cause] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1423 Ptosis of Eyelid [Unspecified Cause] (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1424 Constipation [Unspecified Cause] (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1426 Intubation [Respiratory Tract] (Procedure) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1430 Infant Botulism (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1446 Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1447 MRSA (Disorders (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1449 Staphylococcus aureus infection (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.145 Varicella (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1450 Staphylococcus aureus infection (Disorders) (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1452 MRSA (Tests by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1453 MRSA (Tests for Methicillin Resistance Gene)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1454 Staphylococcus aureus (Tests for Staph aureus Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1458 Tests for Cefoxitin Susceptibility [OrdQn]active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1459 Organisms (Tests in Blood by Culture and Identification)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1460 Bacteria (Tests in Blood by Culture and Identification Method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1461 Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1462 Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1463 VRE (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1464 VRE (Organism or Substance in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1465 VRE (Tests by Culture and Identification Method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1466 Enterococcus species (Tests by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1468 Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1469 Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1470 Enterococcus species (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1471 Amebiasis (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1473 Amebiasis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1476 Amebiasis (Tests for Entamoeba histolytica Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1482 Norovirus (Tests for Norovirus Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1485 Norovirus (Organism or Substance in Lab Results)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1487 Clostridioides difficile infection (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1491 C. diff infection (Tests for C diff Toxin Nucleic Acid)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1492 C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1505 Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1507 Arsenic Exposure and Toxicity (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1509 Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1513 Urine (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1514 Mercury Exposure and Toxicity (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1515 Cryptococcosis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1516 Cryptococcosis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1520 Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1523 Cryptococcosis (Tests for Cryptococcus species Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1524 Cryptococcosis (Tests for Cryptococcus species Antigen)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1525 Mercury Exposure and Toxicity (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1528 Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1532 Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1533 Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1534 Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1538 Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.154 Hepatitis C Virus Infection (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1540 Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1541 Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1542 Drug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1543 Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1544 Drug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1545 Drug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1546 Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1551 Meningitis (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1552 Bacterial Meningitis (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1553 Fungal Meningitis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1554 Parasitic Meningitis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1555 Bacterial Meningitis (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1559 Photophobia (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1562 Bacteria [Causing Meningitis] (Organism or Substance in Lab Results)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1563 Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1564 Viruses [Causing Meningitis] (Organism or Substance in Lab Results)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1565 Viruses [Causing Meningitis] (Tests for Nucleic Acid)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1566 Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1567 Bacteria [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1574 Invasive Group B Streptococcus (Disorders) (ICD10CM))active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1577 Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1578 Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1580 Animal Bite [Dog] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1581 Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1582 Animal Bite [Excluding Mammals] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1584 Animal Bite [Unspecified Animal] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1585 Animal Bite [Dog] (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1586 Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1587 Animal Bite [Excluding Mammals] (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1588 Cadmium Exposure and Toxicity (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1594 HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1595 HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1597 HIV Infection (ARV Combination Treatment for HIV) (RXNORM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1598 HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600 HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1604 Vaccine Adverse Event (Disorders) (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1605 Vaccine Adverse Event (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1606 Vaccinia disease or adverse event  (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.161 Vibriosis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1612 Blepharitis [Unspecified Cause] (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1613 Keratitis [Unspecified Cause] (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1614 Keratitis [Unspecified Cause] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1618 Smallpox Vaccine (RXNORM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1620 Anaphylaxis [Unspecified Cause] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1626 Thrombocytopenic Purpura [Unspecified Cause] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1634 Sofosbuvir Velpatasvir Combination (RXNORM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1640 Typhus Fever (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1641 Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1642 Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1643 Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1651 Chagas Disease (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1654 Chagas Disease (Tests for Trypanosoma cruzi Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1661 Cervical lymphadenopathy [Unspecified Cause] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1662 Conjunctival injection (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1663 Drying of lips (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1667 Edema of hands or feet (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1676 Tests for Acinetobacter baumannii Nucleic Acidactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1677 Tests for Pseudomonas aeruginosa by Culture and Identification Methodactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1678 Tests for Pseudomonas aeruginosa Nucleic Acidactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1679 Pseudomonas aeruginosa (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1687 NU_Gunshot Wound (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1688 NU_Gunshot Wound (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.169 Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.170 Chlamydia trachomatis Infection (Organism or Substance in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1700 Encephalitis [Viral] (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1702 Encephalitis [Parasitic] (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1712 Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1714 Parasites [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1715 Viruses [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1716 Drowning and Submersion (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1717 Drowning and Submersion (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1718 Motor Vehicle Injury (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1719 Motor Vehicle Injury (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1720 Enterovirus Infection [Non polio] (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1721 Enterovirus Infection [Non polio] (Disorders) (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1722 Enterovirus Infection [Non polio] (Organism or Substance in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1723 Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1725 Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1726 Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1735 Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1739 Head Injury (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1740 Head Injury (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1742 Brain Injury [Traumatic] (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1745 Rotavirus Disease (Organism or Substance in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1746 Rotavirus Disease (Tests for Rotavirus Nucleic Acid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1748 Chemical Pneumonitis (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1749 Chemical Pneumonitis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1753 Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1755 Vomitus (Specimen Type) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1758 Asbestosis (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.176 West Nile Virus Infection (Disorders) (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1763 Byssinosis (Disorders) (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1769 Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1772 Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1773 CLABSI (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1775 Ophthalmia neonatorum (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1778 Genital herpes (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1779 Genital herpes (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1781 Herpes (Tests for Herpes simplex virus Nucleic Acid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1785 Elevated liver enzyme (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1786 Elevated liver enzyme (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1788 Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1789 Granuloma Inguinale (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1791 Ulcer [Genital, Perineal, or Perianal Area] (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1792 Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1797 Bronchial Wash (Specimen Type) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1800 Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1803 Bacteria (Tests in Sputum Specimen by Culture and Identification Method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.181 Coccidioidomycosis (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1819 Louseborne relapsing fever (Tests for Borrelia species)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1820 Louseborne relapsing fever (Tests for Borrelia species in Blood)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1823 Borrelia species (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1824 Spirochetes (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1829 Polyarthritis [Unspecified Cause] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1835 Rheumatoid nodules (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1842 Ventilator associated event (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1844 Leishmaniasis (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1846 Leishmaniasis (Tests for Leishmania species Nucleic Acid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1847 Leishmaniasis (Tests for Leishmania species Antibody)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1848 Leishmania species (Tests by Microscopic Observation in Tissue)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.185 Brucellosis (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1864 Taeniasis (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1866 Taeniasis (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.187 Dengue Virus Infection (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1875 Cysticercosis (Tests for Taenia solium Antibody)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1878 Surgical Site Infection (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1880 Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acidactive2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1881 NU_Tests for Enterobacteriaceae species Nucleic Acidactive2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1882 Carbapenemase production (Organism or Substance in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1892 Toxoplasmosis (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1893 Toxoplasmosis (Disorders) (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1895 Toxoplasmosis (Organism or Substance in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1897 Toxoplasmosis (Tests by Microscopic Observation)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1898 Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1901 Toxoplasmosis (Tests for Toxoplasma gondii Antibody)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1902 Orthopox (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1908 Organisms (Tests by Electron Microscopic Observation)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1912 Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1913 Penicillin G [Procaine] [Injectable] (RXNORM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1919 Fungi [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1923 Coronary artery aneurysm (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1924 Coronary artery dilatation (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1925 Ectatic coronary artery (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1926 Left ventricular ejection fraction [Decreased Level] (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1927 Coronary artery aneurysm (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1928 Shock (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1929 Shock (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1930 Troponin [Elevated Level] (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1931 Oral mucosa Inflammation (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1932 Oral mucosa Inflammation (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1933 C reactive protein (Tests by Any Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1934 Lymphocytes [Concentration] (Tests by Any Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1935 Strongyloidiasis (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1936 Strongyloidiasis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1937 Strongyloidiasis (Tests for Strongyloides Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1938 Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1939 Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1940 Organisms (Tests by Microscopic Observation in Stool)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1941 Strongyloidiasis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1942 Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1943 Jamestown Canyon Virus Diseases (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1944 Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1945 Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1946 Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1947 Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1948 Keystone Virus Diseases (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1949 La Crosse Virus Diseases (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1950 Snowshoe hare Virus Diseases (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1951 Trivittatus Virus Diseases (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1952 La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1953 Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1954 La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1955 Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1956 La Crosse Virus Diseases (Tests for La Crosse Virus Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1957 Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1958 Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1959 Keystone Virus Diseases (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1960 La Crosse Virus Diseases (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1961 Snowshoe hare Virus Diseases (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1962 Trivittatus Virus Diseases (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1963 Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1964 Encephalomyelitis (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1965 Encephalomyelitis (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1966 Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1967 Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1968 Hepatitis D Virus Infection (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1969 Hepatitis D Virus Infection (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1970 NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1971 Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1972 Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1973 Hepatitis D Virus Infection (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1974 Baylisascariasis (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1975 Baylisascariasis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1976 Baylisascariasis (Tests for Baylisascaris species Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1978 Larva Migrans (Neural, Ocular, or Visceral) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1979 Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1980 California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1981 California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1982 California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1983 California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1984 California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1985 California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1986 Pregnant (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1987 Flank Pain (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1988 Bone Pain (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1989 Abscess (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1990 Abscess (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1991 Focal Brain Lesions (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1992 Pathologic Fractures [Unspecified Cause] (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1993 Pathologic Fractures [Unspecified Cause] (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1994 Granulomas (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1995 Granulomas (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1996 Skin Lesions (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1997 Skin Lesions (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1998 Angiostrongyliasis (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1999 Lymphocytic Choriomeningitis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2000 Lymphocytic Choriomeningitis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2001 Lymphocytic Choriomeningitis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2002 Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2003 Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2004 Lymphocytic Choriomeningitis (Tests for LCMV Antibody)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2005 Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2006 Angiostrongyliasis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2007 Eosinophilic meningitis (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2009 Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2010 Eosinophils [Concentration] (Tests in CSF by Any Method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2011 Eosinophils [Percentage] (Tests in CSF by Any Method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2012 Mpox (Tests for mpox virus by Genomic Sequencing)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2013 Mpox (Test Panels for mpox virus by Genomic Sequencing)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2017 Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2018 Interpretation of an Observation (High)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2019 Interpretation of an Observation (Low)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.202 Trichinellosis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2020 Lymphadenopathy [Acute] (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2023 Tick Paralysis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2024 Bacillary angiomatosis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2025 Animal Bite or Scratch [Cat] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2026 Animal Bite or Scratch [Cat] (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2027 Bartonellosis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2028 Bartonellosis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2029 Bartonellosis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2030 Bartonella henselae infection (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2031 Bartonella quintana infection (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2032 Bartonella bacilliformis infection (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2033 Bartonella henselae infection (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2034 Bartonella quintana infection (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2036 Bartonella henselae (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2037 Bartonella quintana (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2038 Bartonella bacilliformis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2039 Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.204 Giardiasis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2040 Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2041 Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2042 Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2043 Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2044 Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2045 Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2046 Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2047 Bartonellosis (Tests for Bartonella spp. Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2048 Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2049 Bartonella spp. (Tests by Microscopic Observation)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2050 Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2051 Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2052 Echinococcosis (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2053 Echinococcosis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2054 Cystic Echinococcosis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2055 Cystic Echinococcosis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2056 Alveolar Echinococcosis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2057 Alveolar Echinococcosis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2058 Echinococcosis (Tests for Echinococcus species Antibody)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2059 Echinococcus species (Tests by Microscopic Observation)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2060 Echinococcosis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2061 Genital Warts (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2062 Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2063 Genital Warts (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2064 Diphyllobothriasis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2065 Diphyllobothriasis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2066 Diphyllobothriasis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2067 Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2068 Angiostrongyliasis (Organism or Substance in Lab Results)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2069 Pelvic Inflammatory Disease (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2070 Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2071 Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2072 Pelvic Inflammatory Disease (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2073 Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2074 Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2075 Lower Abdominal Tenderness (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2076 Lower Abdominal Tenderness (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2077 Tenderness with motion of the cervix (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2078 Adnexal Tenderness (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2079 Uterine Tenderness (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2080 Leukocytosis (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2081 Leukocytosis (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2082 Purulent material in the peritoneal cavity (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2083 Pelvic Abscess (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2084 Pelvic Abscess (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2085 Leukocytes [Concentration] (Tests in Blood by Any Method)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2087 Nongonococcal Urethritis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2088 Nongonococcal Urethritis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2089 Urethritis (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2090 Urethritis (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2091 Urethral discharge (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2092 Urethral discharge (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2093 Dysuria (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2094 Dysuria (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2095 Gonorrhea (Tests for Neisseria gonorrhoeae Antigen)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2096 Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2098 Rhinitis (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2100 Rhinitis (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2101 Pleuritis (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2102 Pleuritis (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2103 Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2105 Methemoglobinemia (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2106 Methemoglobinemia [Non Congenital] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2107 Methemoglobinemia (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2108 Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2109 Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative])active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2110 Anencephaly (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2111 Anencephaly (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2112 Fetal Anencephaly (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2113 Fetal Anencephaly (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2114 Cleft Lip Alone (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2115 Cleft Lip Alone (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2116 Fetal Cleft Lip (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2117 Cleft Palate Alone (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2118 Cleft Palate Alone (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2119 Cleft Lip with Cleft Palate (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2120 Cleft Lip with Cleft Palate (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2121 Fetal Spina Bifida (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2122 Spina Bifida (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2123 Spina Bifida (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2124 Down Syndrome (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2125 Down Syndrome (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2126 Fetal Down Syndrome (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2127 Fetal Down Syndrome (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2128 Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2129 Bacteremia (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2130 Bacteremia (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2131 Gastroschisis (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2132 Gastroschisis (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2133 Fatal Familial Insomnia (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2134 Fatal Familial Insomnia (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2135 Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2136 Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2137 Prion Disease (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2138 Prion Disease (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2139 Prion Disease (Tests for Abnormal PRNP Gene Variant)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2140 Phenylketonuria (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2141 Phenylketonuria (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2142 Linezolid (RXNORM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2143 Tuberculosis (Pretomanid) (RXNORM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2144 Tuberculosis (Bedaquiline) (RXNORM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2145 Tuberculosis [Suspected] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2146 Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2147 Limb Reduction (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2148 Limb Reduction (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2149 NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2150 Congenital Hearing Loss (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2151 Congenital Hearing Loss (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2152 Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2153 Primary Congenital Hypothyroidism (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2154 Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2155 Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2156 Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2157 Mpox (Combination Tests that include mpox virus Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2158 Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2159 Mpox (Test Panels for mpox virus Nucleic Acid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.216 Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody])active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2160 Orthopox (Test Panels for orthopoxvirus Nucleic Acid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2161 COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2163 Dengue Virus Infection [Suspected] (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2164 Mumps [Suspected] (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2165 Pertussis [Suspected] (Disorders) (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2166 Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2167 Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2168 Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2169 Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2170 Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2171 Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2172 Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2173 Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2174 Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2175 Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2176 Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2177 Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2178 Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2179 Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.218 Listeriosis (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2180 Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2181 Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2183 Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2187 Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2188 Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2189 Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2190 Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2192 Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2193 Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2194 Organisms (Combination Tests by Culture and Identification)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2195 Organisms (Combination Tests for Nucleic Acid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2196 Lung Tissue (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2197 Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2198 Anaplasmosis (Disorders) (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2199 NU_Organisms (Tests in Specimen from Wound by Culture and Identification Methodactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2200 Organisms (Tests by Animal Inoculation Method)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2201 Agricultural Chemical Poisoning [Unspecified Chemical] (Disorders) (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2202 Abnormal Lung Sounds (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2203 Abnormal Lung Sounds (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2204 Anemia [Unspecified Cause] (SNOMED)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2205 Anemia [Unspecified Cause] (ICD10CM)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2206 Creatinine (Tests in Serum by Any Method)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2207 Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2208 Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2209 Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2210 Histopathology or Cytopathology Tests by Microscopic Observationactive2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2211 Ehrlichiosis (Tests for Ehrlichia species IgG Antibody)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2212 Invasive Cronobacter Infection (Organism or Substance in Lab Results)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2213 Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2214 Necrotizing Enterocolitis (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2215 Necrotizing Enterocolitis (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2216 Abscess [Brain] (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2217 Abscess [Brain] (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2218 Urinary Tract Infection (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2219 Urinary Tract Infection (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2220 Amniotic Fluid (Specimen Type) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2221 Congenital Cytomegalovirus (Organism or Substance in Lab Results)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2222 Organisms (Tests in Amniotic Fluid by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2223 Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2224 Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2225 Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2226 Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2227 Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2228 Congenital Cytomegalovirus (Tests for CMV Antigen)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2229 Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2230 Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2231 Congenital Cytomegalovirus Infection (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2232 Congenital Cytomegalovirus Infection (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2233 Cytomegalovirus Disease (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2234 Cytomegalovirus Disease (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2235 Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2236 Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2237 Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2238 Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2239 Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2240 Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2241 Stillbirth (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2242 Stillbirth (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2243 Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2244 Candida species (Tests by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2245 Organisms (Tests in Extrapulmonary Specimen by Culture and Identification)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2246 Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2247 Extrapulmonary [NTM] (Specimen Type) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2248 Plasmodium species (Tests by Microscopic Observation)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2249 Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2250 Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2251 Organisms (Tests in Sputum Specimen by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2252 Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2253 Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] )active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2254 Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2255 Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2256 CP_CRE (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2257 Organisms (Tests in Stool by Culture and Identification Method)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2258 Loss of Consciousness (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2259 Neonatal Abstinence Syndrome (Disorders) (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.226 Lyme Disease (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2260 Neonatal Abstinence Syndrome (Disorders) (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2261 High Pitched Cry (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2262 Inability to Console (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2263 Inability to Console (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2264 Hypertonia (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2265 Hypertonia (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2266 Tremors (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2267 Tremors (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2268 Myoclonus (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2269 Myoclonus (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.227 Lyme Disease (Disorders) (ICD10CM)active2023-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2270 Poor Sleep (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2271 Poor Sleep (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2272 Alterations in Feeding (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2273 Alterations in Feeding (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2274 Excoriation (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2275 Excoriation (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2276 Sneezing (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2277 Sneezing (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2278 Nasal Congestion (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2279 Nasal Congestion (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2280 Yawning (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2281 Cutaneous Mottling (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2282 Sweating (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2283 Sweating (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2284 Feeding Intolerance (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2285 Feeding Intolerance (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2286 Respiratory Distress or Nasal Flaring (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2287 Respiratory Distress or Nasal Flaring (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2288 In Utero Exposure to Opioids, Benzodiazepines, or Barbiturates (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2289 In Utero Substance Exposure (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2290 In Utero Substance Exposure (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2291 Childbirth (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2292 Childbirth (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2293 Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2294 NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2295 Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2296 NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2297 Exposure or suspected exposure to harmful algae or algae toxins (SNOMED)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2298 Exposure or suspected exposure to harmful algae or algae toxins (ICD10CM)active2024-01
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2299 Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2300 Babesia species (Tests by Microscopic Observation)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2301 Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2302 Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2303 Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2304 Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2305 Gram_negative Diplococcus (Organism or Substance in Lab Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2306 Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2307 D_Transposition of the Great Arteries (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2308 L_Transposition of the Great Arteries (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2309 Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2310 Transposition of the Great Arteries [Unspecified] (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2311 Interrupted Aortic Arch (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2312 Interrupted Aortic Arch (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2313 Coarctation of the Aorta (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2314 Coarctation of the Aorta (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2315 Ebstein Anomaly (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2316 Ebstein Anomaly (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2317 Pulmonary valve atresia (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2318 Pulmonary valve atresia (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2319 Pulmonary valve stenosis (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2320 Pulmonary valve stenosis (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2321 Fetal Pulmonary valve stenosis (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2322 Double Outlet Right Ventricle (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2323 Double Outlet Right Ventricle (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2324 Hypoplastic left heart syndrome (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2325 Hypoplastic left heart syndrome (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2326 Single Ventricle (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2327 Single Ventricle (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2328 Tetralogy of Fallot (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2329 Tetralogy of Fallot (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2330 Truncus Arteriosus (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2331 Truncus Arteriosus (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2332 Atrioventricular septal defect (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2333 Atrioventricular septal defect (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2334 Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2335 Total Anomalous Pulmonary Venous Connection (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2336 Tricuspid valve atresia (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2337 Tricuspid valve atresia (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2338 Tricuspid valve stenosis (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2339 Tricuspid valve stenosis (Disorders) (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2340 Fetal Tricuspid valve stenosis (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2341 Exposure to Measles (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2342 Increased Risk for Exposure to Measles (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2343 Giardiasis (Tests by Microscopic Observation)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2344 Diphtheria (Tests for Diphtheria Toxin Nucleic Acid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2345 Lead in Blood (Tests for Lead in Venous Blood)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2346 Lead in Blood (Tests for Lead in Capillary Blood)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2347 Opioid Overdose and Poisoning (Test Panels for Opioids)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2348 Rubella (Test Panels for rubella virus IgM Antibody)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2349 Consistent with Tuberculosis (Finding in Chest Xray Imaging Results)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2350 Acute Viral Hepatitis (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2351 Shigellosis (Combination Tests that include Shigella species by Culture and Identification)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2352 Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2353 Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2354 Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2355 Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2356 Skin (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2357 Organisms (Tests by Microscopic Observation in Skin)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2358 Unspecified Tissue (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2359 Organisms (Tests by Microscopic Observation in Unspecified Tissue)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2360 S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2361 S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2362 Tuberculosis (Ethambutol) (RXNORM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2363 Tuberculosis (Isoniazid [INH]) (RXNORM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2364 Tuberculosis (Pyrazinamide [PZA]) (RXNORM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2365 Tuberculosis (Rifabutin) (RXNORM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2366 Tuberculosis (Rifampin) (RXNORM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2367 Tuberculosis (Rifapentine) (RXNORM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2368 Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2369 Necrotizing Fasciitis (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2370 Necrotizing Fasciitis (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2371 Renal Impairment [Acute or Unspecified] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2372 Renal Impairment [Acute or Unspecified] (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2373 Coagulopathy [Unspecified Cause] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2374 Coagulopathy [Unspecified Cause] (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2375 Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2376 Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2377 Soft Tissue Necrosis (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2378 Soft Tissue Necrosis (ICD10CM)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2379 Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2380 Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2381 Specimen from a Nonsterile Site (Specimen Type) (SNOMED)active2024-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2382 Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2383 Absence of Skin Lesions (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2384 Neuralgia (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2385 Neuralgia (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2386 Peripheral Nerve Thickening (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2387 Nerve (Specimen Type) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2388 Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.239 Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.240 Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen)active2023-06
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2403 NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2404 Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2405 Hepatitis D Virus Infection (Test for hepatitis D virus Antigen)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2406 Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2407 Firearm Injury (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2408 Firearm Injury (Disorders) (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2409 Babesiosis (Tests for B. microti IgG or Total Antibody [Titer])active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2410 Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer])active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2411 Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer])active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2412 Babesiosis (Tests for Babesia species IgG or Total Antibody)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2413 Brucellosis (Tests for Brucella species IgG Antibody by ELISA)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2414 Cranial Nerve Involvement (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2415 Cranial Nerve Involvement (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2416 Unusual Change in Behavior (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2417 Radiculitis (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2418 Subarachnoid Hemorrhage (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2419 Subarachnoid Hemorrhage (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2420 Discitis (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2421 Discitis (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2423 Respiratory Insufficiency [Unspecified Cause] (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2424 Respiratory Insufficiency [Unspecified Cause] (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2425 Conjunctival Suffusion (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2426 Leptospira species (Tests by Microscopic Observation)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2427 Leptospirosis (Tests for Leptospira Antibody by Agglutination)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2428 Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2429 Conjunctival Suffusion (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2430 Pleural effusion (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2431 Pleural effusion (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2432 Abdominal swelling (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2433 Abdominal swelling (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2434 Neck swelling (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2435 Neck swelling (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2436 Diaphoresis (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2437 Diaphoresis (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2438 Edema (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2439 Edema (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.244 Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2440 Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2441 Anthrax (Tests for Bacillus species by Culture and Identification Method)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2442 Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2443 Influenza A (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2444 Influenza B (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2445 Influenza [Unspecified] (Disorders) (SNOMED)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2446 Influenza A (Disorders) (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2447 Influenza [Unspecified] (Disorders) (ICD10CM)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2448 Influenza (Tests for unspecified influenza virus Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2449 Influenza (Tests for influenza B virus Nucleic Acid)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2450 Influenza (Tests for unspecified influenza virus Antigen)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2451 Influenza (Tests for influenza B virus Antigen)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2452 Influenza (unspecified influenza virus in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2453 Influenza (influenza B virus in Lab Results)active2025-02
us.nlm.vsacR4http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2454 Influenza (Tests for unspecified influenza virus by Culture and Identification Method)active2025-02

XIG built as of 16 Jun 2025. Found 77352 resources in 1241 packages.